Details of Disease

General Information of Disease (ID: DISVZBI4)

• Disease Name: Neuroblastoma
• Synonyms: NB; neuroblastoma; neural Crest tumor, malignant; neuroblastoma (Schwannian Stroma-poor); neuroblastoma, malignant
• Disease Class: 2D11: Adrenal cancer
• Definition: Neuroblastoma (NB) is the most common solid, extracranial childhood tumor. It is an aggressive pediatric cancer that originates from neural crest tissues of the sympathetic nervous system.|NB is a disease of the sympaticoadrenal lineage of the neural crest, with tumors forming anywhere in the sympathetic nervous system. The tumors most commonly arise in the abdomen (65%), however, they also occur in the neck, chest, and pelvis. Approximately 50% of patients present with evidence of metastasis. Frequent metastasis sites include cortical bone, bone marrow, liver, and lymph nodes. The most common genetic change is MYCN amplification, which occurs in approximately 20% of patients, and is strongly correlated with advanced stage NB. Additionally, deletions of the short arm of chromosome 1 (1p) are found in 25?5% of patients and can be correlated with MYCN amplification. Outside of MYC linked changes, allelic loss of 11q is present in 35?5% of patients and is also associated with high-risk disease features.
• Disease Hierarchy:
  DISKWPS1: Neuroblastic tumor
  DIS2IQBH: Neurocristopathy
  DISVZBI4: Neuroblastoma
• ICD Code:
  ICD-11: ICD-11: 2D11.2
  ICD-9: ICD-9: 194
  Expand ICD-9: 194
• Disease Identifiers:
  MONDO ID: MONDO_0005072
  MESH ID: D009447
  UMLS CUI: C0027819
  MedGen ID: 18012
  HPO ID: HP:0003006
  Orphanet ID: 635
  SNOMED CT ID: 432328008

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 24 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Alemtuzumab	DMZL3IV	Approved	Antibody	[1]
Busulfan	DMXYJ9C	Approved	Small molecular drug	[2]
Carboplatin	DMG281S	Approved	Small molecular drug	[3]
Cyclophosphamide	DM4O2Z7	Approved	Small molecular drug	[4]
Dacarbazine	DMNPZL4	Approved	Small molecular drug	[5]
Doxorubicin	DMVP5YE	Approved	Small molecular drug	[6]
Entrectinib	DMMPTLH	Approved	Small molecular drug	[7]
Erlotinib	DMCMBHA	Approved	Small molecular drug	[8]
Etoposide	DMNH3PG	Approved	Small molecular drug	[9]
Everolimus	DM8X2EH	Approved	Small molecular drug	[10]
Fludarabine	DMVRLT7	Approved	Small molecular drug	[11]
Ifosfamide	DMCT3I8	Approved	Small molecular drug	[12]
Irinotecan	DMP6SC2	Approved	Small molecular drug	[13]
Isotretinoin	DM4QTBN	Approved	Small molecular drug	[14]
Melphalan	DMOLNHF	Approved	Small molecular drug	[15]
Naxitamab	DMXB7V8	Approved	NA	[16]
Pertuzumab	DMHJV0X	Approved	Monoclonal antibody	[1]
Sirolimus	DMGW1ID	Approved	Small molecular drug	[17]
Temozolomide	DMKECZD	Approved	Small molecular drug	[18]
Thiotepa	DMIZKOP	Approved	Small molecular drug	[19]
Topotecan	DMP6G8T	Approved	Small molecular drug	[20]
Tretinoin	DM49DUI	Approved	Small molecular drug	[21]
Vidarabine	DM0N85H	Approved	Small molecular drug	[22]
Vincristine	DMINOX3	Approved	Small molecular drug	[23]

This Disease is Treated as An Indication in 28 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Ch14.18 mab	DMMDBF5	Phase 3	Monoclonal antibody	[24]
131 I-omburtamab	DM12UX6	Phase 2/3	Antibody	[25]
C-Cure	DMLDN6J	Phase 2/3	NA	[26]
Dinutuximab	DMWBWNG	Phase 2/3	NA	[27]
Omburtamab	DMTIESG	Phase 2/3	Antibody	[25]
Omburtamab I-131	DMPDA17	Phase 2/3	NA	[28]
Anti-GD2 CART	DMVQHBK	Phase 2	CAR T Cell Therapy	[29]
APN-301	DM32YTJ	Phase 2	NA	[30]
APN301	DMGNFBC	Phase 2	Antibody	[31]
GD2-GD3 vaccine	DMQ3S7Q	Phase 2	Vaccine	[32]
Hu3F8 mAb	DM9MKQ5	Phase 2	NA	[30]
Metaiodobenzylguanidine I-131	DMNST69	Phase 2	Small molecular drug	[33]
SARTATE	DMAXB1A	Phase 2	Radiopharmaceutical	[34]
67Cu-SARTATE	DMJ8UXO	Phase 1/2	Small molecular drug	[35]
BEL-0222	DMHGDOO	Phase 1/2	NA	[7]
CUDC-907	DMHIQDC	Phase 1/2	Small molecular drug	[36]
GD2-CART01	DM5VF04	Phase 1/2	CAR T Cell Therapy	[37]
Anti-GD2 T-cells (1RG-CART)	DMBVUFL	Phase 1	CAR T Cell Therapy	[38]
Anti-GD2-CAR engineered T cells	DMCNFZG	Phase 1	CAR T Cell Therapy	[39]
C7R-GD2.CART cells	DMSO3JA	Phase 1	CAR T Cell Therapy	[40]
CD171 specific CAR T cells expressing EGFRt	DM2AHXW	Phase 1	CAR T Cell Therapy	[41]
GD2 T cells	DM9TD2N	Phase 1	CAR T Cell Therapy	[42]
IC9-GD2-CD28-OX40	DMRYHWA	Phase 1	CAR T Cell Therapy	[43]
IC9.GD2.CAR.IL-15 T-cells	DMMPFZO	Phase 1	CAR T Cell Therapy	[44]
JCAR023	DM324RM	Phase 1	NA	[30]
KUR-501	DMKMN5R	Phase 1	CAR-NKT Cell therapy	[45]
LY294002	DMY1AFS	Phase 1	Small molecular drug	[46]
GD2-targeted CAR-T cells	DM87BTM	Clinical trial	CAR T Cell Therapy	[47]

This Disease is Treated as An Indication in 1 Investigative Agents

Drug Name	Drug ID	Highest Status	Drug Type	REF
Valproic Acid	DMS49KH	Investigative	Small molecular drug	[48]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 657 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ABCC4	TTUEAFL	Limited	Biomarker	[49]
ACVRL1	TTGYPTC	Limited	Genetic Variation	[50]
ADAM17	TT6AZXG	Limited	Biomarker	[51]
ADCY2	TTBQ9IM	Limited	Altered Expression	[52]
ADH1A	TT5AHZ0	Limited	Biomarker	[53]
ADM	TTV14YH	Limited	Altered Expression	[54]
ADRA2A	TTWG9A4	Limited	Altered Expression	[55]
AIMP2	TTXWHGF	Limited	Altered Expression	[56]
AKT2	TTH24WI	Limited	Biomarker	[57]
ALCAM	TT2AFT6	Limited	Altered Expression	[58]
ALOX15	TTN9T81	Limited	Altered Expression	[59]
ALPI	TTHYMUV	Limited	Biomarker	[60]
ANG	TTURHFP	Limited	Genetic Variation	[61]
ANXA5	TT2Z83I	Limited	Biomarker	[62]
APOE	TTKS9CB	Limited	Biomarker	[63]
ASIC1	TTRJYB6	Limited	Biomarker	[64]
ATAT1	TTWUHQ1	Limited	Biomarker	[65]
ATG7	TTLVB9Z	Limited	Biomarker	[66]
ATRAID	TTFLIKM	Limited	Biomarker	[67]
AXL	TTZPY6J	Limited	Genetic Variation	[68]
BACE1	TTJUNZF	Limited	Altered Expression	[69]
BAK1	TTFM7V0	Limited	Biomarker	[70]
BAZ2A	TT2MV0R	Limited	Biomarker	[71]
BCL11A	TTR61MW	Limited	Altered Expression	[72]
BGN	TT0JPVF	Limited	Biomarker	[73]
BLK	TTNDSC3	Limited	Biomarker	[74]
BMPR2	TTGKF90	Limited	Biomarker	[75]
BRD4	TTSRAOU	Limited	Biomarker	[76]
C1QBP	TTWTD7F	Limited	Genetic Variation	[77]
C9orf72	TTA4SHR	Limited	Biomarker	[78]
CA2	TTANPDJ	Limited	Genetic Variation	[79]
CACNA1C	TTZIFHC	Limited	Altered Expression	[80]
CAMKK2	TTV298Y	Limited	Biomarker	[81]
CASR	TTBUYHA	Limited	Genetic Variation	[82]
CCNE1	TTCEJ4F	Limited	Biomarker	[83]
CCR6	TTFDB30	Limited	Posttranslational Modification	[84]
CD248	TTYJWT7	Limited	Altered Expression	[85]
CD276	TT6CQUM	Limited	Biomarker	[86]
CD80	TT89Z17	Limited	Altered Expression	[87]
CD9	TTZEIBV	Limited	Biomarker	[88]
CDC20	TTBKFDV	Limited	Posttranslational Modification	[89]
CDK7	TTQYF7G	Limited	Altered Expression	[90]
CDKN1C	TTBSUAR	Limited	Genetic Variation	[91]
CDKN2C	TTBRUGA	Limited	Biomarker	[92]
CENPE	TTZD5QR	Limited	Biomarker	[93]
CFLAR	TTJZQYH	Limited	Posttranslational Modification	[84]
CHRNA7	TTLA931	Limited	Biomarker	[94]
CLN3	TTORF9W	Limited	Altered Expression	[95]
CMKLR1	TT4UGZL	Limited	Biomarker	[96]
COASY	TT4YO0Z	Limited	Posttranslational Modification	[97]
CRBN	TTDKGTC	Limited	Altered Expression	[98]
CRHR1	TT7EFHR	Limited	Biomarker	[99]
CRK	TTFEUYR	Limited	Altered Expression	[56]
CRLF1	TT6YF5K	Limited	Biomarker	[100]
CRYZ	TTP6UO8	Limited	Biomarker	[101]
CS	TTZA6B3	Limited	Altered Expression	[102]
CSF3R	TTC70AJ	Limited	Altered Expression	[103]
CSNK1E	TTA8PLI	Limited	Biomarker	[104]
CTCFL	TTY0RZT	Limited	Biomarker	[105]
CTSD	TTPT2QI	Limited	Altered Expression	[106]
CYP3A5	TTHS0OK	Limited	Biomarker	[107]
DAPK3	TTERVQN	Limited	Altered Expression	[108]
DFFA	TTYVQ9C	Limited	Biomarker	[109]
DICER1	TTTEOPU	Limited	Biomarker	[110]
DKK1	TTE3RAC	Limited	Altered Expression	[111]
DLG4	TT9PB26	Limited	Altered Expression	[112]
DOT1L	TTSZ8T1	Limited	Biomarker	[113]
DUSP5	TTZN92A	Limited	Biomarker	[114]
E2F1	TTASI04	Limited	Altered Expression	[115]
ECE2	TT5U914	Limited	Biomarker	[116]
EGR1	TTE8LGD	Limited	Altered Expression	[117]
EHMT2	TTS6RZT	Limited	Biomarker	[118]
EIF2AK3	TT79U1M	Limited	Biomarker	[119]
EML4	TT92GY4	Limited	Biomarker	[120]
EPHA2	TTRJB2G	Limited	Biomarker	[121]
EPHB1	TT8MDAC	Limited	Biomarker	[122]
EPHB2	TTKPV6O	Limited	Biomarker	[57]
ERAP2	TTVGS1C	Limited	Biomarker	[123]
ERBB4	TTWALCO	Limited	Genetic Variation	[124]
ESRRA	TTPNQAC	Limited	Altered Expression	[125]
ETS1	TTTGPSD	Limited	Biomarker	[126]
FDXR	TT3W4IX	Limited	Biomarker	[127]
FFAR1	TTB8FUC	Limited	Altered Expression	[128]
FGF21	TTQ916P	Limited	Biomarker	[129]
FLT3	TTGJCWZ	Limited	Genetic Variation	[130]
FOSL1	TTY8LZG	Limited	Biomarker	[131]
FPR1	TT5Y4EM	Limited	Biomarker	[132]
FUS	TTKGYZ9	Limited	Biomarker	[133]
G6PC	TTBQMJ8	Limited	Altered Expression	[134]
GABRB2	TTZA1NY	Limited	Altered Expression	[135]
GADD45B	TTMDW9L	Limited	Biomarker	[121]
GBA	TT1B5PU	Limited	Altered Expression	[136]
GCLM	TTNFESW	Limited	Altered Expression	[137]
GDF2	TTAP4T1	Limited	Biomarker	[138]
GDF5	TT37XV9	Limited	Biomarker	[139]
GDNF	TTF23ML	Limited	Altered Expression	[140]
GFRA3	TT63XRS	Limited	Altered Expression	[141]
GJA5	TTFQKZ7	Limited	Genetic Variation	[142]
GLI1	TTJOMH6	Limited	Biomarker	[143]
GLI2	TT045OH	Limited	Biomarker	[143]
GLP1R	TTVIMDE	Limited	Biomarker	[144]
GLRX	TTRJCNG	Limited	Altered Expression	[145]
GPA33	TT96HUR	Limited	Biomarker	[146]
GRM1	TTVBPDM	Limited	Biomarker	[147]
GRN	TT0LWE3	Limited	Altered Expression	[148]
GRPR	TTC1MVT	Limited	Biomarker	[149]
GUSB	TTHS7CM	Limited	Biomarker	[150]
HBB	TTM6HK1	Limited	Altered Expression	[151]
HBEGF	TT15SL0	Limited	Altered Expression	[152]
HCRTR1	TT60Q8D	Limited	Altered Expression	[153]
HDAC10	TTYHPU6	Limited	Biomarker	[154]
HDAC11	TT8K17W	Limited	Biomarker	[155]
HDAC2	TTSHTOI	Limited	Biomarker	[156]
HDAC6	TT5ZKDI	Limited	Biomarker	[157]
HLA-G	TTLKFB3	Limited	Biomarker	[158]
HNF4A	TT2F3CD	Limited	Altered Expression	[159]
HNRNPA1	TTPJ9XK	Limited	Biomarker	[160]
HPSE	TTR7GJO	Limited	Biomarker	[150]
HSPB8	TTY0OJN	Limited	Altered Expression	[161]
HSPE1	TTWYMFE	Limited	Altered Expression	[162]
HTR2A	TTJQOD7	Limited	Altered Expression	[163]
HTT	TTIWZ0O	Limited	Biomarker	[164]
IAPP	TTHN8EM	Limited	Biomarker	[60]
ID2	TTW8A5N	Limited	Altered Expression	[165]
IFNAR1	TTSYFMA	Limited	Biomarker	[166]
IGFBP5	TTDWEA8	Limited	Biomarker	[167]
IGFBP6	TTLAYV8	Limited	Biomarker	[168]
IL15	TTJFA35	Limited	Biomarker	[169]
IL2	TTF89GD	Limited	Biomarker	[170]
IL24	TT1EPXZ	Limited	Altered Expression	[171]
IL31RA	TT9HPX0	Limited	Genetic Variation	[172]
IRAK1	TTXAJWN	Limited	Altered Expression	[173]
IRS2	TTF95B8	Limited	Biomarker	[174]
ITGA2	TTSJ542	Limited	Biomarker	[175]
ITGA4	TTJMF9P	Limited	Biomarker	[176]
ITGAV	TTT1R2L	Limited	Biomarker	[177]
KAT2B	TTVK7SB	Limited	Biomarker	[178]
KCNH2	TTQ6VDM	Limited	Biomarker	[179]
KITLG	TTDJ51N	Limited	Biomarker	[180]
KLRK1	TTLRN4A	Limited	Biomarker	[181]
KNG1	TTDJ4MY	Limited	Biomarker	[182]
KRAS	TTM8FR7	Limited	Genetic Variation	[120]
L1CAM	TTC9D3K	Limited	Altered Expression	[183]
LAG3	TTNVXAW	Limited	Biomarker	[184]
LCK	TT860QF	Limited	Biomarker	[185]
LDHA	TTW76JE	Limited	Altered Expression	[186]
LDLR	TTH0DUS	Limited	Biomarker	[187]
LGR5	TTTSGRH	Limited	Biomarker	[188]
LIMK2	TTASMD8	Limited	Altered Expression	[189]
LRRK2	TTK0FEA	Limited	Genetic Variation	[190]
MAGEA1	TT63M7Q	Limited	Biomarker	[191]
MAGEA3	TTWSKHD	Limited	Biomarker	[191]
MANF	TT56RYE	Limited	Biomarker	[192]
MAP2K7	TT6QY3J	Limited	Biomarker	[193]
MAP3K1	TTW8TJI	Limited	Altered Expression	[194]
MAPK10	TT056SO	Limited	Altered Expression	[175]
MAPK14	TTQBR95	Limited	Altered Expression	[56]
MAPK3	TT1MG9E	Limited	Altered Expression	[195]
MAPK7	TTU6FSC	Limited	Biomarker	[120]
MAPKAPK2	TTMUG9D	Limited	Altered Expression	[196]
MAPT	TTS87KH	Limited	Biomarker	[197]
MAZ	TT059DA	Limited	Biomarker	[198]
MCAM	TTHRE05	Limited	Altered Expression	[199]
MCHR1	TTX4RTB	Limited	Altered Expression	[200]
MGAT2	TTJOW1I	Limited	Biomarker	[201]
MLH1	TTISG27	Limited	Biomarker	[202]
MSH2	TTCAWRT	Limited	Biomarker	[202]
MSR1	TT2TDH9	Limited	Biomarker	[178]
MTDH	TTH6SA5	Limited	Biomarker	[203]
NCAM1	TTVXPHT	Limited	Biomarker	[204]
NGF	TTDN3LF	Limited	Posttranslational Modification	[205]
NGFR	TTEDJN4	Limited	Biomarker	[206]
NOX4	TTQRBSJ	Limited	Biomarker	[207]
NPFFR2	TTXYNDJ	Limited	Biomarker	[208]
NPTX2	TTNJ5A6	Limited	Biomarker	[209]
NPY	TT64REZ	Limited	Biomarker	[210]
NPY1R	TTRK9JT	Limited	Altered Expression	[211]
NPY2R	TTJ6WK9	Limited	Biomarker	[212]
NPY5R	TTY6EWA	Limited	Biomarker	[212]
NQO2	TTJLP0R	Limited	Altered Expression	[213]
NTF3	TTZHKV9	Limited	Altered Expression	[214]
NTN1	TT0AH4L	Limited	Biomarker	[215]
OGDH	TTH8T6I	Limited	Biomarker	[216]
OPRK1	TTQW87Y	Limited	Biomarker	[217]
OPRM1	TTKWM86	Limited	Altered Expression	[218]
OXTR	TTSCIUP	Limited	Biomarker	[219]
P2RX1	TTJW7B3	Limited	Altered Expression	[220]
P2RX3	TT2THBD	Limited	Altered Expression	[220]
P2RX4	TT1NLOA	Limited	Altered Expression	[220]
P2RY1	TTA93TL	Limited	Altered Expression	[220]
P2RY2	TTOZHQC	Limited	Altered Expression	[220]
PADI4	TTQHAXM	Limited	Altered Expression	[221]
PARP1	TTVDSZ0	Limited	Biomarker	[222]
PARP2	TTQ4V96	Limited	Altered Expression	[223]
PARP3	TTD8MEH	Limited	Biomarker	[224]
PAWR	TT3I4WV	Limited	Altered Expression	[225]
PDK1	TTCZOF2	Limited	Altered Expression	[226]
PDXP	TT9UYG4	Limited	Biomarker	[227]
PEBP1	TT1BGU8	Limited	Biomarker	[228]
PIM1	TTTN5QW	Limited	Biomarker	[229]
PLA2G2A	TTO8QRU	Limited	Biomarker	[230]
PLA2G4A	TTT1JVS	Limited	Altered Expression	[231]
PLCB1	TTLPGU7	Limited	Altered Expression	[232]
PNPLA6	TTWAQU2	Limited	Altered Expression	[233]
PPARD	TT2JWF6	Limited	Altered Expression	[234]
PPM1D	TTENJAB	Limited	Altered Expression	[235]
PPT1	TTSQC14	Limited	Biomarker	[236]
PRDX5	TTLPJWH	Limited	Biomarker	[237]
PRKCZ	TTBSN0L	Limited	Biomarker	[238]
PRNP	TTY5F9C	Limited	Altered Expression	[239]
PSEN1	TTZ3S8C	Limited	Genetic Variation	[240]
PTGES	TTYLQ8V	Limited	Biomarker	[241]
PTH1R	TTFPD47	Limited	Biomarker	[242]
PTK2	TTON5IT	Limited	Biomarker	[243]
PTN	TTA9EJK	Limited	Altered Expression	[244]
PTPN11	TT7WUAV	Limited	Genetic Variation	[245]
RAB7A	TTF6WAQ	Limited	Biomarker	[246]
RACK1	TTJ10AL	Limited	Biomarker	[247]
RALBP1	TTVSRUA	Limited	Biomarker	[248]
RECK	TTRZBW7	Limited	Biomarker	[249]
RHO	TTH0KSX	Limited	Biomarker	[250]
ROCK1	TTZN7RP	Limited	Biomarker	[251]
RORA	TT1TYN7	Limited	Altered Expression	[252]
ROS1	TTSZ6Y3	Limited	Biomarker	[253]
RPSA	TTLUW5B	Limited	Biomarker	[254]
RUNX3	TTKCVO7	Limited	Altered Expression	[255]
S100A6	TT716MY	Limited	Biomarker	[256]
SCG3	TTY5R9H	Limited	Biomarker	[257]
SELPLG	TTS5K8U	Limited	Biomarker	[258]
SENP1	TTW9HY5	Limited	Biomarker	[259]
SIRPA	TTBRJS9	Limited	Biomarker	[260]
SIRT5	TTH0IOD	Limited	Biomarker	[261]
SLC12A3	TTP362L	Limited	Genetic Variation	[262]
SLC18A2	TTNZRI3	Limited	Altered Expression	[263]
SLC19A1	TT09I7D	Limited	Biomarker	[264]
SLC1A1	TTG2A6F	Limited	Altered Expression	[265]
SLC6A3	TTVBI8W	Limited	Biomarker	[266]
SLC6A8	TTYUHB5	Limited	Altered Expression	[267]
SMC2	TTS8D17	Limited	Biomarker	[268]
SNAP25	TTYQWA0	Limited	Biomarker	[269]
SOX5	TTXHSZK	Limited	Biomarker	[270]
SPTBN1	TTS9BDA	Limited	Genetic Variation	[271]
SST	TTWF7UG	Limited	Biomarker	[272]
ST8SIA4	TTDP8YM	Limited	Biomarker	[273]
STAB1	TTJFEOC	Limited	Altered Expression	[274]
SULF2	TTLQTHB	Limited	Biomarker	[275]
TACR1	TTZPO1L	Limited	Altered Expression	[276]
TARDBP	TT9RZ03	Limited	Altered Expression	[277]
TBXA2R	TT2O84V	Limited	Biomarker	[278]
THRA	TTTSEPU	Limited	Biomarker	[279]
TMPRSS15	TTXL0GC	Limited	Biomarker	[280]
TMSB4X	TTMVAIU	Limited	Altered Expression	[281]
TNFRSF25	TTDV6BQ	Limited	Biomarker	[282]
TNKS	TTVUSO7	Limited	Biomarker	[283]
TPH1	TTZSJHV	Limited	Altered Expression	[284]
TPT1	TT3PTB6	Limited	Altered Expression	[285]
TRH	TT2Z39D	Limited	Genetic Variation	[286]
TRPA1	TTELV3W	Limited	Biomarker	[287]
TXN	TTZJ5U9	Limited	Biomarker	[288]
TXNRD1	TTR7UJ3	Limited	Biomarker	[289]
UBE3A	TTUZX6V	Limited	Biomarker	[290]
UTRN	TTNO1VA	Limited	Biomarker	[291]
VHL	TTEMWSD	Limited	Altered Expression	[292]
VIP	TTGTWLF	Limited	Biomarker	[293]
WDR5	TT7OFWB	Limited	Altered Expression	[294]
XIAP	TTK3WBU	Limited	Altered Expression	[295]
ADK	TTL732K	Disputed	Biomarker	[195]
CA1	TTHQPL7	Disputed	Biomarker	[296]
CDKL1	TTBTI6P	Disputed	Biomarker	[297]
CHN2	TT39YVO	Disputed	Biomarker	[298]
GSTO1	TTWO3SH	Disputed	Biomarker	[299]
HOXA7	TTMRE4Q	Disputed	Biomarker	[300]
MGLL	TTZ963I	Disputed	Altered Expression	[301]
PHB	TT6U071	Disputed	Biomarker	[302]
PRMT1	TTVOJAI	Disputed	Biomarker	[303]
PTK2B	TTTEFBV	Disputed	Biomarker	[304]
SEMA3A	TTVKD3S	Disputed	Biomarker	[305]
SLC34A2	TTQPZTM	Disputed	Biomarker	[306]
SREBF1	TTER0UB	Disputed	Altered Expression	[69]
TPP1	TTOVYPT	Disputed	Biomarker	[307]
TRIM59	TT613U4	Disputed	Biomarker	[62]
USP14	TTVSYP9	Disputed	Biomarker	[308]
ABCB4	TTJUXV6	moderate	Altered Expression	[309]
ADH7	TT3LE7P	moderate	Biomarker	[310]
ALOX12	TT12ABZ	moderate	Biomarker	[311]
AMACR	TTLN1AP	moderate	Biomarker	[312]
APEH	TTYWEDQ	moderate	Biomarker	[313]
BCL2L2	TTQ79W8	moderate	Altered Expression	[314]
BIRC2	TTQ5LRD	moderate	Altered Expression	[315]
BMP6	TT07RIB	moderate	Biomarker	[316]
C5	TTKANGO	moderate	Altered Expression	[317]
C5AR1	TTHXFA1	moderate	Altered Expression	[317]
CDC25B	TTR0SWN	moderate	Biomarker	[318]
CDH2	TT1WS0T	moderate	Altered Expression	[319]
CDH5	TTXLCFO	moderate	Altered Expression	[320]
CDK5R1	TTBYM6V	moderate	Biomarker	[321]
CHM	TTOA18V	moderate	Genetic Variation	[322]
CMA1	TT8VUE0	moderate	Biomarker	[323]
CXCR5	TTIW59R	moderate	Biomarker	[324]
DFFB	TT2SRE0	moderate	Genetic Variation	[325]
DNM2	TTVRA5G	moderate	Biomarker	[326]
ENPP2	TTSCIM2	moderate	Biomarker	[327]
EPCAM	TTZ8WH4	moderate	Biomarker	[328]
EYA2	TTUY9C6	moderate	Biomarker	[329]
FKBP4	TTHY0FT	moderate	Biomarker	[330]
FST	TTDNM9W	moderate	Biomarker	[331]
GCH1	TTLSWP6	moderate	Altered Expression	[332]
HCAR3	TT8WFXV	moderate	Altered Expression	[333]
HEXIM1	TTFOKAH	moderate	Biomarker	[334]
IFNAR2	TTMQB37	moderate	Biomarker	[335]
IL12A	TTRTK6Y	moderate	Biomarker	[321]
IMP3	TTEJA2R	moderate	Altered Expression	[336]
KCNQ4	TT8HGRW	moderate	Biomarker	[337]
KIR2DS2	TTV3CFI	moderate	Biomarker	[338]
LIFR	TTID542	moderate	Altered Expression	[339]
LPAR1	TTQ6S1K	moderate	Biomarker	[340]
MAG	TT9XFON	moderate	Biomarker	[341]
MCHR2	TTS17MG	moderate	Altered Expression	[342]
MET	TTNDSF4	moderate	Altered Expression	[343]
MFGE8	TT1GLAJ	moderate	Biomarker	[344]
MTAP	TTDBX7N	moderate	Biomarker	[345]
NACC1	TT4AQ5F	moderate	Altered Expression	[346]
NES	TTHZ752	moderate	Altered Expression	[347]
NTF4	TTIM2WO	moderate	Biomarker	[348]
P2RY4	TT24DGP	moderate	Biomarker	[349]
P2RY6	TTNVSKA	moderate	Altered Expression	[350]
PAK4	TT7Y3BZ	moderate	Biomarker	[351]
PCSK6	TT75LN9	moderate	Altered Expression	[352]
PGRMC1	TTY3LAZ	moderate	Biomarker	[353]
PHGDH	TT8DRCK	moderate	Biomarker	[354]
PNMT	TT0NZIC	moderate	Altered Expression	[355]
PNP	TTMCF1Y	moderate	Genetic Variation	[356]
PPP2CA	TTHTKNY	moderate	Genetic Variation	[357]
PPP5C	TTTW7FJ	moderate	Altered Expression	[353]
PRKCE	TT57MT2	moderate	Biomarker	[358]
PTGDR	TTNVEIR	moderate	Biomarker	[359]
PTGER2	TT1ZAVI	moderate	Posttranslational Modification	[359]
PTP4A3	TT7YM8D	moderate	Altered Expression	[360]
QPCT	TTJ7YTV	moderate	Genetic Variation	[361]
RAF1	TTAN5W2	moderate	Biomarker	[131]
REL	TT1ZCTH	moderate	Biomarker	[362]
RGS16	TTFRES8	moderate	Biomarker	[363]
RGS2	TTKB7T3	moderate	Altered Expression	[364]
RPS6KA3	TTUM2ZR	moderate	Altered Expression	[365]
RTN4R	TTVRZUO	moderate	Altered Expression	[366]
RUNX1	TTWIN3H	moderate	Biomarker	[367]
RXRB	TTKLV96	moderate	Biomarker	[368]
SAA1	TTY0DN9	moderate	Altered Expression	[369]
SCN1A	TTANOZH	moderate	Altered Expression	[346]
SDHD	TTVH9W8	moderate	Biomarker	[370]
SERPING1	TTVQ6R9	moderate	Biomarker	[371]
SGCB	TTEDCQ0	moderate	Biomarker	[372]
SLC23A2	TTOP832	moderate	Altered Expression	[373]
SLC25A1	TTTD730	moderate	Altered Expression	[374]
SREBF2	TTRQ4AP	moderate	Biomarker	[375]
STC2	TT4EFTR	moderate	Biomarker	[376]
TAF2	TTHMP8B	moderate	Biomarker	[377]
TERF2	TT5XSLT	moderate	Biomarker	[378]
THPO	TTCG5PE	moderate	Biomarker	[379]
TOP1	TTGTQHC	moderate	Genetic Variation	[380]
TOP2A	TTCGY2K	moderate	Biomarker	[381]
TRIM24	TT9Q7AE	moderate	Altered Expression	[382]
TRPM8	TTXDKTO	moderate	Altered Expression	[383]
UCP3	TT12RJK	moderate	Altered Expression	[384]
VIPR1	TTCL30I	moderate	Biomarker	[385]
VIPR2	TT4O5P0	moderate	Altered Expression	[386]
WNT7A	TT8NARC	moderate	Altered Expression	[387]
XPA	TTGT87E	moderate	Biomarker	[388]
ACAT1	TTK3C21	Strong	Biomarker	[389]
ACHE	TT1RS9F	Strong	Biomarker	[390]
ACTG1	TTGAZF9	Strong	Altered Expression	[391]
ADAM10	TTVXEGU	Strong	Altered Expression	[392]
ADRB3	TTMXGCW	Strong	Altered Expression	[393]
AGRP	TT4DE1O	Strong	Biomarker	[394]
AHCY	TTE2KUJ	Strong	Genetic Variation	[395]
AKT3	TTO6SGY	Strong	Altered Expression	[396]
ANXA2	TT4YANI	Strong	Biomarker	[397]
ARG1	TT7ZQEV	Strong	Biomarker	[398]
ARG2	TTV1AG6	Strong	Altered Expression	[56]
ARRB2	TT8SO2I	Strong	Altered Expression	[399]
ASIC2	TTVMWLP	Strong	Biomarker	[400]
ASIC3	TTLGDIS	Strong	Genetic Variation	[401]
ASPA	TT6TLZP	Strong	Biomarker	[402]
ASPH	TT2KHP7	Strong	Altered Expression	[403]
ATF4	TTQCKWT	Strong	Biomarker	[404]
ATR	TT8ZYBQ	Strong	Biomarker	[405]
ATXN3	TT6A17J	Strong	Genetic Variation	[406]
AURKB	TT9RTBL	Strong	Biomarker	[407]
B2M	TTY7FKA	Strong	Biomarker	[408]
BACH1	TT2ME4S	Strong	Biomarker	[409]
BBC3	TT7JUKC	Strong	Biomarker	[410]
BIRC5	TTTPU1G	Strong	Biomarker	[411]
BMI1	TTIPNSR	Strong	Biomarker	[412]
CALCR	TTLWS2O	Strong	Altered Expression	[413]
CALR	TTUZ7OA	Strong	Biomarker	[267]
CASP1	TTCQIBE	Strong	Biomarker	[414]
CASP2	TT12VNG	Strong	Altered Expression	[415]
CASP4	TT6KIOT	Strong	Biomarker	[416]
CCK	TT90CMU	Strong	Altered Expression	[417]
CD19	TTW640A	Strong	Biomarker	[418]
CD24	TTCTYNP	Strong	Altered Expression	[419]
CD47	TT28S46	Strong	Biomarker	[420]
CD55	TT5Z9WY	Strong	Biomarker	[421]
CD59	TTBGTEJ	Strong	Biomarker	[422]
CDK1	TTH6V3D	Strong	Biomarker	[423]
CDK2	TT7HF4W	Strong	Biomarker	[423]
CDK5	TTL4Q97	Strong	Biomarker	[424]
CDK6	TTO0FDJ	Strong	Altered Expression	[425]
CDK9	TT1LVF2	Strong	Biomarker	[426]
CGA	TTFC29G	Strong	Genetic Variation	[427]
CHAT	TTKYFSB	Strong	Biomarker	[428]
CHEK1	TTTU902	Strong	Biomarker	[429]
CHKA	TT10AWB	Strong	Altered Expression	[430]
CHRNA4	TT4H1MQ	Strong	Altered Expression	[431]
CLU	TTRL76H	Strong	Genetic Variation	[432]
CREB1	TTH4AN3	Strong	Altered Expression	[433]
CSK	TTX6F0Q	Strong	Biomarker	[434]
CTAG1A	TTE5ITK	Strong	Biomarker	[435]
CTH	TTLQUZS	Strong	Altered Expression	[436]
CXCL12	TT4UGTF	Strong	Biomarker	[437]
CXCL13	TT0NIZ1	Strong	Altered Expression	[438]
DBH	TTYIP79	Strong	Biomarker	[439]
DCLK1	TTOHTCY	Strong	Biomarker	[440]
DCLK3	TTMYK4Z	Strong	Biomarker	[441]
DDC	TTN451K	Strong	Altered Expression	[442]
DHCR24	TTTK0NH	Strong	Biomarker	[443]
DHPS	TTBO2A9	Strong	Biomarker	[444]
DIABLO	TTN74LE	Strong	Biomarker	[445]
DPYSL2	TTZCW3T	Strong	Biomarker	[446]
E2F2	TT5FYX0	Strong	Biomarker	[113]
EBP	TT4VQZX	Strong	Altered Expression	[447]
EDNRB	TT3ZTGU	Strong	Biomarker	[448]
EGF	TTED8JB	Strong	Biomarker	[449]
EIF5A	TTIVCNR	Strong	Biomarker	[444]
EPHA3	TTHS2LR	Strong	Altered Expression	[450]
EPHB6	TTZEMUY	Strong	Biomarker	[121]
EPOR	TTAUX24	Strong	Biomarker	[451]
ERN1	TTKIAT3	Strong	Biomarker	[452]
ESR1	TTZAYWL	Strong	Biomarker	[453]
F10	TTCIHJA	Strong	Altered Expression	[454]
FASLG	TTO7014	Strong	Genetic Variation	[455]
FGF2	TTGKIED	Strong	Biomarker	[456]
FGF8	TTIUF3J	Strong	Altered Expression	[457]
FOS	TTOM5AU	Strong	Biomarker	[279]
FTH1	TT975ZT	Strong	Biomarker	[458]
GAL	TTXZAJ5	Strong	Altered Expression	[459]
GALR2	TTBPW3J	Strong	Biomarker	[460]
GAPDH	TTUGSWA	Strong	Biomarker	[461]
GATA3	TT45KOB	Strong	Biomarker	[462]
GPC3	TTJTSX4	Strong	Altered Expression	[463]
GRB2	TTEYRJ9	Strong	Biomarker	[464]
GREM1	TTOUZN5	Strong	Biomarker	[465]
GRIA2	TTWM461	Strong	Altered Expression	[466]
GRK2	TTAZ3MN	Strong	Altered Expression	[228]
GRM2	TTXJ47W	Strong	Altered Expression	[466]
GRM3	TT8A9EF	Strong	Altered Expression	[467]
GRM8	TT0IFKL	Strong	Biomarker	[468]
GUCY2D	TTWNFC2	Strong	Genetic Variation	[469]
HDAC5	TTUELN5	Strong	Biomarker	[470]
HDAC8	TTT6LFV	Strong	Altered Expression	[471]
HDAC9	TT8M4E1	Strong	Biomarker	[472]
HGF	TT4V2JM	Strong	Altered Expression	[343]
HHAT	TT1VNCG	Strong	Biomarker	[473]
HIPK2	TTOB49C	Strong	Biomarker	[474]
HK2	TTK02H8	Strong	Biomarker	[475]
HMGA1	TTBA219	Strong	Biomarker	[396]
HSPA9	TTMTPG3	Strong	Biomarker	[476]
HSPB1	TT9AZWY	Strong	Biomarker	[477]
HSPB3	TTLH8WG	Strong	Biomarker	[477]
HTR1A	TTSQIFT	Strong	Biomarker	[478]
HTR1B	TTK8CXU	Strong	Altered Expression	[479]
HTR4	TT07C3Y	Strong	Biomarker	[479]
HTR7	TTO9X1H	Strong	Biomarker	[480]
ICA1	TTMX06B	Strong	Biomarker	[481]
IFNB1	TT4TZ8J	Strong	Biomarker	[482]
IGFBP2	TTU4QSN	Strong	Biomarker	[483]
IL2RB	TT9721Y	Strong	Altered Expression	[194]
IL7R	TTAWI51	Strong	Altered Expression	[484]
ITGA5	TTHIZP9	Strong	Altered Expression	[485]
JUN	TTS7IR5	Strong	Biomarker	[279]
KCNJ3	TTGM19J	Strong	Biomarker	[486]
KCNJ5	TTEO25X	Strong	Biomarker	[486]
KDM1A	TTNR0UQ	Strong	Biomarker	[487]
KDM3A	TTKXS4A	Strong	Biomarker	[488]
KDM5B	TTCLI75	Strong	Biomarker	[489]
KDM6B	TTDIJUQ	Strong	Biomarker	[490]
KIR2DL2	TTU0P73	Strong	Altered Expression	[491]
KLF4	TTTI53X	Strong	Biomarker	[492]
KRT6A	TT2FX8W	Strong	Biomarker	[493]
LGALS1	TTO3NYT	Strong	Biomarker	[494]
LGALS3	TTFPQV7	Strong	Biomarker	[495]
LGMN	TTPTWV5	Strong	Altered Expression	[496]
LIF	TTGZ5WN	Strong	Biomarker	[497]
LILRB1	TTC0QRJ	Strong	Biomarker	[498]
LIN28A	TTO50LN	Strong	Genetic Variation	[499]
LNPEP	TTY2KP7	Strong	Biomarker	[500]
LYN	TT1RWNJ	Strong	Altered Expression	[501]
MAOA	TT3WG5C	Strong	Biomarker	[502]
MAOB	TTGP7BY	Strong	Altered Expression	[503]
MAP3K5	TTOQCD8	Strong	Biomarker	[504]
MAPK8	TT0K6EO	Strong	Biomarker	[505]
MAPKAP1	TTWDKCL	Strong	Biomarker	[506]
MARCKS	TTHRM39	Strong	Posttranslational Modification	[507]
MAT2A	TTSMPXQ	Strong	Biomarker	[508]
MDK	TTV8UE7	Strong	Altered Expression	[509]
MDM4	TT9OUDQ	Strong	Biomarker	[88]
MECP2	TTTAU9R	Strong	Altered Expression	[510]
MELK	TTBZOTY	Strong	Altered Expression	[511]
MIA	TT5HNVS	Strong	Genetic Variation	[512]
MLANA	TT362RB	Strong	Biomarker	[513]
MMP14	TTJ4QE7	Strong	Altered Expression	[514]
MSI1	TTSM4BA	Strong	Altered Expression	[515]
MYB	TT8V13P	Strong	Altered Expression	[516]
NAGLU	TTDM6HZ	Strong	Biomarker	[517]
NCL	TTK1V5Q	Strong	Biomarker	[518]
NDUFAF2	TTCHGVF	Strong	Biomarker	[519]
NEDD9	TT1UREA	Strong	Biomarker	[520]
NELL1	TT7H4BF	Strong	Altered Expression	[521]
NLRP1	TTQX29T	Strong	Biomarker	[522]
NME1	TTDY8JH	Strong	Biomarker	[523]
NPM1	TTHBS98	Strong	Biomarker	[524]
NR0B1	TTTK36V	Strong	Genetic Variation	[525]
NR1I3	TTRANFM	Strong	Genetic Variation	[82]
NR4A2	TT9HKN3	Strong	Biomarker	[526]
NRAS	TTW2R9X	Strong	Genetic Variation	[527]
NRP1	TTIPJCB	Strong	Altered Expression	[528]
NRP2	TTRXUVC	Strong	Altered Expression	[529]
NT5E	TTK0O6Y	Strong	Altered Expression	[233]
NTRK1	TTTDVOJ	Strong	Biomarker	[530]
NTRK2	TTKN7QR	Strong	Biomarker	[531]
NTRK3	TTXABCW	Strong	Genetic Variation	[532]
ODC1	TTUMGNO	Strong	Biomarker	[533]
OPRL1	TTNT7K8	Strong	Altered Expression	[534]
P2RX7	TT473XN	Strong	Altered Expression	[182]
PABPC1	TTHC8EF	Strong	Biomarker	[535]
PAH	TTGSVH2	Strong	Biomarker	[536]
PCNA	TTLG1PD	Strong	Altered Expression	[515]
PDGFA	TTSM78N	Strong	Altered Expression	[537]
PFKFB3	TTTHMQJ	Strong	Biomarker	[538]
PKMYT1	TTB4PAZ	Strong	Biomarker	[395]
PLA2G1B	TT9V5JH	Strong	Altered Expression	[230]
PLK1	TTH4IP0	Strong	Biomarker	[539]
PLK4	TTGPNZQ	Strong	Biomarker	[540]
PML	TTLH9NY	Strong	Biomarker	[541]
PREP	TTNGKET	Strong	Biomarker	[528]
PRKCA	TTFJ8Q1	Strong	Biomarker	[481]
PRKCB	TTYPXQF	Strong	Biomarker	[481]
PRKCI	TTWJTHX	Strong	Biomarker	[481]
PRKDC	TTK3PY9	Strong	Biomarker	[542]
PROM1	TTXMZ81	Strong	Biomarker	[543]
PSEN2	TTWN3F4	Strong	Altered Expression	[544]
PSIP1	TTH9LDP	Strong	Altered Expression	[194]
PTBP1	TTWMX0U	Strong	Altered Expression	[545]
PTPN1	TTELIN2	Strong	Biomarker	[546]
PTPN14	TTNIR6C	Strong	Altered Expression	[547]
PTPRC	TTUS45N	Strong	Altered Expression	[548]
RARA	TTW38KT	Strong	Biomarker	[549]
RARB	TTISP28	Strong	Altered Expression	[550]
RARG	TT1Q3IE	Strong	Altered Expression	[551]
RBPJ	TT72D4Z	Strong	Biomarker	[552]
RENBP	TTZCG0Q	Strong	Biomarker	[553]
RET	TT4DXQT	Strong	Genetic Variation	[554]
RGS6	TTJ96M8	Strong	Altered Expression	[555]
RHD	TTLCKI8	Strong	Biomarker	[556]
RNPEP	TTD74YX	Strong	Biomarker	[500]
ROCK2	TTGWKQJ	Strong	Altered Expression	[557]
ROR1	TTDEJAU	Strong	Biomarker	[558]
ROR2	TTUDPCI	Strong	Altered Expression	[558]
RORB	TTGB2LZ	Strong	Altered Expression	[559]
RXRA	TT6PEUO	Strong	Biomarker	[560]
S100A12	TTQ4ESF	Strong	Biomarker	[561]
S100B	TTQ0V86	Strong	Biomarker	[562]
S1PR1	TT9JZCK	Strong	Biomarker	[563]
S1PR2	TTVSMOH	Strong	Altered Expression	[393]
SCN10A	TT90XZ8	Strong	Biomarker	[564]
SERPINH1	TTPSWQG	Strong	Posttranslational Modification	[565]
SIRT6	TTUXYWF	Strong	Biomarker	[566]
SKP2	TT5B2EO	Strong	Altered Expression	[567]
SLC11A2	TT2IS7P	Strong	Biomarker	[568]
SLC1A5	TTF7WRM	Strong	Biomarker	[569]
SLC3A2	TT5CZSM	Strong	Biomarker	[533]
SLC6A2	TTAWNKZ	Strong	Biomarker	[570]
SMN1	TT8QL6X	Strong	Biomarker	[571]
SORD	TTLSRBZ	Strong	Biomarker	[572]
SP1	TTZEP6S	Strong	Altered Expression	[413]
SPARC	TTBQFM7	Strong	Biomarker	[274]
SPHK1	TTOHFIY	Strong	Altered Expression	[573]
SPHK2	TTCN0M9	Strong	Altered Expression	[393]
SRC	TT6PKBN	Strong	Biomarker	[434]
STMN1	TT7W5OT	Strong	Altered Expression	[547]
TCF3	TTULOD8	Strong	Altered Expression	[194]
TERT	TTQY2EJ	Strong	Biomarker	[574]
TFRC	TT8MG4S	Strong	Biomarker	[575]
TGFBR1	TTP4520	Strong	Altered Expression	[576]
TIAM1	TTNU6I5	Strong	Biomarker	[577]
TLR3	TTD24Y0	Strong	Biomarker	[578]
TMEM97	TT9NXW4	Strong	Altered Expression	[579]
TNFRSF1B	TT63WSF	Strong	Altered Expression	[194]
TNFSF10	TTA5MS9	Strong	Biomarker	[580]
TPCN1	TTODQE2	Strong	Biomarker	[581]
TPX2	TT0PHL4	Strong	Biomarker	[582]
TRPC1	TTA76X0	Strong	Altered Expression	[583]
TRPC3	TTNVC34	Strong	Altered Expression	[584]
TRPM2	TTEBMN7	Strong	Biomarker	[585]
TRPM7	TTFPVZO	Strong	Altered Expression	[586]
TTR	TTPOYU7	Strong	Altered Expression	[587]
TYRP1	TTFRV98	Strong	Biomarker	[588]
UCHL1	TTX9IFP	Strong	Altered Expression	[589]
ULK1	TT4D7MJ	Strong	Biomarker	[590]
USP7	TTXU3EQ	Strong	Altered Expression	[591]
UTS2	TTERU0T	Strong	Altered Expression	[592]
WAS	TTE8T73	Strong	Biomarker	[593]
WEE1	TTJFOAL	Strong	Posttranslational Modification	[594]
YAP1	TT8UN2D	Strong	Altered Expression	[595]
BIRC7	TTHZ8TA	Definitive	Biomarker	[596]
CASP10	TTX5HEK	Definitive	Biomarker	[597]
CDA	TTQ12RK	Definitive	Altered Expression	[598]
CDK11B	TT5Q79O	Definitive	Genetic Variation	[599]
CEBPA	TT5LWG1	Definitive	Altered Expression	[600]
CERK	TT9XRNV	Definitive	Biomarker	[601]
CNTF	TTGEM5Q	Definitive	Biomarker	[602]
CUL7	TTI8R0P	Definitive	Altered Expression	[603]
CX3CL1	TT1OFBQ	Definitive	Biomarker	[604]
CYP26A1	TTD7Q0R	Definitive	Altered Expression	[605]
DCK	TTJOCE4	Definitive	Altered Expression	[374]
DKK3	TTY2ZV6	Definitive	Biomarker	[606]
DNASE1	TTYWGOJ	Definitive	Biomarker	[607]
E2F3	TTWIJYH	Definitive	Altered Expression	[608]
ECE1	TTQ9RYT	Definitive	Biomarker	[116]
EIF2AK2	TTXEZJ4	Definitive	Genetic Variation	[609]
F2RL3	TTD0652	Definitive	Altered Expression	[225]
FLT4	TTDCBX5	Definitive	Biomarker	[610]
FYN	TT2B9KF	Definitive	Altered Expression	[112]
HDAC3	TT4YWTO	Definitive	Biomarker	[611]
HTR2C	TTWJBZ5	Definitive	Biomarker	[612]
ISG15	TTVOH3T	Definitive	Biomarker	[613]
ITPR1	TT5HWAT	Definitive	Altered Expression	[614]
ITPR2	TTK9OV3	Definitive	Altered Expression	[614]
ITPR3	TTH1769	Definitive	Altered Expression	[614]
KCNJ2	TTH7UO3	Definitive	Altered Expression	[615]
KRT19	TT3JF9E	Definitive	Altered Expression	[616]
LRP1	TTF2V7I	Definitive	Biomarker	[254]
MAD1L1	TTNE9U7	Definitive	Biomarker	[617]
MAPK9	TT3IVG2	Definitive	Biomarker	[618]
MCM7	TT1RM3F	Definitive	Altered Expression	[619]
METAP2	TTZL0OI	Definitive	Biomarker	[620]
NOTCH3	TTVX7IA	Definitive	Altered Expression	[621]
NSD1	TTTSJ3H	Definitive	Posttranslational Modification	[622]
PAM	TTF4ZPC	Definitive	Biomarker	[623]
PCSK1	TTED9LZ	Definitive	Biomarker	[624]
PIN1	TTJNTSI	Definitive	Altered Expression	[625]
RGS4	TTGTKX9	Definitive	Altered Expression	[626]
SLC16A1	TTN1J82	Definitive	Biomarker	[627]
SYVN1	TT8XKYM	Definitive	Biomarker	[628]
TOP2B	TT4NVEM	Definitive	Altered Expression	[629]
VDAC1	TTAMKGB	Definitive	Altered Expression	[630]
VEGFD	TTOM5H4	Definitive	Altered Expression	[631]

This Disease Is Related to 21 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
ABCA2	DTJ4NEG	Limited	Altered Expression	[187]
SLC16A7	DTLT3UG	Limited	Altered Expression	[632]
SLC24A3	DTO18LP	Limited	Genetic Variation	[633]
SLC25A27	DT0HW5C	Limited	Biomarker	[634]
SLC2A3	DT9SQ3L	Limited	Posttranslational Modification	[635]
SLC30A10	DTYBI73	Limited	Altered Expression	[636]
SLC30A3	DTKMECW	Limited	Altered Expression	[637]
SLC39A8	DTLPQGT	Limited	Biomarker	[638]
SLC44A1	DT3I2SU	Limited	Biomarker	[639]
SLC9A6	DTN0JXW	Limited	Altered Expression	[640]
SLCO6A1	DTIFXNS	Limited	Altered Expression	[641]
SLC11A1	DT650XW	Disputed	Altered Expression	[106]
SLC8A3	DTYFRQT	Disputed	Altered Expression	[642]
ATP7A	DT0LT17	moderate	Altered Expression	[643]
SLC18A1	DTM953D	moderate	Altered Expression	[644]
SLC2A5	DTOR02F	moderate	Biomarker	[645]
SLC45A1	DTMSNOU	moderate	Altered Expression	[646]
SLC16A5	DT3I124	Strong	Posttranslational Modification	[647]
SLC25A21	DT2UQYR	Strong	Biomarker	[648]
SLC31A1	DTP8L4F	Strong	Biomarker	[413]
SLC52A1	DT7NOKR	Definitive	Altered Expression	[649]

This Disease Is Related to 37 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
CES2	DETHCPD	Limited	Altered Expression	[650]
DIO3	DET89OV	Limited	Altered Expression	[651]
EGLN3	DEMQTKH	Limited	Altered Expression	[226]
GLDC	DEIN8FB	Limited	Biomarker	[652]
GLS	DE3E0VT	Limited	Altered Expression	[653]
GSTZ1	DEQPEMB	Limited	Biomarker	[654]
HSD17B12	DE915QP	Limited	Genetic Variation	[655]
LDHC	DEQG7F9	Limited	Altered Expression	[186]
MGST1	DEAPJSO	Limited	Altered Expression	[656]
NMNAT2	DE2HB58	Limited	Biomarker	[657]
NNMT	DECVGJ3	Limited	Altered Expression	[658]
NT5C2	DE1DOKJ	Limited	Biomarker	[659]
PARK7	DEPOVCH	Limited	Biomarker	[660]
PER1	DE9HF0I	Limited	Altered Expression	[661]
SMOX	DEOH5V3	Limited	Biomarker	[662]
CYP26B1	DEZT8FM	moderate	Altered Expression	[605]
DHRS3	DEXPVUN	moderate	Biomarker	[310]
LAP3	DENZF0O	moderate	Altered Expression	[663]
NAT1	DE7OAB3	moderate	Biomarker	[664]
SULT1C2	DEYMAD4	moderate	Altered Expression	[665]
XPNPEP1	DE8E6X9	moderate	Biomarker	[666]
ALDH1A2	DEKN1H4	Strong	Altered Expression	[667]
APRT	DE2MV1R	Strong	Biomarker	[668]
BCO1	DE6BOK3	Strong	Biomarker	[669]
CMPK1	DEMPH4I	Strong	Genetic Variation	[670]
CRMP1	DE0EUXB	Strong	Altered Expression	[671]
DTYMK	DEOTVYU	Strong	Altered Expression	[672]
HPRT1	DEVXTP5	Strong	Biomarker	[673]
MAT2B	DEKF1OH	Strong	Biomarker	[508]
MSRA	DEU2ZBY	Strong	Altered Expression	[674]
SPR	DEJVDAT	Strong	Altered Expression	[675]
UCK1	DE478BP	Strong	Altered Expression	[676]
UCK2	DETN1O0	Strong	Biomarker	[676]
WARS1	DEPVE0M	Strong	Altered Expression	[677]
WARS2	DEPTKBQ	Strong	Altered Expression	[677]
GCLC	DESYL1F	Definitive	Biomarker	[678]
MAT1A	DEQ6NC9	Definitive	Altered Expression	[679]

This Disease Is Related to 996 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
AAAS	OTJT9T23	Limited	Biomarker	[680]
AACS	OTGGPR6J	Limited	Altered Expression	[681]
ACADM	OTA4P0FC	Limited	Biomarker	[682]
ACTB	OT1MCP2F	Limited	Biomarker	[562]
AGO1	OTD3R434	Limited	Altered Expression	[683]
AHSA1	OTC7AFHT	Limited	Altered Expression	[56]
AIPL1	OT4VBD78	Limited	Biomarker	[684]
ALDH1A3	OT1C9NKQ	Limited	Altered Expression	[667]
ALKAL2	OTTLHL64	Limited	Biomarker	[685]
ALPP	OTZU4G9W	Limited	Biomarker	[60]
APAF1	OTJWIVY0	Limited	Biomarker	[686]
APBB1	OTZPVSSC	Limited	Altered Expression	[687]
APBB2	OT1VD51B	Limited	Biomarker	[688]
APLP1	OTD176ZS	Limited	Altered Expression	[689]
APOC1	OTA58CED	Limited	Biomarker	[690]
ARMC12	OTBT9GZ8	Limited	Biomarker	[691]
ARSF	OTC0L12N	Limited	Biomarker	[692]
ASAH2	OT47TIF3	Limited	Biomarker	[693]
ASH1L	OTUT5NLJ	Limited	Biomarker	[257]
ATE1	OT3QNM39	Limited	Biomarker	[694]
ATL1	OTR2788Y	Limited	Biomarker	[695]
ATP13A2	OTKWBUGK	Limited	Genetic Variation	[696]
ATP2B4	OTMWFDAC	Limited	Genetic Variation	[697]
AXIN2	OTRMGQNU	Limited	Altered Expression	[698]
B3GNT3	OTVT1Q25	Limited	Biomarker	[699]
B4GALNT1	OTCY80HS	Limited	Biomarker	[700]
B4GALT3	OTHX77K8	Limited	Altered Expression	[701]
BAG2	OTI6LD27	Limited	Biomarker	[702]
BCS1L	OT5PY5CY	Limited	Biomarker	[257]
BEX3	OTW1V1L5	Limited	Biomarker	[703]
BEX4	OT3LXD15	Limited	Biomarker	[703]
BIRC6	OTCQJAB0	Limited	Biomarker	[445]
BLM	OTEJOAJX	Limited	Genetic Variation	[395]
BNIP3	OT4SO7J4	Limited	Biomarker	[704]
BRK1	OTTUB5KS	Limited	Biomarker	[705]
BTRC	OT2EZDGR	Limited	Biomarker	[180]
C1D	OTI9PMN1	Limited	Altered Expression	[88]
C1orf52	OT8RQW3W	Limited	Biomarker	[706]
CA11	OT8RX3AJ	Limited	Altered Expression	[707]
CA8	OT9Y8GA8	Limited	Altered Expression	[406]
CACYBP	OTJMZD2T	Limited	Altered Expression	[708]
CALB1	OTM7IXDG	Limited	Biomarker	[709]
CALM2	OTNYA92F	Limited	Biomarker	[710]
CAMKMT	OTLJBRUW	Limited	Biomarker	[710]
CAST	OTBXZZGF	Limited	Genetic Variation	[711]
CAVIN3	OTOLBK79	Limited	Biomarker	[712]
CBLIF	OTNE20WU	Limited	Altered Expression	[484]
CC2D1A	OTVPU04K	Limited	Biomarker	[713]
CCM2	OT2I5DOW	Limited	Altered Expression	[714]
CD177	OTS79FNF	Limited	Altered Expression	[158]
CD226	OT4UG0KB	Limited	Altered Expression	[715]
CD2AP	OTC76KQM	Limited	Altered Expression	[716]
CD8A	OTDWQJXK	Limited	Genetic Variation	[77]
CDKL5	OTGL5HRV	Limited	Altered Expression	[717]
CDKN2D	OT2TTZPZ	Limited	Altered Expression	[718]
CFC1	OT5DHGI8	Limited	Biomarker	[719]
CHAC1	OTJGE772	Limited	Altered Expression	[720]
CHD9	OTWNFDKJ	Limited	Altered Expression	[698]
CHERP	OTJL4OB3	Limited	Biomarker	[721]
CHGA	OTXYX5JH	Limited	Biomarker	[722]
CHGB	OT7SAQT2	Limited	Biomarker	[723]
CHN1	OTM196M3	Limited	Biomarker	[724]
CHP1	OTHTXN1A	Limited	Biomarker	[725]
CHRNA3	OTCZQY1U	Limited	Altered Expression	[726]
CISD1	OT0MTVGF	Limited	Biomarker	[727]
CISD2	OTVS7S2H	Limited	Biomarker	[728]
CLEC4D	OTT7X1UC	Limited	Biomarker	[729]
CLMN	OT7U5J3T	Limited	Altered Expression	[730]
CLPB	OT1I0IBK	Limited	Altered Expression	[731]
CNMD	OTHND8EL	Limited	Biomarker	[732]
CNOT1	OTTEU05F	Limited	Biomarker	[733]
COL11A2	OT3BQUBH	Limited	Altered Expression	[223]
COL5A2	OT5VOSQE	Limited	Biomarker	[168]
COMMD1	OT7WUD5R	Limited	Biomarker	[734]
COPS4	OTNK2KS1	Limited	Biomarker	[735]
COX2	OTTMVBJJ	Limited	Altered Expression	[389]
CPD	OT2CS64Y	Limited	Biomarker	[736]
CPZ	OT5HUR28	Limited	Genetic Variation	[737]
CSH1	OT33HTRR	Limited	Biomarker	[476]
CSH2	OTW8JVAN	Limited	Biomarker	[476]
CTBP2	OTGZGT87	Limited	Biomarker	[738]
CTTNBP2	OT4CL1EW	Limited	Altered Expression	[739]
CUL1	OTXPE1UZ	Limited	Biomarker	[180]
CUX1	OTU1LCNJ	Limited	Biomarker	[198]
CYLD	OT37FKH0	Limited	Altered Expression	[740]
DAPK2	OTWODUQG	Limited	Biomarker	[291]
DAXX	OTX6O7PL	Limited	Biomarker	[741]
DCDC2	OTSUFH1H	Limited	Biomarker	[742]
DDT	OTF5HTYL	Limited	Biomarker	[743]
DDX4	OTQOV093	Limited	Genetic Variation	[172]
DEAF1	OTCLX3ZW	Limited	Biomarker	[713]
DENR	OTXP9HOY	Limited	Biomarker	[291]
DEPDC5	OTE70JLY	Limited	Biomarker	[744]
DHX9	OT5AAOQI	Limited	Biomarker	[745]
DNAAF4	OTVDYBJE	Limited	Altered Expression	[746]
DNAH8	OTGES2OU	Limited	Altered Expression	[747]
DNLZ	OT48CG1W	Limited	Biomarker	[748]
DNM1L	OTXK1Q1G	Limited	Biomarker	[291]
DPP6	OTWW3H0K	Limited	Biomarker	[749]
DSC3	OTYG47F8	Limited	Altered Expression	[750]
DUSP23	OTE2PG54	Limited	Biomarker	[712]
DUSP26	OTI7WIYN	Limited	Biomarker	[751]
DVL3	OTPRROHJ	Limited	Biomarker	[752]
DYM	OTQ670WI	Limited	Genetic Variation	[753]
E2F4	OTB3JFH4	Limited	Biomarker	[168]
EEF1E1	OTRA6XOB	Limited	Biomarker	[67]
EEF2	OTZ7SZ39	Limited	Altered Expression	[754]
EFNB2	OT0DCUOM	Limited	Altered Expression	[755]
EFNB3	OT12WTXQ	Limited	Biomarker	[121]
EGR2	OTAVQ78J	Limited	Altered Expression	[756]
ELOC	OT0XHHWP	Limited	Genetic Variation	[757]
ELP1	OTYEWBF7	Limited	Altered Expression	[758]
ENDOG	OT5IM7B3	Limited	Biomarker	[759]
ERCC4	OTFIOPG1	Limited	Genetic Variation	[760]
ERCC6	OT2QZKSF	Limited	Biomarker	[476]
ERCC8	OT0T4WKI	Limited	Biomarker	[476]
ERP44	OT7ZI7AG	Limited	Altered Expression	[761]
ETV5	OTE2OBM4	Limited	Altered Expression	[762]
FABP7	OTRE2H4G	Limited	Biomarker	[763]
FAIM2	OT6QINVO	Limited	Biomarker	[764]
FBXO5	OTTR957W	Limited	Biomarker	[765]
FGF13	OTHNNVSG	Limited	Altered Expression	[766]
FGF6	OTRJ679P	Limited	Biomarker	[767]
FH	OTEQWU6Q	Limited	Biomarker	[729]
FIG4	OT501PY9	Limited	Biomarker	[768]
FLOT1	OT0JPPJZ	Limited	Altered Expression	[769]
FNDC5	OT5CSK9X	Limited	Altered Expression	[770]
FOSB	OTW6C05J	Limited	Biomarker	[279]
FOXP2	OTVX6A59	Limited	Altered Expression	[771]
FTMT	OTIUX6XG	Limited	Altered Expression	[772]
FZD6	OTBCPII8	Limited	Biomarker	[773]
GAB2	OTBFN705	Limited	Altered Expression	[774]
GABRB3	OT80C3D4	Limited	Altered Expression	[726]
GALNT14	OT9BSDDQ	Limited	Biomarker	[775]
GAREM2	OTQNQAC7	Limited	Altered Expression	[776]
GCA	OTAJ7ZHG	Limited	Biomarker	[777]
GCNT1	OTF6OC66	Limited	Altered Expression	[778]
GDPD5	OTUM65JL	Limited	Altered Expression	[779]
GLS2	OT08MSHL	Limited	Altered Expression	[780]
GLUD2	OTF3GGYY	Limited	Biomarker	[781]
GMCL1	OTRZHUFV	Limited	Biomarker	[777]
GNB2	OT3JPRCQ	Limited	Biomarker	[782]
GOLPH3	OTDLGYM3	Limited	Biomarker	[582]
GPC2	OT3WSQE1	Limited	Altered Expression	[783]
GPM6A	OT8G13EG	Limited	Biomarker	[784]
GPR78	OT8TKE6F	Limited	Genetic Variation	[785]
GRAP2	OTS5NIZ3	Limited	Altered Expression	[56]
GRB10	OTCKXGRC	Limited	Altered Expression	[786]
GRHL1	OTZ4MNEW	Limited	Altered Expression	[787]
GRP	OT8JDFNI	Limited	Biomarker	[788]
GSTK1	OTDNGWAF	Limited	Altered Expression	[641]
GTSE1	OTPP742Z	Limited	Altered Expression	[688]
GYPE	OTBHAG6A	Limited	Biomarker	[789]
H1-2	OT0AVI4M	Limited	Altered Expression	[790]
H4C1	OTB71W46	Limited	Altered Expression	[135]
HAS3	OTPM8IL8	Limited	Biomarker	[791]
HCFC1	OT0UCK62	Limited	Altered Expression	[792]
HCN3	OTMO1ZYQ	Limited	Altered Expression	[793]
HDX	OTXD5MU6	Limited	Altered Expression	[794]
HENMT1	OTM5I26B	Limited	Biomarker	[795]
HES2	OTMWY2KV	Limited	Posttranslational Modification	[796]
HGS	OTCYYCAC	Limited	Biomarker	[797]
HHIP	OT77RQYS	Limited	Posttranslational Modification	[798]
HLA-E	OTX1CTFB	Limited	Biomarker	[799]
HNRNPR	OT3FITK2	Limited	Biomarker	[800]
HOXD1	OTN4V9ZF	Limited	Altered Expression	[801]
HOXD13	OTWSC8TF	Limited	Altered Expression	[651]
HOXD9	OTZ4GVR1	Limited	Altered Expression	[801]
HSPA2	OTSDET7B	Limited	Altered Expression	[802]
HSPA4	OT5HR0AR	Limited	Altered Expression	[803]
HTRA2	OTC7616F	Limited	Biomarker	[804]
IARS1	OT9WXH5N	Limited	Biomarker	[805]
ICAM2	OT3E070F	Limited	Genetic Variation	[806]
IGF2BP1	OT9G360P	Limited	Biomarker	[807]
IMMT	OTBDSLE7	Limited	Altered Expression	[808]
ING1	OTEZBRKW	Limited	Altered Expression	[809]
ING2	OT6H0EWF	Limited	Genetic Variation	[77]
ING5	OTRNNSFM	Limited	Biomarker	[810]
INSM1	OTG8RV8E	Limited	Altered Expression	[195]
ITGA3	OTBCH21D	Limited	Biomarker	[175]
ITLN1	OT7ZLJVV	Limited	Altered Expression	[811]
ITM2B	OTMXEPXB	Limited	Biomarker	[812]
ITSN1	OT8YF3S5	Limited	Biomarker	[813]
JMJD6	OTILR7E4	Limited	Biomarker	[90]
JUNB	OTG2JXV5	Limited	Biomarker	[279]
JUND	OTNKACJD	Limited	Biomarker	[279]
KANK2	OT3SZIWM	Limited	Altered Expression	[708]
KCNIP3	OTCQPEM4	Limited	Biomarker	[814]
KDM4B	OT5P1UPY	Limited	Altered Expression	[815]
KIR3DL1	OTPOSXFX	Limited	Biomarker	[816]
KRIT1	OT58AP1I	Limited	Biomarker	[710]
KRT1	OTIOJWA4	Limited	Biomarker	[817]
LAMTOR1	OTIBJBW9	Limited	Biomarker	[67]
LBR	OT1HG3HG	Limited	Biomarker	[201]
LCMT1	OTRJQ16X	Limited	Biomarker	[818]
LDHB	OT9B1CT3	Limited	Biomarker	[186]
LGALS4	OTKQCG0H	Limited	Biomarker	[819]
LIG3	OT48SKET	Limited	Biomarker	[820]
LIG4	OT40DNXU	Limited	Biomarker	[821]
LMAN2	OT8UQKS6	Limited	Altered Expression	[822]
LMO3	OTR7AJHN	Limited	Altered Expression	[823]
LOXL3	OTLLY1QI	Limited	Altered Expression	[485]
LRG1	OTLD0KWA	Limited	Posttranslational Modification	[808]
LRP8	OTZ71YV2	Limited	Altered Expression	[824]
LRRC4	OT7XJ70N	Limited	Biomarker	[706]
LRSAM1	OTOKWR6C	Limited	Altered Expression	[825]
LYAR	OTQNA67C	Limited	Biomarker	[720]
MAD2L1	OTXNGZCG	Limited	Altered Expression	[826]
MAFK	OTZJUE4P	Limited	Biomarker	[67]
MAGED4B	OTO37U7W	Limited	Biomarker	[191]
MAGT1	OTQSAV5C	Limited	Biomarker	[60]
MAP1LC3B	OTUYHB84	Limited	Altered Expression	[827]
MAP2	OT6UYT3X	Limited	Altered Expression	[828]
MAP3K12	OT5HODDD	Limited	Altered Expression	[108]
MASTL	OTQ7YKK5	Limited	Biomarker	[829]
MB	OTYWYL2D	Limited	Altered Expression	[830]
MCRS1	OT8K2X8P	Limited	Biomarker	[831]
MEIS2	OTG4ADLM	Limited	Biomarker	[832]
MICA	OTPEIEAR	Limited	Biomarker	[833]
MLF1	OTC5BKHU	Limited	Biomarker	[785]
MMUT	OTBBBV70	Limited	Altered Expression	[834]
MNAT1	OTXLOYCB	Limited	Biomarker	[321]
MNX1	OTXP9FH1	Limited	Altered Expression	[835]
MPHOSPH9	OTNUNDQN	Limited	Biomarker	[836]
MPPED2	OT7XLMJ6	Limited	Altered Expression	[837]
MPST	OTCDPH5D	Limited	Biomarker	[436]
MRE11	OTGU8TZM	Limited	Altered Expression	[838]
MSX1	OT5U41ZP	Limited	Biomarker	[839]
MT3	OTVCZ7HI	Limited	Altered Expression	[840]
MTG1	OTC9U1LI	Limited	Biomarker	[841]
MVP	OTJGHJRB	Limited	Biomarker	[254]
MXD1	OTS5CTHX	Limited	Biomarker	[842]
MYBL2	OTZ3JX8Q	Limited	Altered Expression	[843]
MYCL	OT1MFQ5U	Limited	Biomarker	[844]
MYEOV	OTDC7UHL	Limited	Biomarker	[845]
MYO10	OTHB78ZQ	Limited	Biomarker	[846]
MYO5A	OTMWLP3E	Limited	Biomarker	[847]
MZF1	OTMVZCPW	Limited	Biomarker	[222]
N4BP1	OTN2TL6N	Limited	Altered Expression	[848]
NANOG	OTUEY1FM	Limited	Altered Expression	[849]
NAV1	OT667KTL	Limited	Altered Expression	[698]
NCS1	OT6JHAWM	Limited	Altered Expression	[850]
NDUFA4L2	OTK0PG7R	Limited	Altered Expression	[292]
NDUFB11	OTFG5777	Limited	Genetic Variation	[851]
NECTIN1	OTTE5ZR6	Limited	Altered Expression	[852]
NEFH	OTMSCW5I	Limited	Altered Expression	[853]
NEGR1	OT57ECW9	Limited	Biomarker	[845]
NEUROD1	OTZQ7QJ2	Limited	Biomarker	[854]
NFYA	OTWFFOVH	Limited	Biomarker	[855]
NGB	OTW0SIUY	Limited	Altered Expression	[856]
NHLH1	OTXN5B9R	Limited	Biomarker	[795]
NHLH2	OT88N84O	Limited	Altered Expression	[857]
NKAIN2	OTI4H30Z	Limited	Biomarker	[858]
NKX2-2	OTDCOYNG	Limited	Biomarker	[798]
NLGN3	OTKDEC1Q	Limited	Altered Expression	[859]
NLK	OT2LETFS	Limited	Biomarker	[860]
NMB	OT4NLN6H	Limited	Biomarker	[118]
NME2	OTCYGLHV	Limited	Altered Expression	[861]
NME3	OT0CA0GF	Limited	Biomarker	[862]
NME4	OT2JTT42	Limited	Biomarker	[863]
NOL3	OT1K0L0D	Limited	Altered Expression	[864]
NPC1	OTRIPICX	Limited	Biomarker	[865]
NPFF	OT3WXFPR	Limited	Biomarker	[208]
NPRL3	OTS4HE8E	Limited	Biomarker	[744]
NSF	OTKRJ2ZT	Limited	Altered Expression	[866]
NUBP1	OTE8RAKZ	Limited	Posttranslational Modification	[97]
NUCB2	OTHO6JWN	Limited	Biomarker	[867]
NUP98	OTNT12G2	Limited	Genetic Variation	[868]
OAZ2	OTV1XSWG	Limited	Altered Expression	[869]
OPTN	OT2UXWH9	Limited	Biomarker	[870]
P2RX2	OT0LF34A	Limited	Altered Expression	[220]
P2RX5	OTLBR20R	Limited	Altered Expression	[220]
P2RX6	OT1FNTXA	Limited	Altered Expression	[220]
PAEP	OTQA0NV4	Limited	Biomarker	[528]
PAG1	OTFOJUIQ	Limited	Altered Expression	[871]
PANK2	OTFBW889	Limited	Biomarker	[872]
PCDH7	OTP091X8	Limited	Biomarker	[873]
PCDHB1	OTFPKRA5	Limited	Biomarker	[873]
PCF11	OT54GCY6	Limited	Altered Expression	[874]
PCMT1	OTGYVSGU	Limited	Altered Expression	[875]
PDIA2	OTC2WMXS	Limited	Altered Expression	[876]
PDIA3	OTHPQ0Q3	Limited	Biomarker	[877]
PDLIM5	OTLQVV22	Limited	Genetic Variation	[485]
PER3	OTVKYVJA	Limited	Biomarker	[878]
PES1	OTMZK7XE	Limited	Altered Expression	[879]
PGP	OT6QQ7OR	Limited	Altered Expression	[880]
PHF20	OTCBVH5P	Limited	Biomarker	[881]
PHF6	OT8DXI40	Limited	Biomarker	[882]
PHLDA1	OTFTWMIQ	Limited	Biomarker	[883]
PHOX2A	OTVS3R2X	Limited	Biomarker	[884]
PIAS2	OTJLSC3V	Limited	Biomarker	[121]
PIK3C2B	OTY2PROB	Limited	Biomarker	[885]
PKNOX1	OTUDMNHX	Limited	Biomarker	[763]
PLA2G6	OT5FL0WU	Limited	Biomarker	[568]
POLDIP2	OT8SZSJ6	Limited	Altered Expression	[56]
PPP1R12A	OT4AVU95	Limited	Biomarker	[886]
PPP2R2B	OTSFVC82	Limited	Altered Expression	[887]
PPP3R1	OTGQNFJQ	Limited	Biomarker	[888]
PRB1	OTV0SYMD	Limited	Biomarker	[889]
PRB2	OTAD4JZ0	Limited	Altered Expression	[890]
PRDM2	OT8L7CGX	Limited	Biomarker	[891]
PRDX1	OTZ3BEC4	Limited	Biomarker	[892]
PRDX2	OTLWCY9T	Limited	Biomarker	[893]
PRDX3	OTLB2WEU	Limited	Biomarker	[894]
PRICKLE2	OTWBA48T	Limited	Biomarker	[895]
PRPF31	OTSJ0Z1Y	Limited	Biomarker	[896]
PRPS1	OTN3A6CN	Limited	Biomarker	[897]
PRUNE2	OTGW2974	Limited	Altered Expression	[898]
PSMD4	OTH1VZTM	Limited	Biomarker	[692]
QPRT	OT6SKKLL	Limited	Biomarker	[899]
RAB10	OT8ZN26V	Limited	Biomarker	[900]
RAB15	OTU0GGR3	Limited	Biomarker	[901]
RAB1A	OTKPHRD0	Limited	Biomarker	[870]
RAB29	OTDZT6LP	Limited	Biomarker	[902]
RAB40B	OTCA9ZF5	Limited	Altered Expression	[903]
RAB7B	OT60A0E9	Limited	Biomarker	[246]
RAB8A	OTPB54Y3	Limited	Genetic Variation	[904]
RAG1	OTV131E4	Limited	Biomarker	[905]
RALYL	OT232N7Q	Limited	Biomarker	[906]
RAPGEF1	OTZ0TBN1	Limited	Biomarker	[907]
RASL11B	OTHEVZS6	Limited	Biomarker	[175]
RASSF10	OTGB7EBG	Limited	Biomarker	[908]
RASSF6	OT25GVWY	Limited	Biomarker	[908]
RBBP4	OTG3BT3M	Limited	Altered Expression	[691]
RBM14	OTO9GMBD	Limited	Altered Expression	[708]
RBX1	OTYA1UIO	Limited	Biomarker	[909]
REEP3	OTM7YVIE	Limited	Altered Expression	[739]
RELN	OTLKMW1O	Limited	Altered Expression	[824]
RFC2	OTJ9N6BD	Limited	Biomarker	[910]
RFX1	OTZUDMPR	Limited	Altered Expression	[911]
RGS14	OTYN79AG	Limited	Biomarker	[912]
RHOV	OTW4N3QN	Limited	Biomarker	[725]
RITA1	OTUH8IPS	Limited	Biomarker	[913]
RNF11	OTFBJSKQ	Limited	Genetic Variation	[914]
RNF19A	OTKWCV80	Limited	Altered Expression	[56]
ROBO2	OTFJ9FQW	Limited	Biomarker	[915]
RRBP1	OT4ZTPTM	Limited	Altered Expression	[796]
RSAD2	OTCA9WCM	Limited	Biomarker	[916]
RYR2	OT0PF19E	Limited	Altered Expression	[917]
S100A1	OT1F2G4J	Limited	Biomarker	[562]
SBNO1	OTNX3RL0	Limited	Biomarker	[918]
SBNO2	OT1C6J3K	Limited	Biomarker	[918]
SCG2	OTXWUQQL	Limited	Biomarker	[919]
SCNN1A	OTE2KVZV	Limited	Biomarker	[712]
SDHAF2	OT0UG9H5	Limited	Biomarker	[920]
SEC61B	OTY1X6A2	Limited	Altered Expression	[137]
SELENOS	OTUEWIU9	Limited	Biomarker	[921]
SERF2	OTZQDYCZ	Limited	Biomarker	[922]
SFRP1	OT0U9G41	Limited	Biomarker	[923]
SH2B1	OTJZO2CI	Limited	Biomarker	[924]
SH2D5	OTJDS1NN	Limited	Biomarker	[925]
SHMT2	OT5NCAZN	Limited	Altered Expression	[926]
SIN3A	OTM8OZWV	Limited	Biomarker	[927]
SIRT4	OT5S0J23	Limited	Biomarker	[928]
SKIL	OTNBXH32	Limited	Biomarker	[918]
SKP1	OT5BPAZ4	Limited	Biomarker	[929]
SMAD2	OTC6VB4K	Limited	Posttranslational Modification	[576]
SNAP23	OTY2MYBX	Limited	Biomarker	[930]
SNIP1	OTL3RA91	Limited	Altered Expression	[541]
SNRPN	OTQB1ID1	Limited	Biomarker	[931]
SOD3	OTIOZQAB	Limited	Biomarker	[932]
SP3	OTYDQZ1T	Limited	Biomarker	[933]
SPINK1	OTSUVAL2	Limited	Altered Expression	[487]
SRGAP3	OT9ZS72C	Limited	Biomarker	[934]
SRSF1	OTF61HOV	Limited	Biomarker	[692]
SRSF3	OTOFT707	Limited	Biomarker	[935]
SSBP1	OTH2PZWH	Limited	Biomarker	[936]
STAG2	OTR6X1Q7	Limited	Genetic Variation	[937]
STAU1	OTTR5311	Limited	Altered Expression	[938]
STIM2	OTYNXAW0	Limited	Altered Expression	[939]
STK25	OT4YPNTF	Limited	Altered Expression	[940]
STMN4	OT7ZUKW6	Limited	Biomarker	[915]
SUZ12	OT655XF8	Limited	Biomarker	[941]
SYN1	OTMNPWC1	Limited	Posttranslational Modification	[942]
SYNCRIP	OTRNDZXB	Limited	Biomarker	[800]
SYNJ1	OTTE02XC	Limited	Altered Expression	[943]
SYP	OTFJKMO4	Limited	Biomarker	[944]
TAC1	OTM842YW	Limited	Biomarker	[945]
TAF1	OTDYS5G4	Limited	Altered Expression	[857]
TAS2R10	OT4RWZZD	Limited	Biomarker	[946]
TAS2R13	OTSTOX5G	Limited	Altered Expression	[947]
TEAD4	OTJS0T2B	Limited	Altered Expression	[948]
TESC	OTI8C76M	Limited	Genetic Variation	[262]
TFAP2B	OTR1T8E9	Limited	Biomarker	[949]
TFAP2C	OTUDIW05	Limited	Biomarker	[950]
TFAP4	OT1KQIUX	Limited	Biomarker	[951]
THBS2	OTXET551	Limited	Biomarker	[541]
TIMP2	OT8S1RRP	Limited	Altered Expression	[952]
TLE1	OT50MRZ1	Limited	Biomarker	[953]
TMOD1	OTTRYF9Y	Limited	Altered Expression	[954]
TNFAIP8L2	OTII0RM0	Limited	Biomarker	[955]
TNFRSF10D	OTOSRDJT	Limited	Posttranslational Modification	[84]
TNIP1	OTRAOTEW	Limited	Biomarker	[848]
TPD52	OTPKSK43	Limited	Altered Expression	[956]
TPI1	OT14KP4B	Limited	Genetic Variation	[957]
TPM3	OT5RU5G6	Limited	Biomarker	[958]
TPPP2	OTI3WA6X	Limited	Biomarker	[67]
TRAF2	OT1MEZZN	Limited	Altered Expression	[661]
TRAP1	OTNG0L8J	Limited	Altered Expression	[959]
TREX1	OTQG7K12	Limited	Biomarker	[960]
TSACC	OT3QW6PH	Limited	Altered Expression	[708]
TSPAN5	OTHCCHHV	Limited	Biomarker	[284]
TSPYL2	OTGGW2EF	Limited	Biomarker	[961]
ADAM12	OTZKOTDB	Disputed	Biomarker	[962]
AGO2	OT4JY32Q	Disputed	Altered Expression	[963]
CABIN1	OT4G5CIK	Disputed	Biomarker	[964]
CTNNA2	OTJ8G92T	Disputed	Biomarker	[965]
DUSP6	OT4H6RKW	Disputed	Biomarker	[966]
EIF6	OTEXMUED	Disputed	Biomarker	[296]
ELF4	OT167PR5	Disputed	Altered Expression	[967]
FRS2	OTDMD800	Disputed	Altered Expression	[968]
GADL1	OTJM4A0R	Disputed	Biomarker	[969]
GDF1	OTZ1VRBH	Disputed	Biomarker	[970]
GFRA2	OT34CXNN	Disputed	Biomarker	[971]
KDM2B	OTDMCVW7	Disputed	Altered Expression	[430]
KLF9	OTBFEJRQ	Disputed	Altered Expression	[972]
LEMD2	OT0YLT7L	Disputed	Biomarker	[973]
LIN28B	OTVWP0FN	Disputed	Altered Expression	[974]
LYPD5	OTGP7UKA	Disputed	Altered Expression	[975]
MATR3	OTESJ5S7	Disputed	Biomarker	[976]
MCU	OTQZAYWQ	Disputed	Altered Expression	[977]
NPDC1	OT788NC8	Disputed	Biomarker	[296]
PPP1R13L	OTNCPLWE	Disputed	Biomarker	[970]
PPP3CB	OTEGNEHW	Disputed	Altered Expression	[964]
PRIMA1	OT9ITT3P	Disputed	Biomarker	[978]
PTPN5	OT2H1KDK	Disputed	Altered Expression	[979]
RAD52	OT0OTDHI	Disputed	Biomarker	[980]
RDM1	OTBSJEAG	Disputed	Biomarker	[980]
RNH1	OT6EC79B	Disputed	Biomarker	[970]
RRM2B	OTE8GBUR	Disputed	Biomarker	[423]
SHC1	OT1J5IRN	Disputed	Biomarker	[970]
SNW1	OTKWG3PS	Disputed	Biomarker	[552]
SOX6	OTT0W0LE	Disputed	Biomarker	[424]
STAT2	OTO9G2RZ	Disputed	Altered Expression	[981]
SUGCT	OTA8L0TN	Disputed	Biomarker	[982]
TAS2R16	OT67HLNS	Disputed	Altered Expression	[983]
TCERG1	OTH1LCGH	Disputed	Biomarker	[984]
TMEM59	OTX4EKES	Disputed	Biomarker	[985]
ACP1	OTJ9CKLU	moderate	Altered Expression	[986]
ADAM23	OTVWT6JZ	moderate	Altered Expression	[987]
AGTPBP1	OTR92JFR	moderate	Altered Expression	[988]
ALDOC	OTEC13I5	moderate	Altered Expression	[989]
ALX3	OTXZ25PZ	moderate	Posttranslational Modification	[990]
APOBEC3B	OTHLNI51	moderate	Altered Expression	[991]
ARF3	OTYYQX85	moderate	Biomarker	[992]
ARFGEF2	OTM3CQZT	moderate	Biomarker	[993]
ARHGEF18	OTOXEK8Y	moderate	Biomarker	[994]
ARHGEF2	OTBQTFRT	moderate	Biomarker	[994]
ARID1B	OTILK3Q7	moderate	Genetic Variation	[995]
ARID3B	OTUP9MS4	moderate	Altered Expression	[996]
ARNT2	OTAQD3YV	moderate	Biomarker	[997]
ARSH	OTG0X9UQ	moderate	Biomarker	[464]
ASXL3	OTNDJWEZ	moderate	Altered Expression	[998]
ATF1	OT251CI0	moderate	Altered Expression	[999]
ATF5	OT03QCLM	moderate	Altered Expression	[1000]
BACH2	OT17GS18	moderate	Biomarker	[1001]
BAD	OT63ERYM	moderate	Altered Expression	[1002]
BCAR1	OTKT2C2N	moderate	Biomarker	[1003]
BCL11B	OT8KKCVJ	moderate	Biomarker	[1004]
BIK	OTTH1T3D	moderate	Altered Expression	[1005]
BMPR1A	OTQOA4ZH	moderate	Altered Expression	[1006]
BNIP2	OTVZD4H6	moderate	Genetic Variation	[1007]
BPTF	OTD1RZAD	moderate	Biomarker	[1008]
C1QL1	OTNQ0G3E	moderate	Altered Expression	[1009]
CCDC115	OT04AZNZ	moderate	Altered Expression	[988]
CCL18	OT7JYSK9	moderate	Altered Expression	[1010]
CCNG1	OT17IA9L	moderate	Altered Expression	[1011]
CCNG2	OTII38K2	moderate	Altered Expression	[1012]
CCNT1	OTDYVGCP	moderate	Altered Expression	[1013]
CD1D	OT3ROU4J	moderate	Biomarker	[1014]
CDC6	OTX93FE7	moderate	Altered Expression	[1015]
CDCA5	OTZLCQ5U	moderate	Biomarker	[321]
CEBPZ	OT11BATG	moderate	Biomarker	[372]
CENPS	OTZ4J391	moderate	Genetic Variation	[377]
CLTC	OTBFASMA	moderate	Biomarker	[1016]
CNN1	OTVPG39Z	moderate	Biomarker	[1017]
CORT	OTX3GUHB	moderate	Genetic Variation	[1018]
CREM	OTJIJ5AL	moderate	Biomarker	[1019]
CRYGC	OTYSTQWI	moderate	Biomarker	[1020]
CTNNBIP1	OTX9SBJG	moderate	Genetic Variation	[1021]
CUL9	OTPUCLZT	moderate	Altered Expression	[1010]
CYGB	OTX153DQ	moderate	Altered Expression	[1022]
CYTL1	OTLYUPUY	moderate	Biomarker	[1023]
DAP	OT5YLL7E	moderate	Biomarker	[353]
DLGAP1	OTF2PUUI	moderate	Biomarker	[353]
DLGAP5	OTWCN39U	moderate	Altered Expression	[1024]
DNAJC10	OTD2EG0R	moderate	Biomarker	[1025]
DR1	OTR081M4	moderate	Biomarker	[1026]
DVL1	OTD67RF1	moderate	Altered Expression	[387]
DYNLL1	OTR69LHT	moderate	Altered Expression	[1027]
EBF1	OTZ61YYH	moderate	Altered Expression	[1028]
ECEL1	OTJ6GNUP	moderate	Altered Expression	[1029]
EIF4G2	OTEO98CR	moderate	Biomarker	[1024]
EPB41	OTGCFPV8	moderate	Biomarker	[1030]
ERRFI1	OT7VZ2IZ	moderate	Biomarker	[1031]
ESCO1	OTZ9P12A	moderate	Biomarker	[1032]
ETV1	OT6PMJIK	moderate	Altered Expression	[1033]
ETV4	OT8C98UZ	moderate	Altered Expression	[1034]
EVI5	OTOPAP55	moderate	Posttranslational Modification	[1035]
FANCL	OTJC7QPQ	moderate	Genetic Variation	[1036]
FCN2	OTTHJBKZ	moderate	Biomarker	[321]
FGA	OTMIHY80	moderate	Biomarker	[1037]
FHL2	OT0OAYWT	moderate	Altered Expression	[165]
FLII	OT7G9JG6	moderate	Biomarker	[1038]
FLT3LG	OTU0YGC4	moderate	Altered Expression	[1039]
FMR1	OTWEV0T5	moderate	Biomarker	[1040]
FZD1	OTZATHVS	moderate	Biomarker	[1041]
FZD5	OTXFFY56	moderate	Biomarker	[1041]
GADD45A	OTDRV63V	moderate	Biomarker	[1042]
GAS1	OTKJXG52	moderate	Altered Expression	[1043]
GCHFR	OTEOT8GI	moderate	Biomarker	[321]
GGNBP2	OT7K9YZV	moderate	Biomarker	[1044]
GHRH	OT94U6MO	moderate	Altered Expression	[615]
GMEB1	OT4F8RFH	moderate	Biomarker	[1045]
GNAS	OTMH8BKJ	moderate	Biomarker	[1046]
HERC2	OTNQYKOB	moderate	Biomarker	[1047]
HOXC11	OT8NMHM6	moderate	Altered Expression	[1048]
HPCAL1	OTOBBFRD	moderate	Biomarker	[1049]
HSD17B6	OTSB55D2	moderate	Biomarker	[310]
IGFBP4	OT2HZRBD	moderate	Biomarker	[1050]
IL12RB1	OTM1IJO2	moderate	Biomarker	[1051]
IL3	OT0CQ35N	moderate	Biomarker	[379]
INA	OT1D33T4	moderate	Altered Expression	[1052]
ISL1	OTVNVKAX	moderate	Biomarker	[1053]
ITGA2B	OT4Y17PY	moderate	Genetic Variation	[1026]
KIF3C	OTTXKIWA	moderate	Altered Expression	[1054]
KIFBP	OT1XADKG	moderate	Altered Expression	[1055]
LGALS7	OTMSVI7R	moderate	Biomarker	[1056]
LMO1	OTB59SKB	moderate	Genetic Variation	[1057]
LZIC	OTT07ZC7	moderate	Altered Expression	[646]
MAP1B	OTVXW089	moderate	Biomarker	[1058]
MCAT	OTH07FIW	moderate	Biomarker	[323]
MCPH1	OTYT3TT5	moderate	Biomarker	[323]
MCTS1	OT7SAOJP	moderate	Biomarker	[323]
MGAT5	OTU4DD4G	moderate	Biomarker	[1059]
MGAT5B	OT5HP73K	moderate	Altered Expression	[1059]
MMP20	OT16S5S3	moderate	Genetic Variation	[1060]
MSH6	OT46FP09	moderate	Biomarker	[1061]
MYOG	OTPLJKFA	moderate	Altered Expression	[1062]
NAALADL1	OTQNOZBP	moderate	Biomarker	[1063]
NAV2	OTGAOL01	moderate	Biomarker	[1064]
NCKAP1	OTEZQXXJ	moderate	Altered Expression	[1065]
NCOA7	OT2CNBOG	moderate	Biomarker	[1066]
NCOR2	OTY917X0	moderate	Biomarker	[382]
NEUROG1	OTMJZP9G	moderate	Biomarker	[1067]
NEUROG2	OTAEMIGT	moderate	Biomarker	[1068]
NFIA	OTDHQ9CG	moderate	Biomarker	[1032]
NFIB	OTX94PD0	moderate	Biomarker	[1032]
NFIC	OTLMCUIB	moderate	Biomarker	[1069]
NFIX	OT1DPZAE	moderate	Biomarker	[1032]
NFYB	OTXSE7KW	moderate	Altered Expression	[663]
NGRN	OTP51NME	moderate	Biomarker	[1070]
NIF3L1	OT4MP90J	moderate	Altered Expression	[332]
NOA1	OT9GTOAC	moderate	Biomarker	[1071]
NOP53	OTA2YKO6	moderate	Biomarker	[1072]
NPAS4	OTA3HH6W	moderate	Biomarker	[997]
NRSN1	OT1KKXC8	moderate	Genetic Variation	[1073]
NXF1	OTEFHXG6	moderate	Altered Expression	[1074]
OAZ1	OTPT0PKZ	moderate	Biomarker	[869]
OCA2	OTDWIGBF	moderate	Biomarker	[1047]
OSBPL1A	OTQ33OQV	moderate	Altered Expression	[1075]
OTUD4	OT7U62SW	moderate	Biomarker	[1076]
PABPC4	OTICKKBQ	moderate	Biomarker	[666]
PAK5	OT32WQGL	moderate	Altered Expression	[1077]
PDYN	OTEJ6430	moderate	Altered Expression	[1078]
PEG3	OTHQW98S	moderate	Genetic Variation	[1079]
PITX3	OTE2KT8P	moderate	Biomarker	[1080]
PLEKHG5	OTL0S21W	moderate	Biomarker	[1081]
PNPT1	OTBR2Q0F	moderate	Biomarker	[1079]
POM121	OTIA7ZOQ	moderate	Altered Expression	[1082]
POMGNT1	OTBNOUZC	moderate	Altered Expression	[1083]
PPP1R11	OTSHYPPW	moderate	Biomarker	[1084]
PPP1R15A	OTYG179K	moderate	Biomarker	[1042]
PSENEN	OTJ7M7G9	moderate	Biomarker	[1085]
PTBP2	OTF4S7NE	moderate	Biomarker	[1086]
PTMA	OT2W4T1M	moderate	Biomarker	[1087]
PTPRT	OTV5TXNN	moderate	Altered Expression	[1003]
PVR	OT3N91T7	moderate	Altered Expression	[1088]
QSOX2	OTMLKYFP	moderate	Biomarker	[1089]
RAB1B	OTAFCUAS	moderate	Biomarker	[992]
RAE1	OT54OKC3	moderate	Biomarker	[1090]
RAMP1	OT7UT2XB	moderate	Biomarker	[1091]
RAP1B	OTHEIIMM	moderate	Biomarker	[992]
RAP2B	OTD2NDQP	moderate	Biomarker	[992]
RASGRF1	OTNWJ7EN	moderate	Biomarker	[1092]
RASSF5	OT6Q41I2	moderate	Biomarker	[908]
RBL2	OTBQSOE6	moderate	Biomarker	[1093]
RBP7	OT0J3CPT	moderate	Biomarker	[1031]
RCBTB2	OTECBF4R	moderate	Biomarker	[1094]
RFLNB	OTI7ZM75	moderate	Biomarker	[315]
RIOX2	OT2YFPI2	moderate	Biomarker	[1095]
RNF8	OTRR43PZ	moderate	Biomarker	[1044]
RP1	OTDDT69Y	moderate	Altered Expression	[1075]
RSRC1	OTFCJ4S0	moderate	Genetic Variation	[737]
SAA2	OTYAVJWG	moderate	Altered Expression	[369]
SCGB3A1	OTIR98RB	moderate	Biomarker	[1076]
SDHA	OTOJ8QFF	moderate	Altered Expression	[1096]
SDHC	OTC8G2MX	moderate	Biomarker	[1097]
SEPTIN1	OT4GVSU3	moderate	Altered Expression	[1098]
SET	OTGYYQJO	moderate	Genetic Variation	[1099]
SH2D3C	OTAGXO0N	moderate	Biomarker	[1047]
SIX1	OT70YYWM	moderate	Biomarker	[1100]
SMG1	OTTS3SXE	moderate	Biomarker	[327]
SMR3B	OTL5HNM8	moderate	Altered Expression	[360]
SNCB	OTELSEK6	moderate	Altered Expression	[1101]
SORL1	OTQ8FFNS	moderate	Altered Expression	[1102]
SPRY2	OTH0CRCZ	moderate	Biomarker	[1103]
SRCIN1	OTQZNQQ5	moderate	Biomarker	[1104]
SSR2	OTQJSL7M	moderate	Biomarker	[1105]
SSX2	OT2Z6RLL	moderate	Biomarker	[1106]
SSX4	OT0E4H2D	moderate	Biomarker	[1106]
SUMO1	OTJFD4P5	moderate	Biomarker	[353]
TAF12	OTQZII5O	moderate	Altered Expression	[1107]
TAPBP	OTL81AVZ	moderate	Altered Expression	[1074]
TBPL1	OT4I143E	moderate	Biomarker	[378]
TCF7	OT1ID822	moderate	Altered Expression	[387]
TENM2	OTPLUYEF	moderate	Biomarker	[1108]
TLK2	OTZ09CG8	moderate	Genetic Variation	[1109]
TLX1	OTVN0MNW	moderate	Biomarker	[1110]
TMED2	OTBLO7RW	moderate	Genetic Variation	[1073]
TNFSF9	OTV9L89D	moderate	Altered Expression	[1111]
TOB1	OTNW949D	moderate	Altered Expression	[1112]
TOR2A	OT1EGCDU	moderate	Altered Expression	[1113]
TPPP	OTCFMSUF	moderate	Genetic Variation	[1073]
TTL	OTSS1CK4	moderate	Altered Expression	[1114]
TTLL1	OTCE097J	moderate	Altered Expression	[1114]
AATF	OT1QOKLD	Strong	Biomarker	[662]
ACIN1	OTK81F92	Strong	Biomarker	[1115]
ACO1	OT2VUR7L	Strong	Biomarker	[1116]
ACTR1B	OTGBCKLO	Strong	Biomarker	[493]
ACY1	OT9WU7X3	Strong	Biomarker	[402]
ACY3	OTZWAB73	Strong	Biomarker	[402]
ADAP1	OTM4CHU1	Strong	Biomarker	[1117]
APH1A	OT97F1TU	Strong	Genetic Variation	[1118]
APLP2	OTTFE53M	Strong	Altered Expression	[1119]
APOD	OTT77XW8	Strong	Altered Expression	[1120]
ARC	OTN2QQPG	Strong	Biomarker	[1121]
ARID1A	OTRWDV3P	Strong	Biomarker	[1122]
ARR3	OTRZ00CH	Strong	Genetic Variation	[82]
ARTN	OTWIWGL6	Strong	Biomarker	[394]
ASCC1	OTH4VAP9	Strong	Altered Expression	[1123]
ASCL1	OTI4X44G	Strong	Biomarker	[1053]
ASIC4	OT5POMCQ	Strong	Genetic Variation	[401]
ASPSCR1	OTXTOD10	Strong	Genetic Variation	[1124]
ATN1	OTNZFLKY	Strong	Altered Expression	[576]
ATRX	OT77RSQW	Strong	Biomarker	[1125]
B3GAT1	OTXFP98E	Strong	Altered Expression	[1126]
BBS2	OTPF9JIB	Strong	Biomarker	[1127]
BCL2L11	OTNQQWFJ	Strong	Biomarker	[1128]
BCOR	OTG013AX	Strong	Biomarker	[1129]
BRINP1	OTEUVSCP	Strong	Altered Expression	[1130]
BTG2	OTZF6K1H	Strong	Biomarker	[493]
CADM1	OTRWG9QS	Strong	Biomarker	[1131]
CAMK2B	OTS9YK3E	Strong	Biomarker	[1132]
CAMK2G	OTHD9KJG	Strong	Biomarker	[1132]
CAMK4	OT47RDGV	Strong	Biomarker	[1133]
CAMSAP2	OT9KXWE7	Strong	Altered Expression	[1134]
CAMTA1	OTAN1S5B	Strong	Biomarker	[1135]
CAPG	OTJ86KI6	Strong	Altered Expression	[1136]
CBX8	OT4U5V1T	Strong	Biomarker	[493]
CCAR2	OTLUDG5T	Strong	Biomarker	[1130]
CCDC174	OTA0Z9RZ	Strong	Biomarker	[1137]
CCL7	OTDIS99H	Strong	Biomarker	[1138]
CCT4	OT5D452X	Strong	Altered Expression	[1139]
CD99	OTPUZ5DE	Strong	Biomarker	[562]
CDC42	OT5QBC5M	Strong	Biomarker	[1140]
CDCA2	OTX8UF9J	Strong	Altered Expression	[1141]
CDK11A	OTN5TSGQ	Strong	Genetic Variation	[1142]
CEBPD	OTNBIPMY	Strong	Altered Expression	[1143]
CEND1	OTPHOC22	Strong	Biomarker	[1144]
CERS1	OT6EYRM3	Strong	Altered Expression	[1145]
CHAF1A	OTXSSY4H	Strong	Biomarker	[178]
CHD5	OTS5EVHH	Strong	Altered Expression	[1146]
CHD6	OTEHW1U2	Strong	Biomarker	[320]
CHL1	OT6E6E8P	Strong	Biomarker	[1147]
CHPT1	OT4FJ0K3	Strong	Biomarker	[1148]
CIC	OTFXCHNZ	Strong	Genetic Variation	[1129]
CIP2A	OTVS2GXA	Strong	Biomarker	[1149]
CIR1	OTKP5JKH	Strong	Biomarker	[486]
CLCN4	OT4A2UWF	Strong	Altered Expression	[1150]
CLTA	OTLHOXMQ	Strong	Genetic Variation	[469]
CLYBL	OTXZLTST	Strong	Biomarker	[1151]
CPQ	OTTNZNLD	Strong	Biomarker	[500]
CRABP1	OTISDG5X	Strong	Altered Expression	[1152]
CRABP2	OTY01V9G	Strong	Altered Expression	[1153]
CRKL	OTOYSD1R	Strong	Biomarker	[1154]
CRYGD	OTW29JC4	Strong	Genetic Variation	[572]
CTAG1B	OTIQGW6U	Strong	Biomarker	[435]
CTCF	OT8ZB70U	Strong	Biomarker	[1155]
CTNNBL1	OT6KLHPA	Strong	Altered Expression	[1156]
CXADR	OT9ZP02A	Strong	Genetic Variation	[82]
DCC	OT2C1SHW	Strong	Genetic Variation	[1157]
DCTN6	OTI8PIN9	Strong	Altered Expression	[955]
DCX	OTISR7K3	Strong	Biomarker	[1158]
DDIT3	OTI8YKKE	Strong	Altered Expression	[1159]
DDX1	OT3U8FD0	Strong	Altered Expression	[1160]
DECR1	OTCDIR6X	Strong	Altered Expression	[1161]
DEPP1	OTB36PHJ	Strong	Biomarker	[1162]
DES	OTI09KBW	Strong	Altered Expression	[1163]
DHDDS	OTVLYBUS	Strong	Biomarker	[1148]
DHX58	OT19BYB1	Strong	Biomarker	[578]
DLD	OT378CU9	Strong	Biomarker	[1164]
DMBT1	OTVNU9D9	Strong	Biomarker	[1165]
DNER	OT2GH2E5	Strong	Altered Expression	[1166]
DOCK4	OTH3XY8B	Strong	Biomarker	[1167]
DOCK8	OTNQLL21	Strong	Biomarker	[1168]
DPYS	OTLTUIVL	Strong	Altered Expression	[1169]
DPYSL3	OTINJV20	Strong	Biomarker	[1169]
E2F5	OT1XWING	Strong	Biomarker	[1170]
EDIL3	OTDVVNS0	Strong	Genetic Variation	[1171]
EIF3I	OTE07WND	Strong	Altered Expression	[903]
ELAVL4	OT3YH6J6	Strong	Altered Expression	[1172]
EMP3	OTODMJ1D	Strong	Biomarker	[1173]
ENC1	OTJEUB6U	Strong	Altered Expression	[1174]
ENDOU	OTB7OF7Y	Strong	Genetic Variation	[1175]
ERVW-1	OTWV8DXJ	Strong	Altered Expression	[1176]
ETFA	OTXX61VZ	Strong	Genetic Variation	[469]
EWSR1	OT7SRHV3	Strong	Biomarker	[198]
EXOSC6	OTAC10N6	Strong	Genetic Variation	[1175]
FAM107A	OTBG61YZ	Strong	Biomarker	[734]
FAM163A	OT0MYZ0F	Strong	Altered Expression	[1177]
FAM3B	OTC2S91N	Strong	Biomarker	[1178]
FBXL5	OT93D50X	Strong	Biomarker	[1179]
FBXW11	OT2A6RLR	Strong	Biomarker	[765]
FLI1	OT0EV3LX	Strong	Genetic Variation	[1180]
FOXD3	OTXYV6GO	Strong	Biomarker	[1155]
FOXO3	OTHXQG4P	Strong	Biomarker	[1181]
FOXR1	OTL8V888	Strong	Altered Expression	[1182]
FRMD7	OTJ11849	Strong	Altered Expression	[1183]
FRYL	OTBN3XHN	Strong	Altered Expression	[1184]
FUBP1	OT77SC9N	Strong	Biomarker	[1185]
GABPA	OT9YB2SA	Strong	Biomarker	[1186]
GALNT9	OTFRD9RI	Strong	Altered Expression	[1187]
GDAP1	OTQE1O25	Strong	Biomarker	[1188]
GDE1	OTU6FSBF	Strong	Biomarker	[1189]
HACE1	OTEZULKD	Strong	Biomarker	[655]
HAND2	OTCXYW4Y	Strong	Biomarker	[1190]
HCLS1	OTX7WGYN	Strong	Altered Expression	[194]
HES4	OTCGMQDT	Strong	Biomarker	[1191]
HEY1	OTJQL0I3	Strong	Altered Expression	[1192]
HFE	OTDD93KB	Strong	Altered Expression	[1193]
HLA-C	OTV38BUJ	Strong	Altered Expression	[848]
HNRNPC	OT47AK4C	Strong	Altered Expression	[1194]
HNRNPDL	OTB3BFCV	Strong	Altered Expression	[1194]
HNRNPK	OTNPRM8U	Strong	Biomarker	[1195]
HOXB1	OTGC0EKI	Strong	Altered Expression	[1196]
HOXB2	OTTD6HMV	Strong	Altered Expression	[1196]
HOXB3	OT9UC5PE	Strong	Altered Expression	[1196]
HOXB4	OTH1HRW5	Strong	Altered Expression	[1196]
HOXB5	OTU74TB8	Strong	Altered Expression	[1197]
HOXB6	OT3TFQ0U	Strong	Altered Expression	[1196]
HOXB7	OTC7WYU8	Strong	Altered Expression	[1196]
HOXB8	OTKHOD17	Strong	Altered Expression	[1196]
HOXB9	OTMVHQOU	Strong	Altered Expression	[1196]
HOXC9	OT60K4M0	Strong	Biomarker	[490]
HPR	OTXSC9UB	Strong	Biomarker	[1198]
HSPA14	OTZCA5LK	Strong	Biomarker	[1130]
HSPA1A	OTKGIE76	Strong	Altered Expression	[802]
HSPB2	OTS01646	Strong	Biomarker	[477]
HSPB6	OTFPLGZI	Strong	Biomarker	[1199]
ID3	OTUULW5Z	Strong	Biomarker	[1200]
IFI27	OTI2XGIT	Strong	Altered Expression	[955]
IFIH1	OTZA2AHA	Strong	Altered Expression	[578]
IFNA1	OTPMKY0L	Strong	Biomarker	[1201]
INCENP	OT9HFRYK	Strong	Biomarker	[1202]
INTS6	OT6GDV46	Strong	Altered Expression	[1203]
IQCJ	OTOC5U9H	Strong	Altered Expression	[1204]
IREB2	OT747D24	Strong	Biomarker	[1179]
IRF2	OTAZRUW3	Strong	Biomarker	[1205]
ITIH4	OT460OO1	Strong	Biomarker	[1206]
KHSRP	OTDHZARB	Strong	Altered Expression	[194]
KIDINS220	OTLBH2MA	Strong	Biomarker	[1207]
KLC1	OTSTTTW7	Strong	Altered Expression	[1208]
LEF1	OTWS5I5H	Strong	Altered Expression	[860]
LGI1	OTPS77HO	Strong	Altered Expression	[1209]
LIG1	OTEEQS43	Strong	Biomarker	[820]
LRP10	OT8490HT	Strong	Altered Expression	[1210]
LRRC17	OT3NZSX3	Strong	Altered Expression	[1211]
MAX	OTKZ0YKM	Strong	Biomarker	[1212]
MBD2	OTUQPP0R	Strong	Posttranslational Modification	[490]
MCF2L2	OTOGFMIH	Strong	Biomarker	[1213]
MED25	OTDBY87B	Strong	Biomarker	[1214]
MEGF10	OTILSPJ6	Strong	Biomarker	[1215]
MEIS1	OTH9DKAD	Strong	Biomarker	[622]
MFAP1	OTZN4FT3	Strong	Biomarker	[668]
MFN2	OTPYN8A3	Strong	Biomarker	[1216]
MFSD12	OT54Y9TN	Strong	Biomarker	[1217]
MOK	OTQK7M9V	Strong	Biomarker	[206]
MOS	OTNMQPFJ	Strong	Biomarker	[1218]
MPHOSPH6	OT6E2S48	Strong	Biomarker	[1219]
MPZ	OTAR2YXH	Strong	Biomarker	[1219]
MSH3	OTD3YPVL	Strong	Biomarker	[88]
MXD3	OT4U88UP	Strong	Altered Expression	[1220]
MZB1	OT071TET	Strong	Biomarker	[293]
NAA50	OTFJ8S47	Strong	Biomarker	[1221]
NANS	OTMQ2FUH	Strong	Biomarker	[1222]
NAV3	OT97M1TR	Strong	Genetic Variation	[1223]
NBAS	OTW9IBRI	Strong	Genetic Variation	[1224]
NBPF1	OTAZ55UQ	Strong	Biomarker	[401]
NDN	OTYBYJ82	Strong	Altered Expression	[1225]
NDRG2	OT5L6KD7	Strong	Altered Expression	[811]
NDUFV2	OTSZF7D6	Strong	Altered Expression	[1226]
NELL2	OTS4MJZ7	Strong	Altered Expression	[521]
NEO1	OTGJ1997	Strong	Biomarker	[1227]
NEU4	OTM16O9F	Strong	Altered Expression	[1228]
NFATC2	OTK5T6HZ	Strong	Biomarker	[1129]
NLN	OTFRITPU	Strong	Altered Expression	[1229]
NNAT	OTNRLO7G	Strong	Altered Expression	[1230]
NOVA2	OTQ2X3Q4	Strong	Biomarker	[1231]
NRDC	OTWBBCXO	Strong	Altered Expression	[1117]
NRF1	OTOXWNV8	Strong	Posttranslational Modification	[1232]
NRGN	OTVGE10W	Strong	Altered Expression	[1204]
NRIP1	OTIZOJQV	Strong	Altered Expression	[1233]
NTN4	OTDRRMP3	Strong	Biomarker	[1227]
NUMBL	OTWMTMMH	Strong	Biomarker	[1234]
OPN4	OT1LZ7TS	Strong	Altered Expression	[1229]
OSCP1	OTZ4IFGJ	Strong	Altered Expression	[526]
OXA1L	OTS0BFRD	Strong	Altered Expression	[1235]
OXT	OT48M72Z	Strong	Biomarker	[1236]
P4HB	OTTYNYPF	Strong	Altered Expression	[876]
PA2G4	OT7IG7HT	Strong	Biomarker	[1237]
PACRG	OT1NYNNW	Strong	Biomarker	[1238]
PAX3	OTN5PJZV	Strong	Genetic Variation	[1239]
PCLAF	OTMVIOUU	Strong	Biomarker	[1240]
PCNP	OTJUQ122	Strong	Biomarker	[1241]
PEA15	OTKCKTSX	Strong	Biomarker	[1242]
PENK	OT8P3HMP	Strong	Biomarker	[1243]
PGK1	OT6V1ICH	Strong	Altered Expression	[1244]
PHLDA2	OTMV9DPP	Strong	Biomarker	[1245]
PI15	OTPJL6ML	Strong	Altered Expression	[1246]
PIK3C2G	OTW3LY1C	Strong	Genetic Variation	[711]
PIK3R2	OTZSUQK5	Strong	Altered Expression	[1156]
PINK1	OT50NR57	Strong	Biomarker	[1247]
PIP	OTH719AH	Strong	Biomarker	[1248]
PIWIL1	OT7CRGZ3	Strong	Altered Expression	[1249]
PIWIL4	OTDA9MY0	Strong	Altered Expression	[1249]
PLAAT4	OTI66SAJ	Strong	Biomarker	[578]
PLB1	OTZ6TTYV	Strong	Altered Expression	[230]
PMAIP1	OTXEE550	Strong	Biomarker	[1250]
PMCH	OT3D9SA4	Strong	Altered Expression	[1251]
PNOC	OTJEAADN	Strong	Altered Expression	[1252]
POU4F1	OTMHYGWQ	Strong	Altered Expression	[1253]
POU4F2	OT6SW5H0	Strong	Altered Expression	[1254]
PPARGC1A	OTHCDQ22	Strong	Biomarker	[1186]
PPT2	OTD5VJ9A	Strong	Altered Expression	[1255]
PRICKLE1	OT9HHEM9	Strong	Altered Expression	[1256]
PRRT2	OTCJUBDO	Strong	Biomarker	[481]
PSMD9	OT6Y5CC3	Strong	Altered Expression	[955]
PTHLH	OTI1JF13	Strong	Altered Expression	[242]
PTPA	OTRGFOI7	Strong	Altered Expression	[1257]
PXN	OTVMMUOF	Strong	Altered Expression	[1258]
QRICH1	OTPVAX04	Strong	Altered Expression	[1259]
QRSL1	OTJDU2UG	Strong	Genetic Variation	[1260]
RABGEF1	OTWC3Z3R	Strong	Altered Expression	[1261]
RAN	OT2TER5M	Strong	Biomarker	[1262]
RAP1A	OT5RH6TI	Strong	Altered Expression	[1261]
RBM3	OTAJ7R31	Strong	Biomarker	[1263]
RCAN1	OT1MVXC7	Strong	Altered Expression	[1264]
RD3	OT2L9Y6M	Strong	Biomarker	[1265]
REST	OTLL92LQ	Strong	Biomarker	[1266]
RFC1	OT3L5PK3	Strong	Genetic Variation	[1267]
RGS5	OTUY0Q2I	Strong	Biomarker	[1268]
RHOT1	OTBIRR8Q	Strong	Biomarker	[1269]
RRP1	OT4A8HR3	Strong	Biomarker	[1270]
RRP1B	OTHDRVML	Strong	Biomarker	[1270]
RTL1	OTOT33IM	Strong	Biomarker	[513]
S100A10	OTI71243	Strong	Genetic Variation	[1175]
SARDH	OTQ49Q27	Strong	Biomarker	[572]
SART3	OTC1AM7S	Strong	Biomarker	[1271]
SCAPER	OT7S3B3P	Strong	Altered Expression	[1272]
SCN7A	OTK05PXY	Strong	Biomarker	[517]
SDS	OT5WTJ2M	Strong	Biomarker	[660]
SEL1L	OTC0FB7T	Strong	Biomarker	[628]
SEMA3B	OTCZCPMS	Strong	Altered Expression	[1273]
SERPINA5	OTTZXPGD	Strong	Genetic Variation	[1274]
SERPINE2	OTYF5340	Strong	Biomarker	[1275]
SESN2	OT889IXY	Strong	Altered Expression	[1276]
SFPQ	OTLCIAPJ	Strong	Biomarker	[1118]
SGSM3	OTIB1P8A	Strong	Altered Expression	[114]
SIGLEC7	OTNDLURR	Strong	Altered Expression	[194]
SLC12A9	OTR7VRAK	Strong	Altered Expression	[1277]
SLFN11	OTJWFPMY	Strong	Altered Expression	[1278]
SMN2	OT54RLO1	Strong	Biomarker	[571]
SMOC1	OTJG2JQY	Strong	Altered Expression	[1279]
SMS	OT8JYKNH	Strong	Biomarker	[847]
SNAI2	OT7Y8EJ2	Strong	Altered Expression	[849]
SNCAIP	OTH8VNOK	Strong	Altered Expression	[1280]
SPART	OTIVOS2I	Strong	Altered Expression	[1281]
SPG7	OT8OY9ST	Strong	Genetic Variation	[82]
SRSF6	OTGLOSYE	Strong	Biomarker	[1282]
ST8SIA1	OTGND2YZ	Strong	Altered Expression	[1283]
STMN2	OT0FUHLH	Strong	Altered Expression	[1284]
SUCLA2	OTMZD4PW	Strong	Altered Expression	[69]
TAF13	OT1XMYAD	Strong	Biomarker	[1285]
TBCEL	OT2PZLLL	Strong	Biomarker	[1231]
TBP	OT6C0S52	Strong	Biomarker	[1286]
TBX2	OTTOT7A9	Strong	Altered Expression	[392]
TBX5	OT70PISV	Strong	Biomarker	[556]
TERF2IP	OT3M5P3G	Strong	Altered Expression	[1261]
TFAP2E	OTA4B1SG	Strong	Biomarker	[1287]
TFE3	OTM99ZWH	Strong	Genetic Variation	[1124]
TGFBR3	OTQOOUC4	Strong	Biomarker	[1288]
TICAM2	OTK7GIJ5	Strong	Altered Expression	[955]
TLX2	OTPFAUM8	Strong	Genetic Variation	[1289]
TMED7	OTONO8E6	Strong	Altered Expression	[955]
TMEM132D	OTV6I4Z0	Strong	Genetic Variation	[1290]
TNFAIP1	OT37EWR0	Strong	Biomarker	[1291]
TP53BP2	OTOWJ2Y4	Strong	Biomarker	[1292]
TP53INP1	OT2363Z9	Strong	Biomarker	[1293]
TPPP3	OTU8VUIG	Strong	Altered Expression	[1117]
TRAT1	OTMPUNPD	Strong	Biomarker	[1294]
TRIB3	OTG5OS7X	Strong	Biomarker	[1295]
TRIM13	OTQIUACB	Strong	Genetic Variation	[82]
TRIM16	OTLRXYOZ	Strong	Biomarker	[1296]
TRIM32	OTJOV0PG	Strong	Altered Expression	[1297]
TSPAN3	OT7WS6ZI	Strong	Biomarker	[1298]
TSPAN31	OT8WQ83R	Strong	Biomarker	[1222]
TSPAN8	OT1F68WQ	Strong	Genetic Variation	[1299]
AADAC	OT8VACT2	Definitive	Biomarker	[1300]
ADGRB1	OTJSEXRC	Definitive	Altered Expression	[1301]
AJAP1	OTAAW121	Definitive	Biomarker	[282]
AMBRA1	OTY0YGT9	Definitive	Biomarker	[1302]
ANK2	OTWB4R1Y	Definitive	Altered Expression	[1303]
APTX	OTPAS5G8	Definitive	Genetic Variation	[1304]
ARHGEF7	OT9BPJCL	Definitive	Altered Expression	[1305]
ATF2	OTNIZPEA	Definitive	Altered Expression	[365]
BAG3	OTVXYUDQ	Definitive	Biomarker	[1306]
BAMBI	OTCEJ8W5	Definitive	Biomarker	[1307]
BARD1	OTTC0Z9Y	Definitive	Biomarker	[839]
CASZ1	OTWJ2OR8	Definitive	Altered Expression	[1308]
CD82	OTH8MC64	Definitive	Altered Expression	[1309]
CDKN3	OTBE3H07	Definitive	Biomarker	[1310]
CFL1	OTT6D5MH	Definitive	Biomarker	[1311]
CMPK2	OTOG90R0	Definitive	Genetic Variation	[1312]
CMYA5	OTYV0RME	Definitive	Biomarker	[1313]
CNBP	OTTGM9NK	Definitive	Altered Expression	[1314]
CRISP2	OT8HLTV5	Definitive	Posttranslational Modification	[1315]
DAB1	OTPL9MA3	Definitive	Biomarker	[824]
DDI1	OTNFQSKQ	Definitive	Biomarker	[290]
DNAJC11	OTYLMZWW	Definitive	Genetic Variation	[1316]
DTNBP1	OT9UQT2S	Definitive	Biomarker	[611]
EDC3	OTYS7O69	Definitive	Biomarker	[1317]
EFS	OT06O7XL	Definitive	Biomarker	[1318]
ELK1	OTH9MXD6	Definitive	Biomarker	[1319]
ENO1	OTB1KWJS	Definitive	Altered Expression	[1320]
ERAL1	OTSH78HD	Definitive	Biomarker	[1321]
FBXW4	OTEGSZOX	Definitive	Biomarker	[1300]
HES5	OTW7JEHV	Definitive	Posttranslational Modification	[796]
HIC1	OTI9TWY4	Definitive	Biomarker	[1322]
HOXC6	OTBCRAZV	Definitive	Altered Expression	[1048]
HOXD8	OTJ5H7AT	Definitive	Altered Expression	[1323]
IFIT2	OTI4EOAR	Definitive	Biomarker	[1324]
INSRR	OT3F75WA	Definitive	Altered Expression	[1325]
KCNH4	OTHJ8WTU	Definitive	Biomarker	[1319]
KCNH8	OT3I5FLB	Definitive	Biomarker	[1319]
KIF1A	OT3JVEGV	Definitive	Altered Expression	[726]
KIF5B	OTT34MT8	Definitive	Biomarker	[1326]
LGALS3BP	OT9AGQKH	Definitive	Biomarker	[1327]
LMO4	OT5NDCT9	Definitive	Altered Expression	[1328]
LRRN1	OT6MMO6L	Definitive	Biomarker	[1329]
LRRN3	OT7X0AA7	Definitive	Biomarker	[1330]
MADD	OTUFYVGG	Definitive	Altered Expression	[1331]
MAP2K4	OTZPZX11	Definitive	Altered Expression	[194]
MATK	OTVOJJLJ	Definitive	Altered Expression	[1332]
MXI1	OTUQ9E0D	Definitive	Altered Expression	[1333]
NAP1L1	OTI7WBZV	Definitive	Biomarker	[1334]
NCAN	OT8OO6ZE	Definitive	Altered Expression	[1335]
NCSTN	OT5QBTA4	Definitive	Biomarker	[1336]
NEFL	OTQESJV4	Definitive	Altered Expression	[1337]
NFE2L1	OT1QHOS2	Definitive	Biomarker	[705]
NT5C3A	OT67KZJA	Definitive	Biomarker	[1338]
PACC1	OTKBS8CC	Definitive	Biomarker	[1339]
PDIK1L	OTISF4KG	Definitive	Altered Expression	[1340]
PEX14	OT98BZHE	Definitive	Biomarker	[645]
PLXNA2	OTNNBJMQ	Definitive	Biomarker	[1341]
PRAF2	OT1QN4LV	Definitive	Biomarker	[1342]
PROX1	OT68R6IO	Definitive	Altered Expression	[1343]
PRPH	OT6VUH78	Definitive	Altered Expression	[1052]
PRSS55	OTXXWI5Y	Definitive	Posttranslational Modification	[1315]
PRUNE1	OTQ3UHWQ	Definitive	Biomarker	[1344]
PSMC5	OTJOORMR	Definitive	Biomarker	[382]
PTPRA	OTZA82J1	Definitive	Biomarker	[254]
PTPRD	OTZPJ3GX	Definitive	Genetic Variation	[1345]
PTPRF	OTH5KF2D	Definitive	Biomarker	[1346]
PVALB	OTZW1WVQ	Definitive	Biomarker	[1347]
RAB6B	OT5N57RK	Definitive	Biomarker	[992]
RASSF7	OT0V4EIZ	Definitive	Biomarker	[908]
SIAH1	OT29A838	Definitive	Biomarker	[1348]
SMARCB1	OT2LP7LJ	Definitive	Posttranslational Modification	[84]
SPZ1	OTQH8HJ5	Definitive	Posttranslational Modification	[1315]
ST8SIA2	OTRBBBD8	Definitive	Genetic Variation	[1349]
SYNM	OTOI8TRJ	Definitive	Altered Expression	[112]
TAT	OT2CJ91O	Definitive	Biomarker	[1350]
TMSB10	OTLVZ13T	Definitive	Altered Expression	[1351]
TMSB15A	OTSBWCES	Definitive	Altered Expression	[1352]
TNFRSF10C	OTVHOL9B	Definitive	Posttranslational Modification	[84]

References

• [1] A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
• [2] Busulfan FDA Label
• [3] Carboplatin FDA Label
• [4] Cyclophosphamide FDA Label
• [5] Dacarbazine FDA Label
• [6] Doxorubicin FDA Label
• [7] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [8] Erlotinib FDA Label
• [9] Etoposide FDA Label
• [10] Everolimus FDA Label
• [11] Fludarabine FDA Label
• [12] Ifosfamide FDA Label
• [13] Irinotecan FDA Label
• [14] Isotretinoin FDA Label
• [15] Melphalan FDA Label
• [16] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [17] Sirolimus FDA Label
• [18] Temozolomide FDA Label
• [19] Thiotepa FDA Label
• [20] Topotecan FDA Label
• [21] Tretinoin FDA Label
• [22] Vidarabine FDA Label
• [23] Vincristine FDA Label
• [24] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7979).
• [25] ClinicalTrials.gov (NCT03275402) 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases. U.S. National Institutes of Health.
• [26] ClinicalTrials.gov (NCT00810238) C-Cure Clinical Trial. U.S. National Institutes of Health.
• [27] Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386.
• [28] ClinicalTrials.gov (NCT03275402) 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases. U.S. National Institutes of Health.
• [29] ClinicalTrials.gov (NCT02765243) Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma
• [30] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [31] Clinical pipeline report, company report or official report of Apeiron Biologics.
• [32] Clinical pipeline report, company report or official report of Y-mAbs Therapeutics.
• [33] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004852)
• [34] ClinicalTrials.gov (NCT04438304) Positron Emission Tomography Imaging of Participants With Known or Suspected Neuroendocrine Tumours Using 64Cu SARTATE: A Multi-Centre, Single Arm, Non-Randomised, Blinded-Review, Phase II Study. U.S.National Institutes of Health.
• [35] ClinicalTrials.gov (NCT04023331) 67Cu-SARTATE Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma. U.S. National Institutes of Health.
• [36] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [37] ClinicalTrials.gov (NCT03373097) Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma
• [38] ClinicalTrials.gov (NCT02761915) A Cancer Research UK Trial of Anti-GD2 T-cells (1RG-CART)
• [39] ClinicalTrials.gov (NCT02107963) A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
• [40] ClinicalTrials.gov (NCT03635632) C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma (GAIL-N)
• [41] ClinicalTrials.gov (NCT02311621) Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
• [42] ClinicalTrials.gov (NCT01953900) iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
• [43] ClinicalTrials.gov (NCT01822652) 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
• [44] ClinicalTrials.gov (NCT03721068) Phase I Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma
• [45] Clinical pipeline report, company report or official report of Kuur Therapeutics.
• [46] ClinicalTrials.gov (NCT02337309) SF1126 for Patients With Relapsed or Refractory Neuroblastoma. U.S. National Institutes of Health.
• [47] ClinicalTrials.gov (NCT02919046) Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children
• [48] Valproic Acid FDA Label
• [49] Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan invivo.Eur J Cancer. 2017 Sep;83:132-141. doi: 10.1016/j.ejca.2017.06.024. Epub 2017 Jul 20.
• [50] Platform comparison for evaluation of ALK protein immunohistochemical expression, genomic copy number and hotspot mutation status in neuroblastomas.PLoS One. 2014 Sep 4;9(9):e106575. doi: 10.1371/journal.pone.0106575. eCollection 2014.
• [51] Carnosic acid suppresses the production of amyloid- 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells.Neurosci Res. 2013 Feb;75(2):94-102. doi: 10.1016/j.neures.2012.11.007. Epub 2012 Dec 17.
• [52] Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity.Biochem J. 1996 Sep 15;318 ( Pt 3)(Pt 3):1033-9. doi: 10.1042/bj3181033.
• [53] N-cadherin in neuroblastoma disease: expression and clinical significance.PLoS One. 2012;7(2):e31206. doi: 10.1371/journal.pone.0031206. Epub 2012 Feb 15.
• [54] Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome.Oncotarget. 2017 Nov 6;8(63):106820-106832. doi: 10.18632/oncotarget.22423. eCollection 2017 Dec 5.
• [55] Genetic variant rs3750625 in the 3'UTR of ADRA2A affects stress-dependent acute pain severity after trauma and alters a microRNA-34a regulatory site.Pain. 2017 Feb;158(2):230-239. doi: 10.1097/j.pain.0000000000000742.
• [56] Macrophage-Derived IL1 and TNF Regulate Arginine Metabolism in Neuroblastoma.Cancer Res. 2019 Feb 1;79(3):611-624. doi: 10.1158/0008-5472.CAN-18-2139. Epub 2018 Dec 13.
• [57] Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma.Oncotarget. 2019 Sep 24;10(54):5645-5659. doi: 10.18632/oncotarget.27210. eCollection 2019 Sep 24.
• [58] Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.Anticancer Res. 2016 Aug;36(8):3991-5.
• [59] Expression of DHA-Metabolizing Enzyme Alox15 is Regulated by Selective Histone Acetylation in Neuroblastoma Cells. Neurochem Res. 2018 Mar;43(3):540-555.
• [60] Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.Oncotarget. 2015 Dec 8;6(39):41522-34. doi: 10.18632/oncotarget.6308.
• [61] The secretion of the angiogenic and neurotrophic factor angiogenin is COPII and microtubule dependent.Exp Cell Res. 2019 Aug 15;381(2):265-279. doi: 10.1016/j.yexcr.2019.05.025. Epub 2019 May 22.
• [62] TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/-catenin signaling pathway in neuroblastoma.Biosci Rep. 2019 Jan 18;39(1):BSR20181277. doi: 10.1042/BSR20181277. Print 2019 Jan 31.
• [63] Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.J Alzheimers Dis. 2019;71(2):597-611. doi: 10.3233/JAD-190419.
• [64] ASIC1 promotes differentiation of neuroblastoma by negatively regulating Notch signaling pathway.Oncotarget. 2017 Jan 31;8(5):8283-8293. doi: 10.18632/oncotarget.14164.
• [65] Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.J Virol. 2011 Dec;85(24):13114-23. doi: 10.1128/JVI.05759-11. Epub 2011 Sep 28.
• [66] MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma.Cancer Cell Int. 2018 Jan 4;18:5. doi: 10.1186/s12935-017-0499-2. eCollection 2018.
• [67] The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance.Cancer Lett. 1996 Jul 12;104(2):183-92. doi: 10.1016/0304-3835(96)04250-4.
• [68] ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.Oncogene. 2016 Jul 14;35(28):3681-91. doi: 10.1038/onc.2015.434. Epub 2015 Nov 30.
• [69] Palmitate-Induced SREBP1 Expression and Activation Underlies the Increased BACE 1 Activity and Amyloid Beta Genesis.Mol Neurobiol. 2019 Jul;56(7):5256-5269. doi: 10.1007/s12035-018-1451-8. Epub 2018 Dec 19.
• [70] Therapeutic potential of BAK gene silencing in aluminum induced neural cell degeneration.J Inorg Biochem. 2009 Nov;103(11):1514-20. doi: 10.1016/j.jinorgbio.2009.06.010. Epub 2009 Aug 14.
• [71] The involvement of tau in nucleolar transcription and the stress response.Acta Neuropathol Commun. 2018 Jul 31;6(1):70. doi: 10.1186/s40478-018-0565-6.
• [72] miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A.Med Hypotheses. 2018 Aug;117:21-27. doi: 10.1016/j.mehy.2018.05.019. Epub 2018 May 26.
• [73] Biglycan, a Nitric Oxide-Downregulated Proteoglycan, Prevents Nitric Oxide-Induced Neuronal Cell Apoptosis via Targeting Erk1/2 and p38 Signaling Pathways.J Mol Neurosci. 2018 Sep;66(1):68-76. doi: 10.1007/s12031-018-1151-x. Epub 2018 Aug 7.
• [74] Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells.FEBS J. 2012 Jul;279(14):2579-94. doi: 10.1111/j.1742-4658.2012.08641.x. Epub 2012 Jun 14.
• [75] Downregulation of bone morphogenetic protein receptor 2 promotes the development of neuroblastoma.Biochem Biophys Res Commun. 2017 Jan 29;483(1):609-616. doi: 10.1016/j.bbrc.2016.12.095. Epub 2016 Dec 18.
• [76] Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma.Neoplasia. 2018 Oct;20(10):965-974. doi: 10.1016/j.neo.2018.08.002. Epub 2018 Aug 25.
• [77] Prognostic relevance of genetic alterations in the p32 region of chromosome 1 in neuroblastoma.Eur J Cancer. 1997 Oct;33(12):1983-5. doi: 10.1016/s0959-8049(97)00239-6.
• [78] C9orf72 Proteins Regulate Autophagy and Undergo Autophagosomal or Proteasomal Degradation in a Cell Type-Dependent Manner.Cells. 2019 Oct 10;8(10):1233. doi: 10.3390/cells8101233.
• [79] Modulation of human -synuclein aggregation by a combined effect of calcium and dopamine.Neurobiol Dis. 2014 Mar;63:115-28. doi: 10.1016/j.nbd.2013.11.004. Epub 2013 Nov 20.
• [80] Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.Schizophr Res. 2018 Sep;199:168-175. doi: 10.1016/j.schres.2018.02.036. Epub 2018 Feb 28.
• [81] Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation.RNA Biol. 2011 Nov-Dec;8(6):1061-72. doi: 10.4161/rna.8.6.16691. Epub 2011 Nov 1.
• [82] Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis.Dis Markers. 2019 Feb 11;2019:3425291. doi: 10.1155/2019/3425291. eCollection 2019.
• [83] Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression.Oncogene. 2012 Aug 16;31(33):3785-95. doi: 10.1038/onc.2011.536. Epub 2011 Nov 28.
• [84] Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors.Pediatr Blood Cancer. 2008 Jan;50(1):29-32. doi: 10.1002/pbc.21279.
• [85] Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma.Oncotarget. 2017 Jul 22;8(36):60368-60377. doi: 10.18632/oncotarget.19499. eCollection 2017 Sep 1.
• [86] Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.J Nucl Med. 2019 Sep;60(Suppl 2):13S-19S. doi: 10.2967/jnumed.118.220566.
• [87] TFH cells promote B cell maturation and antibody production in neuroblastoma.BMC Immunol. 2017 Jul 7;18(1):36. doi: 10.1186/s12865-017-0216-x.
• [88] NDRG1 promotes the multidrug resistance of neuroblastoma cells with upregulated expression of drug resistant proteins.Biomed Pharmacother. 2015 Dec;76:46-51. doi: 10.1016/j.biopha.2015.10.015. Epub 2015 Nov 10.
• [89] CDC20siRNA and paclitaxel co-loaded nanometric liposomes of a nipecotic acid-derived cationic amphiphile inhibit xenografted neuroblastoma.Nanoscale. 2017 Jan 19;9(3):1201-1212. doi: 10.1039/c6nr07532k.
• [90] JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.Nat Commun. 2019 Jul 25;10(1):3319. doi: 10.1038/s41467-019-11132-w.
• [91] Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups.Am J Med Genet A. 2016 Sep;170(9):2248-60. doi: 10.1002/ajmg.a.37801. Epub 2016 Jul 15.
• [92] Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma.Pediatr Res. 1998 Jan;43(1):139-44. doi: 10.1203/00006450-199801000-00021.
• [93] Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition.Int J Cancer. 2013 Feb 1;132(3):E149-57. doi: 10.1002/ijc.27781. Epub 2012 Sep 28.
• [94] Arctic A40 blocks the nicotine-induced neuroprotective effect of CHRNA7 by inhibiting the ERK1/2 pathway in human neuroblastoma cells.Neurochem Int. 2017 Nov;110:49-56. doi: 10.1016/j.neuint.2017.09.005. Epub 2017 Sep 8.
• [95] Screening for calcium channel modulators in CLN3 siRNA knock down SH-SY5Y neuroblastoma cells reveals a significant decrease of intracellular calcium levels by selected L-type calcium channel blockers.Biochim Biophys Acta. 2011 Feb;1810(2):186-91. doi: 10.1016/j.bbagen.2010.09.004. Epub 2010 Oct 7.
• [96] Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo.Oncotarget. 2017 Jul 27;8(56):95135-95151. doi: 10.18632/oncotarget.19619. eCollection 2017 Nov 10.
• [97] L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in APP/PS1-Alzheimer's transgenic mice.J Alzheimers Dis. 2012;29(2):379-91. doi: 10.3233/JAD-2011-111577.
• [98] Nuclear cereblon modulates transcriptional activity of Ikaros and regulates its downstream target, enkephalin, in human neuroblastoma cells.Biochem Biophys Res Commun. 2016 Aug 26;477(3):388-94. doi: 10.1016/j.bbrc.2016.06.091. Epub 2016 Jun 18.
• [99] The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27(Kip1) protein up-regulation and c-Myc mRNA down-regulation.Mol Cell Endocrinol. 2015 Sep 5;412:205-15. doi: 10.1016/j.mce.2015.05.004. Epub 2015 May 7.
• [100] Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.PLoS One. 2013 Jun 20;8(6):e66548. doi: 10.1371/journal.pone.0066548. Print 2013.
• [101] Facilitation of 9,10-phenanthrenequinone-elicited neuroblastoma cell apoptosis by NAD(P)H:quinone oxidoreductase 1. Chem Biol Interact. 2018 Jan 5;279:10-20.
• [102] Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma.BMC Cancer. 2010 Apr 19;10:149. doi: 10.1186/1471-2407-10-149.
• [103] G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.Cancer Res. 2013 Jul 1;73(13):4134-46. doi: 10.1158/0008-5472.CAN-12-4056. Epub 2013 May 16.
• [104] Functional genomics identifies therapeutic targets for MYC-driven cancer.Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9545-50. doi: 10.1073/pnas.1121119109. Epub 2012 May 23.
• [105] Down-regulation of BORIS/CTCFL efficiently regulates cancer stemness and metastasis in MYCN amplified neuroblastoma cell line by modulating Wnt/-catenin signaling pathway.Biochem Biophys Res Commun. 2017 Feb 26;484(1):93-99. doi: 10.1016/j.bbrc.2017.01.066. Epub 2017 Jan 17.
• [106] Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP(+) )-induced -synuclein accumulation and neurotoxicity.Neuropathol Appl Neurobiol. 2019 Feb;45(2):157-173. doi: 10.1111/nan.12493. Epub 2018 May 15.
• [107] Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma.Mol Med Rep. 2015 Feb;11(2):1462-8. doi: 10.3892/mmr.2014.2835. Epub 2014 Oct 31.
• [108] Differential expression of delta-like gene and protein in neuroblastoma, ganglioneuroblastoma and ganglioneuroma.Mod Pathol. 2005 May;18(5):656-62. doi: 10.1038/modpathol.3800335.
• [109] DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.Oncogene. 2007 Aug 16;26(38):5669-73. doi: 10.1038/sj.onc.1210352. Epub 2007 Mar 12.
• [110] MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma.PLoS One. 2013 Nov 1;8(11):e78713. doi: 10.1371/journal.pone.0078713. eCollection 2013.
• [111] LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.Cell Cycle. 2019 Aug;18(16):1882-1892. doi: 10.1080/15384101.2019.1632134. Epub 2019 Jul 7.
• [112] ERK1/2-mediated disruption of BDNF-TrkB signaling causes synaptic impairment contributing to fluoride-induced developmental neurotoxicity.Toxicology. 2018 Dec 1;410:222-230. doi: 10.1016/j.tox.2018.08.009. Epub 2018 Aug 18.
• [113] The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.Cancer Res. 2017 May 1;77(9):2522-2533. doi: 10.1158/0008-5472.CAN-16-1663. Epub 2017 Feb 16.
• [114] DUSP5 expression associates with poor prognosis in human neuroblastoma.Exp Mol Pathol. 2018 Dec;105(3):272-278. doi: 10.1016/j.yexmp.2018.08.008. Epub 2018 Aug 30.
• [115] Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma.Biochem Biophys Res Commun. 2019 Jan 1;508(1):9-16. doi: 10.1016/j.bbrc.2018.11.103. Epub 2018 Nov 20.
• [116] Endothelin-converting enzymes degrade -synuclein and are reduced in dementia with Lewy bodies.J Neurochem. 2017 Apr;141(2):275-286. doi: 10.1111/jnc.13974. Epub 2017 Mar 29.
• [117] Lead Neurotoxicity on Human Neuroblastoma Cell Line SH-SY5Y is Mediated via Transcription Factor EGR1/Zif268 Induced Disrupted in Scherophernia-1 Activation.Neurochem Res. 2018 Jul;43(7):1308-1316. doi: 10.1007/s11064-018-2539-2. Epub 2018 Jun 4.
• [118] Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.Anticancer Drugs. 2013 Jun;24(5):484-93. doi: 10.1097/CAD.0b013e32835ffdbb.
• [119] Aluminum Activates PERK-EIF2 Signaling and Inflammatory Proteins in Human Neuroblastoma SH-SY5Y Cells.Biol Trace Elem Res. 2016 Jul;172(1):108-119. doi: 10.1007/s12011-015-0553-7. Epub 2015 Nov 7.
• [120] MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas.Sci Signal. 2017 Nov 28;10(507):eaam7550. doi: 10.1126/scisignal.aam7550.
• [121] Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.Int J Mol Med. 2014 Jan;33(1):35-42. doi: 10.3892/ijmm.2013.1545. Epub 2013 Nov 1.
• [122] Sumoylation of EphB1 Suppresses Neuroblastoma Tumorigenesis via Inhibiting PKC Activation.Cell Physiol Biochem. 2018;45(6):2283-2292. doi: 10.1159/000488174. Epub 2018 Mar 13.
• [123] NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells.Cancer Res. 2010 Feb 1;70(3):916-24. doi: 10.1158/0008-5472.CAN-09-2582. Epub 2010 Jan 26.
• [124] Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations.Ann Surg. 2018 Jan;267(1):149-156. doi: 10.1097/SLA.0000000000001999.
• [125] Differential regulation of HIF-1 and HIF-2 in neuroblastoma: Estrogen-related receptor alpha (ERR) regulates HIF2A transcription and correlates to poor outcome.Biochem Biophys Res Commun. 2015 Jun 5;461(3):560-7. doi: 10.1016/j.bbrc.2015.04.083. Epub 2015 Apr 23.
• [126] Estrogen receptor enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner.BMC Cancer. 2015 Jun 30;15:491. doi: 10.1186/s12885-015-1495-3.
• [127] TAT-mediated transduction of bacterial redox proteins generates a cytoprotective effect on neuronal cells.PLoS One. 2017 Sep 8;12(9):e0184617. doi: 10.1371/journal.pone.0184617. eCollection 2017.
• [128] GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells.Hippocampus. 2014 Jul;24(7):733-9. doi: 10.1002/hipo.22263. Epub 2014 Feb 27.
• [129] Protective Effects of Fibroblast Growth Factor 21 Against Amyloid-Beta(1-42)-Induced Toxicity in SH-SY5Y Cells.Neurotox Res. 2018 Oct;34(3):574-583. doi: 10.1007/s12640-018-9914-2. Epub 2018 Jun 5.
• [130] Duplication of Philadelphia chromosome and trisomy of chromosome 21 in a pediatric patient with acute lymphoblastic leukemia.Med Oncol. 2011 Dec;28 Suppl 1:S501-4. doi: 10.1007/s12032-010-9689-7. Epub 2010 Oct 7.
• [131] HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.Oncotarget. 2016 Feb 9;7(6):6727-47. doi: 10.18632/oncotarget.6797.
• [132] The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.BMC Cancer. 2016 Jul 18;16:490. doi: 10.1186/s12885-016-2545-1.
• [133] MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.Oncol Rep. 2016 May;35(5):2943-51. doi: 10.3892/or.2016.4640. Epub 2016 Feb 26.
• [134] Inhibition of glycogen synthase kinase-3 by falcarindiol isolated from Japanese Parsley (Oenanthe javanica).J Agric Food Chem. 2013 Aug 7;61(31):7515-21. doi: 10.1021/jf401042m. Epub 2013 Jul 29.
• [135] Genetic and epigenetic regulation on the transcription of GABRB2: Genotype-dependent hydroxymethylation and methylation alterations in schizophrenia.J Psychiatr Res. 2017 May;88:9-17. doi: 10.1016/j.jpsychires.2016.12.019. Epub 2016 Dec 28.
• [136] GBA deficiency promotes SNCA/-synuclein accumulation through autophagic inhibition by inactivated PPP2A.Autophagy. 2015;11(10):1803-20. doi: 10.1080/15548627.2015.1086055.
• [137] 3,4-dihydroxybenzalacetone and caffeic acid phenethyl ester induce preconditioning ER stress and autophagy in SH-SY5Y cells.J Cell Physiol. 2018 Feb;233(2):1671-1684. doi: 10.1002/jcp.26080. Epub 2017 Aug 23.
• [138] Peptides derived from the knuckle epitope of BMP-9 induce the cholinergic differentiation and inactivate GSk3beta in human SH-SY5Y neuroblastoma cells.Sci Rep. 2017 Jul 5;7(1):4695. doi: 10.1038/s41598-017-04835-x.
• [139] Neurotrophic effects of growth/differentiation factor 5 in a neuronal cell line.Neurotox Res. 2012 Apr;21(3):256-65. doi: 10.1007/s12640-011-9266-7. Epub 2011 Aug 20.
• [140] MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling.J Mol Neurosci. 2020 Mar;70(3):328-339. doi: 10.1007/s12031-019-01416-7. Epub 2019 Nov 13.
• [141] Paired Expression Analysis of Tumor Cell Surface Antigens.Front Oncol. 2017 Aug 21;7:173. doi: 10.3389/fonc.2017.00173. eCollection 2017.
• [142] A connexin40 mutation associated with a malignant variant of progressive familial heart block type I.Circ Arrhythm Electrophysiol. 2012 Feb;5(1):163-72. doi: 10.1161/CIRCEP.111.967604. Epub 2012 Jan 13.
• [143] The protective autophagy activated by GANT-61 in MYCN amplified neuroblastoma cells is mediated by PERK.Oncotarget. 2018 Jan 13;9(18):14413-14427. doi: 10.18632/oncotarget.24214. eCollection 2018 Mar 6.
• [144] Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.Neuropharmacology. 2020 Jan 1;162:107813. doi: 10.1016/j.neuropharm.2019.107813. Epub 2019 Oct 16.
• [145] Glutaredoxin 1 is a major player in copper metabolism in neuroblastoma cells.Biochim Biophys Acta. 2014 Jan;1840(1):255-61. doi: 10.1016/j.bbagen.2013.09.008. Epub 2013 Sep 13.
• [146] Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.Theranostics. 2018 Oct 6;8(18):5106-5125. doi: 10.7150/thno.26585. eCollection 2018.
• [147] Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND).PLoS One. 2013 Apr 19;8(4):e61399. doi: 10.1371/journal.pone.0061399. Print 2013.
• [148] Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration.J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1124-1129. doi: 10.1093/jnen/nlz102.
• [149] Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.Pediatr Blood Cancer. 2015 Apr;62(4):581-6. doi: 10.1002/pbc.25348. Epub 2015 Jan 28.
• [150] Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase.Sci Rep. 2016 Sep 6;6:32628. doi: 10.1038/srep32628.
• [151] Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.J Mol Neurosci. 2016 May;59(1):1-17. doi: 10.1007/s12031-015-0711-6. Epub 2016 Jan 25.
• [152] Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation.FASEB J. 2017 May;31(5):1903-1915. doi: 10.1096/fj.201600828R. Epub 2017 Feb 7.
• [153] Ghrelin Through GHSR1a and OX1R Heterodimers Reveals a Gs-cAMP-cAMP Response Element Binding Protein Signaling Pathway in Vitro.Front Mol Neurosci. 2018 Jul 17;11:245. doi: 10.3389/fnmol.2018.00245. eCollection 2018.
• [154] Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.J Med Chem. 2019 May 9;62(9):4426-4443. doi: 10.1021/acs.jmedchem.8b01936. Epub 2019 Apr 29.
• [155] Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival.Cell Death Dis. 2017 Mar 2;8(3):e2635. doi: 10.1038/cddis.2017.49.
• [156] Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.Chem Biol. 2013 May 23;20(5):713-25. doi: 10.1016/j.chembiol.2013.03.020.
• [157] Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction.Int J Mol Sci. 2019 Dec 9;20(24):6213. doi: 10.3390/ijms20246213.
• [158] Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.PLoS One. 2012;7(1):e29922. doi: 10.1371/journal.pone.0029922. Epub 2012 Jan 9.
• [159] miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3072-3078. doi: 10.1080/21691401.2019.1637886.
• [160] DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis.Hum Mol Genet. 2017 Oct 15;26(20):4028-4041. doi: 10.1093/hmg/ddx294.
• [161] Heat Shock Protein B8 (HSPB8) Reduces Oxygen-Glucose Deprivation/Reperfusion Injury via the Induction of Mitophagy.Cell Physiol Biochem. 2018;48(4):1492-1504. doi: 10.1159/000492259. Epub 2018 Aug 2.
• [162] Suppression of Cpn10 increases mitochondrial fission and dysfunction in neuroblastoma cells.PLoS One. 2014 Nov 12;9(11):e112130. doi: 10.1371/journal.pone.0112130. eCollection 2014.
• [163] 5-HT2A serotonin receptor agonist DOI alleviates cytotoxicity in neuroblastoma cells: role of the ERK pathway.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:64-72. doi: 10.1016/j.pnpbp.2013.01.017. Epub 2013 Feb 1.
• [164] Mutant Huntingtin Is Secreted via a Late Endosomal/Lysosomal Unconventional Secretory Pathway.J Neurosci. 2017 Sep 13;37(37):9000-9012. doi: 10.1523/JNEUROSCI.0118-17.2017. Epub 2017 Aug 16.
• [165] FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.Nucleic Acids Res. 2009 Jul;37(12):3996-4009. doi: 10.1093/nar/gkp332. Epub 2009 May 5.
• [166] Type-1 interferons contribute to oxygen glucose deprivation induced neuro-inflammation in BE(2)M17 human neuroblastoma cells.J Neuroinflammation. 2014 Mar 6;11:43. doi: 10.1186/1742-2094-11-43.
• [167] Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells.Cell Death Differ. 2005 Mar;12(3):213-23. doi: 10.1038/sj.cdd.4401546.
• [168] Weighted gene co-expression network analysis in identification of endometrial cancer prognosis markers.Asian Pac J Cancer Prev. 2012;13(9):4607-11. doi: 10.7314/apjcp.2012.13.9.4607.
• [169] Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15.Clin Cancer Res. 2019 May 1;25(9):2915-2924. doi: 10.1158/1078-0432.CCR-18-1811. Epub 2019 Jan 7.
• [170] Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma.Clin Cancer Res. 2019 Dec 15;25(24):7554-7564. doi: 10.1158/1078-0432.CCR-19-1045. Epub 2019 Aug 27.
• [171] Interleukin-24 inhibits osteosarcoma cell migration and invasion via the JNK/c-Jun signaling pathways.Oncol Lett. 2017 Jun;13(6):4505-4511. doi: 10.3892/ol.2017.5990. Epub 2017 Apr 5.
• [172] Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.Carcinogenesis. 2013 Mar;34(3):605-11. doi: 10.1093/carcin/bgs380. Epub 2012 Dec 7.
• [173] Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.Epigenetics. 2010 Oct 1;5(7):656-63. doi: 10.4161/epi.5.7.13055. Epub 2010 Oct 1.
• [174] Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.Sci Signal. 2018 Nov 20;11(557):eaap9752. doi: 10.1126/scisignal.aap9752.
• [175] Upregulation of MAPK10, TUBB2B and RASL11B may contribute to the development of neuroblastoma.Mol Med Rep. 2019 Oct;20(4):3475-3486. doi: 10.3892/mmr.2019.10589. Epub 2019 Aug 20.
• [176] Integrin 4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN-low Neuroblastoma.PLoS One. 2015 May 14;10(5):e0120815. doi: 10.1371/journal.pone.0120815. eCollection 2015.
• [177] Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells.Am J Pathol. 1997 May;150(5):1631-46.
• [178] Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development.J Pathol. 2016 Oct;240(2):211-23. doi: 10.1002/path.4769. Epub 2016 Sep 19.
• [179] Hypoxia induced hERG trafficking defect linked to cell cycle arrest in SH-SY5Y cells.PLoS One. 2019 Apr 24;14(4):e0215905. doi: 10.1371/journal.pone.0215905. eCollection 2019.
• [180] Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(-TRCP) in neuroblastoma cells.Cancer. 2011 Nov 15;117(22):5189-202. doi: 10.1002/cncr.26145. Epub 2011 Apr 26.
• [181] The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors.Oncotarget. 2019 Mar 15;10(22):2151-2160. doi: 10.18632/oncotarget.26736. eCollection 2019 Mar 15.
• [182] Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis.Front Pharmacol. 2018 May 18;9:500. doi: 10.3389/fphar.2018.00500. eCollection 2018.
• [183] A mimetic peptide of 2,6-sialyllactose promotes neuritogenesis.Neural Regen Res. 2020 Jun;15(6):1058-1065. doi: 10.4103/1673-5374.270313.
• [184] PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.Clin Cancer Res. 2017 Aug 1;23(15):4462-4472. doi: 10.1158/1078-0432.CCR-16-2601. Epub 2017 Mar 7.
• [185] Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas.Proc Natl Acad Sci U S A. 1986 Oct;83(19):7400-4. doi: 10.1073/pnas.83.19.7400.
• [186] LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis.Clin Cancer Res. 2018 Nov 15;24(22):5772-5783. doi: 10.1158/1078-0432.CCR-17-2578. Epub 2018 Jun 20.
• [187] The ATP-binding cassette transporter-2 (ABCA2) regulates cholesterol homeostasis and low-density lipoprotein receptor metabolism in N2a neuroblastoma cells. Biochim Biophys Acta. 2011 Dec;1811(12):1152-64.
• [188] LGR5 and Downstream Intracellular Signaling Proteins Play Critical Roles in the Cell Proliferation of Neuroblastoma, Meningioma and Pituitary Adenoma.Exp Neurobiol. 2019 Oct 31;28(5):628-641. doi: 10.5607/en.2019.28.5.628.
• [189] LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs.Oncogene. 2010 Jan 28;29(4):597-607. doi: 10.1038/onc.2009.367. Epub 2009 Nov 2.
• [190] Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.Cell Death Dis. 2018 Feb 12;9(2):204. doi: 10.1038/s41419-017-0221-2.
• [191] Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma.Anticancer Res. 1999 May-Jun;19(3B):2205-9.
• [192] Mesencephalic astrocyte-derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors.J Biol Chem. 2013 Feb 8;288(6):4209-25. doi: 10.1074/jbc.M112.400648. Epub 2012 Dec 19.
• [193] In vivo effects of short- and long-term MAPK pathway inhibition against neuroblastoma.J Pediatr Surg. 2018 Dec;53(12):2454-2459. doi: 10.1016/j.jpedsurg.2018.08.026. Epub 2018 Sep 1.
• [194] p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.Cancer Chemother Pharmacol. 2014 Feb;73(2):271-9. doi: 10.1007/s00280-013-2355-y. Epub 2013 Nov 20.
• [195] 5'-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth.J Biol Chem. 2019 Apr 5;294(14):5456-5465. doi: 10.1074/jbc.RA118.006761. Epub 2019 Feb 12.
• [196] Interferon- counter-regulates its own pro-apoptotic action by activating p38 MAPK signalling in human SH-SY5Y neuroblastoma cells.Apoptosis. 2014 Oct;19(10):1509-26. doi: 10.1007/s10495-014-1024-x.
• [197] Tau folding and cytotoxicity of neuroblastoma cells in the presence of manganese oxide nanoparticles: Biophysical, molecular dynamics, cellular, and molecular studies.Int J Biol Macromol. 2019 Mar 15;125:674-682. doi: 10.1016/j.ijbiomac.2018.11.191. Epub 2018 Nov 20.
• [198] Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.EMBO Mol Med. 2019 Dec;11(12):e10835. doi: 10.15252/emmm.201910835. Epub 2019 Nov 11.
• [199] Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes.Stem Cells Int. 2017;2017:4972078. doi: 10.1155/2017/4972078. Epub 2017 May 3.
• [200] Melanin-concentrating hormone induces neurite outgrowth in human neuroblastoma SH-SY5Y cells through p53 and MAPKinase signaling pathways.Peptides. 2009 Nov;30(11):2014-24. doi: 10.1016/j.peptides.2009.06.015. Epub 2009 Jun 21.
• [201] Lack of complex type N-glycans lessens aberrant neuronal properties.PLoS One. 2018 Jun 14;13(6):e0199202. doi: 10.1371/journal.pone.0199202. eCollection 2018.
• [202] Expression of DNA mismatch repair proteins hMSH2 and hMLH1 and the cyclin G1 inhibitor, p21(waf1/cip1) in pediatric tumors: correlation with response to therapy.Oncol Rep. 2001 Sep-Oct;8(5):965-71. doi: 10.3892/or.8.5.965.
• [203] AEG-1 is associated with clinical outcome in neuroblastoma patients.Cancer Biomark. 2012;11(2-3):115-21. doi: 10.3233/CBM-2012-0268.
• [204] Author Correction: Neuroglobin promotes neurogenesis through Wnt signaling pathway.Cell Death Dis. 2019 Mar 1;10(3):212. doi: 10.1038/s41419-019-1421-8.
• [205] NGF protects neuroblastoma cells against -amyloid-induced apoptosis via the Nrf2/HO-1 pathway.FEBS Open Bio. 2019 Dec;9(12):2063-2071. doi: 10.1002/2211-5463.12742. Epub 2019 Nov 1.
• [206] Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions.Mol Cell Biochem. 2017 Jan;425(1-2):85-93. doi: 10.1007/s11010-016-2864-1. Epub 2016 Nov 1.
• [207] Silencing of NADPH Oxidase 4 Attenuates Hypoxia Resistance in Neuroblastoma Cells SH-SY5Y by Inhibiting PI3K/Akt-Dependent Glycolysis.Oncol Res. 2019 May 7;27(5):525-532. doi: 10.3727/096504018X15179668157803. Epub 2018 Feb 9.
• [208] GRK2 protein-mediated transphosphorylation contributes to loss of function of -opioid receptors induced by neuropeptide FF (NPFF2) receptors.J Biol Chem. 2012 Apr 13;287(16):12736-49. doi: 10.1074/jbc.M111.314617. Epub 2012 Feb 28.
• [209] The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.Cancer Res. 2015 Oct 15;75(20):4265-71. doi: 10.1158/0008-5472.CAN-15-0649. Epub 2015 Aug 20.
• [210] Neuropeptide Y mitigates ER stress-induced neuronal cell death by activating the PI3K-XBP1 pathway.Eur J Cell Biol. 2018 Jun;97(5):339-348. doi: 10.1016/j.ejcb.2018.04.003. Epub 2018 Apr 6.
• [211] Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway.Hum Mol Genet. 2014 Jun 15;23(12):3299-306. doi: 10.1093/hmg/ddu043. Epub 2014 Jan 31.
• [212] Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18.
• [213] Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease.J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):127-34. doi: 10.1093/gerona/63.2.127.
• [214] Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma.J Korean Med Sci. 2019 Oct 14;34(39):e254. doi: 10.3346/jkms.2019.34.e254.
• [215] The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration.Oncotarget. 2017 Feb 7;8(6):9767-9782. doi: 10.18632/oncotarget.14213.
• [216] Carnosic Acid Suppresses the H(2)O(2)-Induced Mitochondria-Related Bioenergetics Disturbances and Redox Impairment in SH-SY5Y Cells: Role for Nrf2.Mol Neurobiol. 2018 Feb;55(2):968-979. doi: 10.1007/s12035-016-0372-7. Epub 2017 Jan 13.
• [217] Hypoxia Induces Internalization of -Opioid Receptor.Anesthesiology. 2017 May;126(5):842-854. doi: 10.1097/ALN.0000000000001571.
• [218] Post-Transcriptional Regulation of the Human Mu-Opioid Receptor (MOR) by Morphine-Induced RNA Binding Proteins hnRNP K and PCBP1.J Cell Physiol. 2017 Mar;232(3):576-584. doi: 10.1002/jcp.25455. Epub 2016 Jun 24.
• [219] Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells.J Mol Neurosci. 2013 Jul;50(3):462-8. doi: 10.1007/s12031-013-9960-4. Epub 2013 Jan 20.
• [220] The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.J Biol Chem. 2011 Jan 28;286(4):2596-606. doi: 10.1074/jbc.M110.200618. Epub 2010 Nov 16.
• [221] Anti-oxidative stress effect of red ginseng in the brain is mediated by peptidyl arginine deiminase type IV (PADI4) repression via estrogen receptor (ER) up-regulation.J Ethnopharmacol. 2013 Jul 9;148(2):474-85. doi: 10.1016/j.jep.2013.04.041. Epub 2013 May 7.
• [222] Therapeutic Targeting of MZF1-AS1/PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression.Adv Sci (Weinh). 2019 Aug 10;6(19):1900581. doi: 10.1002/advs.201900581. eCollection 2019 Oct 2.
• [223] PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.Oncogene. 2017 Aug 17;36(33):4682-4691. doi: 10.1038/onc.2017.40. Epub 2017 Apr 10.
• [224] A key role for poly(ADP-ribose) polymerase 3 in ectodermal specification and neural crest development.PLoS One. 2011 Jan 17;6(1):e15834. doi: 10.1371/journal.pone.0015834.
• [225] LXR- genomics programmes neuronal death observed in Alzheimer's disease.Apoptosis. 2010 Dec;15(12):1461-9. doi: 10.1007/s10495-010-0541-5.
• [226] Immunohistochemical analysis of PDK1, PHD3 and HIF-1 expression defines the hypoxic status of neuroblastoma tumors.PLoS One. 2017 Nov 8;12(11):e0187206. doi: 10.1371/journal.pone.0187206. eCollection 2017.
• [227] Chromosome instability in neuroblastoma.Oncol Lett. 2018 Dec;16(6):6887-6894. doi: 10.3892/ol.2018.9545. Epub 2018 Oct 3.
• [228] Didymin: an orally active citrus flavonoid for targeting neuroblastoma.Oncotarget. 2017 Apr 25;8(17):29428-29441. doi: 10.18632/oncotarget.15204.
• [229] The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.Nat Commun. 2019 Nov 28;10(1):5428. doi: 10.1038/s41467-019-13315-x.
• [230] Taiwan cobra phospholipase A2 elicits posttranscriptional up-regulation of ADAM17 in human neuroblastoma SK-N-SH cells.J Cell Biochem. 2010 Sep 1;111(1):148-57. doi: 10.1002/jcb.22681.
• [231] Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells. Mol Neurobiol. 2016 Aug;53(6):3854-3872.
• [232] Elevated levels of alpha-synuclein blunt cellular signal transduction downstream of Gq protein-coupled receptors.Cell Signal. 2017 Jan;30:82-91. doi: 10.1016/j.cellsig.2016.11.012. Epub 2016 Nov 18.
• [233] The Antidiabetic Drug Liraglutide Minimizes the Non-Cholinergic Neurotoxicity of the Pesticide Mipafox in SH-SY5Y Cells.Neurotox Res. 2019 Jan;35(1):150-159. doi: 10.1007/s12640-018-9941-z. Epub 2018 Aug 7.
• [234] Activation of peroxisome proliferator-activated receptor delta suppresses BACE1 expression by up-regulating SOCS1 in a JAK2/STAT1-dependent manner.J Neurochem. 2019 Nov;151(3):370-385. doi: 10.1111/jnc.14715. Epub 2019 Jun 18.
• [235] Inhibition of Ser/Thr phosphatase PPM1D induces neutrophil differentiation in HL-60 cells.J Biochem. 2017 Oct 1;162(4):303-308. doi: 10.1093/jb/mvx032.
• [236] Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells.J Proteomics. 2015 Jun 18;123:42-53. doi: 10.1016/j.jprot.2015.03.038. Epub 2015 Apr 10.
• [237] Diphenyl diselenide protects against methylmercury-induced inhibition of thioredoxin reductase and glutathione peroxidase in human neuroblastoma cells: a comparison with ebselen.J Appl Toxicol. 2017 Sep;37(9):1073-1081. doi: 10.1002/jat.3458. Epub 2017 Apr 6.
• [238] Stage-dependent expression of PI3K/Aktpathway genes in neuroblastoma.Int J Oncol. 2013 Feb;42(2):609-16. doi: 10.3892/ijo.2012.1732. Epub 2012 Dec 12.
• [239] Membrane-enriched proteome changes and prion protein expression during neural differentiation and in neuroblastoma cells.BMC Genomics. 2017 Apr 22;18(1):319. doi: 10.1186/s12864-017-3694-6.
• [240] Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer's pedigrees and their functional characterization.Biochem Biophys Res Commun. 2019 Aug 13;516(1):264-269. doi: 10.1016/j.bbrc.2019.05.185. Epub 2019 Jun 21.
• [241] Targeting the COX/mPGES-1/PGE(2) Pathway in Neuroblastoma.Adv Exp Med Biol. 2019;1161:89-100. doi: 10.1007/978-3-030-21735-8_9.
• [242] Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression.Mol Oncol. 2019 Sep;13(9):1959-1975. doi: 10.1002/1878-0261.12542. Epub 2019 Jul 19.
• [243] Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.Sci Rep. 2019 Sep 13;9(1):13259. doi: 10.1038/s41598-019-49853-z.
• [244] In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?.Cell Signal. 2007 Dec;19(12):2434-43. doi: 10.1016/j.cellsig.2007.07.011. Epub 2007 Jul 25.
• [245] Somatic PTPN11 Mutation in a Child With Neuroblastoma and Protein Losing Enteropathy.J Pediatr Hematol Oncol. 2018 May;40(4):328-330. doi: 10.1097/MPH.0000000000000903.
• [246] Human Rab7 mutation mimics features of Charcot-Marie-Tooth neuropathy type 2B in Drosophila.Neurobiol Dis. 2014 May;65:211-9. doi: 10.1016/j.nbd.2014.01.021. Epub 2014 Feb 9.
• [247] Ribosomal RACK1 promotes proliferation of neuroblastoma cells independently of global translation upregulation.Cell Signal. 2019 Jan;53:102-110. doi: 10.1016/j.cellsig.2018.09.020. Epub 2018 Oct 1.
• [248] RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.Pharm Res. 2017 Aug;34(8):1673-1682. doi: 10.1007/s11095-017-2154-y. Epub 2017 Apr 6.
• [249] MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.FEBS J. 2013 Feb;280(3):855-66. doi: 10.1111/febs.12074. Epub 2013 Jan 16.
• [250] Construction of photoenergetic mitochondria in cultured mammalian cells.Sci Rep. 2013;3:1635. doi: 10.1038/srep01635.
• [251] miR-506 suppresses neuroblastoma metastasis by targeting ROCK1.Oncol Lett. 2017 Jan;13(1):417-422. doi: 10.3892/ol.2016.5442. Epub 2016 Nov 29.
• [252] Therapeutic Effect of a Synthetic ROR/ Agonist in an Animal Model of Autism.ACS Chem Neurosci. 2016 Feb 17;7(2):143-8. doi: 10.1021/acschemneuro.5b00159. Epub 2015 Dec 3.
• [253] Cearoin Induces Autophagy, ERK Activation and Apoptosis via ROS Generation in SH-SY5Y Neuroblastoma Cells.Molecules. 2017 Feb 6;22(2):242. doi: 10.3390/molecules22020242.
• [254] Knockdown of LRP/LR induces apoptosis in pancreatic cancer and neuroblastoma cells through activation of caspases.Exp Cell Res. 2017 Nov 15;360(2):264-272. doi: 10.1016/j.yexcr.2017.09.016. Epub 2017 Sep 10.
• [255] RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.Oncogene. 2014 May 15;33(20):2601-9. doi: 10.1038/onc.2013.221. Epub 2013 Jul 15.
• [256] Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.BMC Dev Biol. 2009 Feb 12;9:12. doi: 10.1186/1471-213X-9-12.
• [257] Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy.Hum Gene Ther. 2013 Aug;24(8):766-75. doi: 10.1089/hum.2012.132.
• [258] Targeting P-selectin blocks neuroblastoma growth.Oncotarget. 2017 Sep 28;8(49):86657-86670. doi: 10.18632/oncotarget.21364. eCollection 2017 Oct 17.
• [259] SENP1 regulates cell migration and invasion in neuroblastoma.Biotechnol Appl Biochem. 2016 May;63(3):435-40. doi: 10.1002/bab.1375. Epub 2015 Aug 18.
• [260] Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.Pediatr Blood Cancer. 2017 Aug;64(8):10.1002/pbc.26448. doi: 10.1002/pbc.26448. Epub 2017 Jan 23.
• [261] Sirtuin 5 is Anti-apoptotic and Anti-oxidative in Cultured SH-EP Neuroblastoma Cells.Neurotox Res. 2017 Jan;31(1):63-76. doi: 10.1007/s12640-016-9664-y. Epub 2016 Aug 30.
• [262] Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum.Am J Surg Pathol. 2018 Sep;42(9):1166-1181. doi: 10.1097/PAS.0000000000001111.
• [263] Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma.Endocr Pathol. 2019 Sep;30(3):173-179. doi: 10.1007/s12022-019-09584-3.
• [264] MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma.Oncotarget. 2015 Jun 20;6(17):15510-23. doi: 10.18632/oncotarget.3732.
• [265] Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.PLoS One. 2017 Sep 8;12(9):e0183854. doi: 10.1371/journal.pone.0183854. eCollection 2017.
• [266] Fast enzymatic synthesis of n.c.a. 6-[(18) F]fluorodopamine (FDA) from n.c.a. 6-[(18) F]FDOPA and the fate of 6-FDOPA and 6-FDA in neuroblastoma and Caki-1 cells after their uptake.J Labelled Comp Radiopharm. 2019 Jun 30;62(8):438-447. doi: 10.1002/jlcr.3752.
• [267] Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.J Mol Med (Berl). 2019 Mar;97(3):325-339. doi: 10.1007/s00109-018-1730-x. Epub 2019 Jan 5.
• [268] Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells.Cell Cycle. 2014;13(7):1115-31. doi: 10.4161/cc.27983. Epub 2014 Feb 7.
• [269] Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.Appl Environ Microbiol. 2018 Nov 30;84(24):e01280-18. doi: 10.1128/AEM.01280-18. Print 2018 Dec 15.
• [270] Silencing of the Drosophila ortholog of SOX5 leads to abnormal neuronal development and behavioral impairment.Hum Mol Genet. 2017 Apr 15;26(8):1472-1482. doi: 10.1093/hmg/ddx051.
• [271] Evidences of plasma membrane-mediated ROS generation upon ELF exposure in neuroblastoma cells supported by a computational multiscale approach.Biochim Biophys Acta Biomembr. 2019 Aug 1;1861(8):1446-1457. doi: 10.1016/j.bbamem.2019.06.005. Epub 2019 Jun 11.
• [272] Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):402-411. doi: 10.1007/s00259-017-3856-4. Epub 2017 Oct 17.
• [273] Expression of the neural cell adhesion molecule and polysialic acid in human neuroblastoma cell lines.Int J Oncol. 2011 Aug;39(2):417-24. doi: 10.3892/ijo.2011.1038. Epub 2011 May 10.
• [274] Decorin gene upregulation mediated by an adeno-associated virus vector increases intratumoral uptake of nab-paclitaxel in neuroblastoma via inhibition of stabilin-1.Invest New Drugs. 2017 Oct;35(5):566-575. doi: 10.1007/s10637-017-0477-5. Epub 2017 Jun 20.
• [275] MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival.Cancer Res. 2014 Nov 1;74(21):5999-6009. doi: 10.1158/0008-5472.CAN-13-2513. Epub 2014 Aug 27.
• [276] LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases.Cancer Biol Ther. 2019;20(5):653-665. doi: 10.1080/15384047.2018.1550568. Epub 2018 Dec 24.
• [277] HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation.Amyotroph Lateral Scler Frontotemporal Degener. 2020 Feb;21(1-2):51-62. doi: 10.1080/21678421.2019.1672749. Epub 2019 Oct 30.
• [278] Thromboxane A2 receptor antagonist SQ29548 attenuates SHSY5Y neuroblastoma cell impairments induced by oxidative stress.Int J Mol Med. 2018 Jul;42(1):479-488. doi: 10.3892/ijmm.2018.3589. Epub 2018 Mar 27.
• [279] Downregulation of Type 3 Deiodinase in the Hypothalamus During Inflammation.Thyroid. 2019 Sep;29(9):1336-1343. doi: 10.1089/thy.2019.0201. Epub 2019 Aug 15.
• [280] Anti-Neuroblastoma Properties of a Recombinant Sunflower Lectin.Int J Mol Sci. 2017 Jan 10;18(1):92. doi: 10.3390/ijms18010092.
• [281] Thymosin-4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.Mol Oncol. 2015 Aug;9(7):1484-500. doi: 10.1016/j.molonc.2015.04.005. Epub 2015 Apr 29.
• [282] Complex constitutional subtelomeric 1p36.3 deletion/duplication in a mentally retarded child with neonatal neuroblastoma.Eur J Med Genet. 2008 Nov-Dec;51(6):679-84. doi: 10.1016/j.ejmg.2008.06.004. Epub 2008 Jul 11.
• [283] XAV939 inhibits the stemness and migration of neuroblastoma cancer stem cells via repression of tankyrase 1.Int J Oncol. 2014 Jul;45(1):121-8. doi: 10.3892/ijo.2014.2406. Epub 2014 Apr 28.
• [284] TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.Mol Psychiatry. 2016 Dec;21(12):1717-1725. doi: 10.1038/mp.2016.6. Epub 2016 Feb 23.
• [285] High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas.J Neurooncol. 2015 Oct;125(1):103-11. doi: 10.1007/s11060-015-1900-4. Epub 2015 Aug 29.
• [286] The thyrotropin-releasing hormone gene 1998: cloning, characterization, and transcriptional regulation in the central nervous system, heart, and testis.Thyroid. 1998 Oct;8(10):897-901. doi: 10.1089/thy.1998.8.897.
• [287] CGRPergic Nerve TRPA1 Channels Contribute to Epigallocatechin Gallate-Induced Neurogenic Vasodilation.ACS Chem Neurosci. 2019 Jan 16;10(1):216-220. doi: 10.1021/acschemneuro.8b00493. Epub 2018 Dec 10.
• [288] In Vitro Assessment of the Efficacy of a Macrocyclic Chelator in Reversing Methylmercury Toxicity.Int J Environ Res Public Health. 2019 Nov 30;16(23):4817. doi: 10.3390/ijerph16234817.
• [289] Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.Eur J Med Chem. 2019 Nov 1;181:111580. doi: 10.1016/j.ejmech.2019.111580. Epub 2019 Aug 1.
• [290] Detailed Dissection of UBE3A-Mediated DDI1 Ubiquitination.Front Physiol. 2019 May 3;10:534. doi: 10.3389/fphys.2019.00534. eCollection 2019.
• [291] Ginkgolide K attenuates neuronal injury after ischemic stroke by inhibiting mitochondrial fission and GSK-3-dependent increases in mitochondrial membrane permeability.Oncotarget. 2017 Jul 4;8(27):44682-44693. doi: 10.18632/oncotarget.17967.
• [292] NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.Ren Fail. 2016 Sep;38(8):1199-205. doi: 10.1080/0886022X.2016.1208517. Epub 2016 Jul 25.
• [293] PACAP and VIP regulate hypoxia-inducible factors in neuroblastoma cells exposed to hypoxia.Neuropeptides. 2018 Jun;69:84-91. doi: 10.1016/j.npep.2018.04.009. Epub 2018 Apr 17.
• [294] WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.Cancer Res. 2015 Dec 1;75(23):5143-54. doi: 10.1158/0008-5472.CAN-15-0423. Epub 2015 Oct 15.
• [295] In Vitro Anti-Neuroblastoma Activity of Thymoquinone Against Neuro-2a Cells via Cell-cycle Arrest.Asian Pac J Cancer Prev. 2015;16(18):8313-9. doi: 10.7314/apjcp.2015.16.18.8313.
• [296] Polypyrrole-coated cellulose nanofibers: influence of orientation, coverage and electrical stimulation on SH-SY5Y behavior.J Mater Chem B. 2019 Nov 14;7(42):6500-6507. doi: 10.1039/c9tb01300h. Epub 2019 Oct 2.
• [297] Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.Cell Mol Biol Lett. 2019 Mar 7;24:19. doi: 10.1186/s11658-019-0139-z. eCollection 2019.
• [298] Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma.Cancer Med. 2019 Apr;8(4):1558-1566. doi: 10.1002/cam4.2045. Epub 2019 Feb 21.
• [299] Glutathione transferase Omega 1-1 (GSTO1-1) modulates Akt and MEK1/2 signaling in human neuroblastoma cell SH-SY5Y.Proteins. 2019 Jul;87(7):588-595. doi: 10.1002/prot.25683. Epub 2019 Mar 25.
• [300] microRNA-144-3p suppresses human neuroblastoma cell proliferation by targeting HOXA7.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):716-723. doi: 10.26355/eurrev_201901_16885.
• [301] Low mRNA expression and activity of monoacylglycerol lipase in human SH-SY5Y neuroblastoma cells.Prostaglandins Other Lipid Mediat. 2019 Jun;142:59-67. doi: 10.1016/j.prostaglandins.2019.04.003. Epub 2019 Apr 9.
• [302] Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma.JCI Insight. 2019 Apr 18;5(10):e127130. doi: 10.1172/jci.insight.127130.
• [303] Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells.Sci Rep. 2019 Feb 11;9(1):1771. doi: 10.1038/s41598-018-38394-6.
• [304] Complexes formed with integrin-5 and KCNB1 potassium channel wild type or epilepsy-susceptibility variants modulate cellular plasticity via Ras and Akt signaling.FASEB J. 2019 Dec;33(12):14680-14689. doi: 10.1096/fj.201901792R. Epub 2019 Nov 2.
• [305] Cell survival controlled by lens-derived Sema3A-Nrp1 is vital on caffeine-suppressed corneal innervation during chick organogenesis.J Cell Physiol. 2019 Jun;234(6):9826-9838. doi: 10.1002/jcp.27671. Epub 2018 Oct 26.
• [306] SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3-mediated activation of Wnt/-catenin signaling.FEBS Open Bio. 2019 Feb 7;9(3):527-537. doi: 10.1002/2211-5463.12594. eCollection 2019 Mar.
• [307] Effect of atorvastatin on A(1-42) -induced alteration of SESN2, SIRT1, LC3II and TPP1 protein expressions in neuronal cell cultures.J Pharm Pharmacol. 2020 Mar;72(3):424-436. doi: 10.1111/jphp.13208. Epub 2019 Dec 17.
• [308] Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma.Mol Cancer Ther. 2019 Jun;18(6):1045-1056. doi: 10.1158/1535-7163.MCT-18-0146. Epub 2019 Apr 8.
• [309] DNA (cytosine) methyltransferase overexpression is associated with acquired drug resistance of murine neuroblastoma cells.Int J Oncol. 2001 Feb;18(2):323-9. doi: 10.3892/ijo.18.2.323.
• [310] retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines.Cancer Res. 2002 Feb 15;62(4):1196-204.
• [311] GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.Cancer Res. 2002 Sep 15;62(18):5158-67.
• [312] Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.Neoplasia. 2004 Sep-Oct;6(5):503-12. doi: 10.1593/neo.04157.
• [313] Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-beta peptide.J Neurochem. 2007 Jan;100(2):458-67. doi: 10.1111/j.1471-4159.2006.04251.x.
• [314] Neuroprotective properties of Bcl-w in Alzheimer disease.J Neurochem. 2004 Jun;89(5):1233-40. doi: 10.1111/j.1471-4159.2004.02416.x.
• [315] Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.PLoS One. 2014 Jul 17;9(7):e102567. doi: 10.1371/journal.pone.0102567. eCollection 2014.
• [316] BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.Anticancer Res. 2003 Mar-Apr;23(2B):1297-303.
• [317] C5a receptor expression by TGW neuroblastoma cells.Neuroreport. 1999 Sep 29;10(14):3021-5. doi: 10.1097/00001756-199909290-00027.
• [318] Expression of the cdc25B mRNA correlated with that of N-myc in neuroblastoma.Jpn J Clin Oncol. 2001 Sep;31(9):428-31. doi: 10.1093/jjco/hye093.
• [319] The expression of cadherins in human neuroblastoma cell lines and clinical tumors.Anticancer Res. 2000 Mar-Apr;20(2A):917-23.
• [320] CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.J Natl Cancer Inst. 2008 Jul 2;100(13):940-9. doi: 10.1093/jnci/djn176. Epub 2008 Jun 24.
• [321] Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.J Neurochem. 2004 Nov;91(3):634-47. doi: 10.1111/j.1471-4159.2004.02770.x.
• [322] Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene.Hum Genet. 2003 Oct;113(5):426-31. doi: 10.1007/s00439-003-1002-9. Epub 2003 Aug 16.
• [323] The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.Mol Pharmacol. 2006 Dec;70(6):2108-15. doi: 10.1124/mol.106.026245. Epub 2006 Sep 25.
• [324] CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow.Cancer Immunol Immunother. 2008 Apr;57(4):541-8. doi: 10.1007/s00262-007-0392-2. Epub 2007 Sep 5.
• [325] Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene.Hum Genet. 2000 Apr;106(4):406-13. doi: 10.1007/s004390000257.
• [326] Decrease of dynamin 2 levels in late-onset Alzheimer's disease alters Abeta metabolism.Biochem Biophys Res Commun. 2009 Feb 13;379(3):691-5. doi: 10.1016/j.bbrc.2008.12.147. Epub 2009 Jan 4.
• [327] Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.Cancer Res. 1997 Jun 15;57(12):2516-21.
• [328] Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.EBioMedicine. 2018 Sep;35:244-250. doi: 10.1016/j.ebiom.2018.08.005. Epub 2018 Aug 10.
• [329] A novel Eyes Absent 2 protein is expressed in the human eye.Gene. 2002 Feb 20;285(1-2):221-8. doi: 10.1016/s0378-1119(02)00404-3.
• [330] Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506.J Pharmacol Exp Ther. 1999 Jun;289(3):1202-10.
• [331] Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.Cancer Res. 2004 Oct 15;64(20):7420-5. doi: 10.1158/0008-5472.CAN-04-2141.
• [332] Characterization of GTP cyclohydrolase I gene expression in the human neuroblastoma SKN-BE(2)M17: enhanced transcription in response to cAMP is conferred by the proximal promoter.J Neurochem. 2001 Nov;79(3):576-87. doi: 10.1046/j.1471-4159.2001.00583.x.
• [333] Inhibition of gamma ray-induced apoptosis by stimulatory heterotrimeric GTP binding protein involves Bcl-xL down-regulation in SH-SY5Y human neuroblastoma cells.Exp Mol Med. 2007 Oct 31;39(5):583-93. doi: 10.1038/emm.2007.64.
• [334] Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation.J Cell Physiol. 2006 Mar;206(3):603-10. doi: 10.1002/jcp.20502.
• [335] Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma.Oncol Rep. 1999 Jan-Feb;6(1):149-53.
• [336] IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.Oncol Rep. 2018 Jan;39(1):3-12. doi: 10.3892/or.2017.6072. Epub 2017 Nov 2.
• [337] Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels.Pflugers Arch. 2003 Sep;446(6):684-94. doi: 10.1007/s00424-003-1111-2. Epub 2003 Jun 21.
• [338] Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.Tissue Antigens. 2015 Sep;86(3):172-7. doi: 10.1111/tan.12608. Epub 2015 Jul 22.
• [339] Transregulation of leukemia inhibitory [corrected] factor receptor expression and function by growth factors in neuroblastoma cells.J Neurochem. 2008 Aug;106(4):1941-51. doi: 10.1111/j.1471-4159.2008.05535.x. Epub 2008 Jul 4.
• [340] Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.Mol Biol Cell. 2008 Dec;19(12):5435-45. doi: 10.1091/mbc.e08-03-0316. Epub 2008 Oct 8.
• [341] Expression of glycosylated recombinant human myelin-associated glycoprotein on a neuroblastoma cell line and its reactivity with HNK-1 but not human anti-MAG antibodies.Neurosci Lett. 1998 May 1;246(3):157-60. doi: 10.1016/s0304-3940(98)00261-4.
• [342] Endogenous receptor for melanin-concentrating hormone in human neuroblastoma Kelly cells.Biochem Biophys Res Commun. 2002 Oct 18;298(1):54-9. doi: 10.1016/s0006-291x(02)02400-2.
• [343] Virtual Screening Guided Design, Synthesis and Bioactivity Study of Benzisoselenazolones (BISAs) on Inhibition of c-Met and Its Downstream Signalling Pathways.Int J Mol Sci. 2019 May 20;20(10):2489. doi: 10.3390/ijms20102489.
• [344] MFG-E8 regulates microglial phagocytosis of apoptotic neurons.J Neuroimmune Pharmacol. 2008 Dec;3(4):246-56. doi: 10.1007/s11481-008-9118-2. Epub 2008 Aug 1.
• [345] Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours.Br J Cancer. 2004 Sep 13;91(6):1112-8. doi: 10.1038/sj.bjc.6602094.
• [346] The mouse nac1 gene, encoding a cocaine-regulated Bric-a-brac Tramtrac Broad complex/Pox virus and Zinc finger protein, is regulated by AP1.Neuroscience. 2003;121(2):355-61. doi: 10.1016/s0306-4522(03)00376-2.
• [347] Prolactin increases expression of cytoskeletal proteins in SK-N-SH cells.Folia Biol (Praha). 2014;60(6):281-5.
• [348] Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment.Lab Invest. 2003 Jun;83(6):813-23. doi: 10.1097/01.lab.0000074895.48776.d8.
• [349] The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells.Neurobiol Dis. 2005 Feb;18(1):100-9. doi: 10.1016/j.nbd.2004.09.001.
• [350] Attenuation of signal flow from P2Y6 receptor by protein kinase C-alpha in SK-N-BE(2)C human neuroblastoma cells.J Neurochem. 2003 May;85(4):1043-53. doi: 10.1046/j.1471-4159.2003.01761.x.
• [351] Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4. Oncol Rep. 2017 Nov;38(5):2705-2716. doi: 10.3892/or.2017.5989. Epub 2017 Sep 22.
• [352] Proprotein convertase PACE4 is down-regulated by the basic helix-loop-helix transcription factor hASH-1 and MASH-1.Biochem J. 2001 Dec 15;360(Pt 3):683-9. doi: 10.1042/0264-6021:3600683.
• [353] Antisense palmitoyl protein thioesterase 1 (PPT1) treatment inhibits PPT1 activity and increases cell death in LA-N-5 neuroblastoma cells.J Neurosci Res. 2000 Oct 15;62(2):234-40. doi: 10.1002/1097-4547(20001015)62:2<234::AID-JNR8>3.0.CO;2-8.
• [354] Small-interfering-RNA-mediated silencing of human glutamate dehydrogenase induces apoptosis in neuroblastoma cells.Biotechnol Appl Biochem. 2008 Oct;51(Pt 2):107-10. doi: 10.1042/BA20070190.
• [355] Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma.Int J Oncol. 2010 Sep;37(3):695-705. doi: 10.3892/ijo_00000719.
• [356] Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase.Pediatr Blood Cancer. 2005 Jan;44(1):77-84. doi: 10.1002/pbc.20163.
• [357] Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.J Cell Mol Med. 2008 Jan-Feb;12(1):241-57. doi: 10.1111/j.1582-4934.2008.00249.x. Epub 2008 Jan 19.
• [358] A novel PIP2 binding of epsilonPKC and its contribution to the neurite induction ability.J Neurochem. 2007 Sep;102(5):1635-1644. doi: 10.1111/j.1471-4159.2007.04702.x.
• [359] Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas.Oncogene. 2007 Nov 22;26(53):7401-13. doi: 10.1038/sj.onc.1210550. Epub 2007 May 28.
• [360] Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.Mol Cancer Ther. 2006 Feb;5(2):219-29. doi: 10.1158/1535-7163.MCT-05-0289.
• [361] Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma.Oncogene. 2001 Jul 19;20(32):4424-32. doi: 10.1038/sj.onc.1204521.
• [362] NF-kappaB/Rel proteins are required for neuronal differentiation of SH-SY5Y neuroblastoma cells.J Biol Chem. 1999 Oct 22;274(43):30341-4. doi: 10.1074/jbc.274.43.30341.
• [363] The retinoid anticancer signal: mechanisms of target gene regulation. Br J Cancer. 2005 Aug 8;93(3):310-8. doi: 10.1038/sj.bjc.6602700.
• [364] RGS2: regulation of expression and nuclear localization.Biochem Biophys Res Commun. 2001 Apr 27;283(1):102-6. doi: 10.1006/bbrc.2001.4742.
• [365] The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation.Mol Cell Biol. 2004 Sep;24(17):7514-23. doi: 10.1128/MCB.24.17.7514-7523.2004.
• [366] Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.J Neurosci. 2006 Feb 1;26(5):1386-95. doi: 10.1523/JNEUROSCI.3291-05.2006.
• [367] Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein.Gene. 2011 Nov 10;487(2):151-5. doi: 10.1016/j.gene.2011.05.016. Epub 2011 May 27.
• [368] Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter.Int J Cancer. 2003 Jul 20;105(6):856-67. doi: 10.1002/ijc.11153.
• [369] Protein chip array profiling analysis of sera from neuroblastoma patients.Cancer Lett. 2005 Oct 18;228(1-2):91-6. doi: 10.1016/j.canlet.2004.12.053.
• [370] No evidence for involvement of SDHD in neuroblastoma pathogenesis.BMC Cancer. 2004 Aug 24;4:55. doi: 10.1186/1471-2407-4-55.
• [371] Complement C1-inhibitor expression in Alzheimer's disease.Acta Neuropathol. 1998 Sep;96(3):287-96. doi: 10.1007/s004010050896.
• [372] CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line.Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11523-8. doi: 10.1073/pnas.1934338100. Epub 2003 Sep 22.
• [373] The Na+-dependent L-ascorbic acid transporter SVCT2 expressed in brainstem cells, neurons, and neuroblastoma cells is inhibited by flavonoids.J Neurochem. 2009 Feb;108(3):563-77. doi: 10.1111/j.1471-4159.2008.05788.x. Epub 2008 Nov 17.
• [374] Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma.Cancer Chemother Pharmacol. 2006 Jan;57(1):105-13. doi: 10.1007/s00280-005-0005-8. Epub 2005 Nov 5.
• [375] Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis.J Biol Chem. 2008 Jan 25;283(4):2231-45. doi: 10.1074/jbc.M703583200. Epub 2007 Nov 20.
• [376] Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma.Int J Cancer. 2009 Nov 1;125(9):2049-57. doi: 10.1002/ijc.24564.
• [377] A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.Br J Cancer. 2004 Sep 13;91(6):1119-30. doi: 10.1038/sj.bjc.6602083.
• [378] TRF2 dysfunction elicits DNA damage responses associated with senescence in proliferating neural cells and differentiation of neurons.J Neurochem. 2006 Apr;97(2):567-81. doi: 10.1111/j.1471-4159.2006.03779.x. Epub 2006 Mar 15.
• [379] Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma.Bone Marrow Transplant. 2003 Sep;32(5):485-8. doi: 10.1038/sj.bmt.1704189.
• [380] Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan.Oncogene. 2006 May 25;25(22):3150-9. doi: 10.1038/sj.onc.1209348.
• [381] Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.Cancer. 2008 Sep 15;113(6):1412-22. doi: 10.1002/cncr.23720.
• [382] Differential effects of retinoic acid isomers on the expression of nuclear receptor co-regulators in neuroblastoma.FEBS Lett. 1999 Feb 26;445(2-3):415-9. doi: 10.1016/s0014-5793(99)00162-3.
• [383] Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells.J Cell Physiol. 2009 Oct;221(1):67-74. doi: 10.1002/jcp.21828.
• [384] Insulin-like growth factor type 1 upregulates uncoupling protein 3.Biochem Biophys Res Commun. 2001 Oct 12;287(5):1105-11. doi: 10.1006/bbrc.2001.5702.
• [385] 3D structure prediction of VAPC1 and identification of dual natural inhibitors for VPAC1 and EGFR.J Bioenerg Biomembr. 2019 Apr;51(2):89-102. doi: 10.1007/s10863-019-09790-y. Epub 2019 Feb 27.
• [386] Calmodulin interacts with PAC1 and VPAC2 receptors and regulates PACAP-induced FOS expression in human neuroblastoma cells.Neuropeptides. 2009 Apr;43(2):53-61. doi: 10.1016/j.npep.2009.02.001. Epub 2009 Mar 6.
• [387] Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.Oncogene. 2008 Feb 28;27(10):1478-88. doi: 10.1038/sj.onc.1210769. Epub 2007 Aug 27.
• [388] Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for beta-amyloid precursor protein and ubiquitin B.Neurobiol Aging. 2005 Feb;26(2):145-55. doi: 10.1016/j.neurobiolaging.2004.03.011.
• [389] Silencing the ACAT1 Gene in Human SH-SY5Y Neuroblastoma Cells Inhibits the Expression of Cyclo-Oxygenase 2 (COX2) and Reduces -Amyloid-Induced Toxicity Due to Activation of Protein Kinase C (PKC) and ERK.Med Sci Monit. 2018 Dec 12;24:9007-9018. doi: 10.12659/MSM.912862.
• [390] Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.Eur J Med Chem. 2019 Apr 1;167:510-524. doi: 10.1016/j.ejmech.2019.02.030. Epub 2019 Feb 14.
• [391] Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.J Natl Cancer Inst. 2006 Oct 4;98(19):1363-74. doi: 10.1093/jnci/djj372.
• [392] Transcriptional repression of the ectodomain sheddase ADAM10 by TBX2 and potential implication for Alzheimer's disease.Cell Mol Life Sci. 2019 Mar;76(5):1005-1025. doi: 10.1007/s00018-018-2998-2. Epub 2019 Jan 1.
• [393] 3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P(2) modulation.Oncogene. 2020 Jan;39(2):368-384. doi: 10.1038/s41388-019-0993-1. Epub 2019 Sep 2.
• [394] Novel therapeutic compound acridine-retrotuftsin action on biological forms of melanoma and neuroblastoma.J Cancer Res Clin Oncol. 2019 Jan;145(1):165-179. doi: 10.1007/s00432-018-2776-4. Epub 2018 Oct 26.
• [395] BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.Med Hypotheses. 2016 Dec;97:22-25. doi: 10.1016/j.mehy.2016.10.008. Epub 2016 Oct 20.
• [396] The Wnt Signaling Pathway Is Differentially Expressed during the Bovine Herpesvirus 1 Latency-Reactivation Cycle: Evidence That Two Protein Kinases Associated with Neuronal Survival, Akt3 and BMPR2, Are Expressed at Higher Levels during Latency.J Virol. 2018 Mar 14;92(7):e01937-17. doi: 10.1128/JVI.01937-17. Print 2018 Apr 1.
• [397] Annexin A2 could enhance multidrug resistance by regulating NF-B signaling pathway in pediatric neuroblastoma.J Exp Clin Cancer Res. 2017 Aug 16;36(1):111. doi: 10.1186/s13046-017-0581-6.
• [398] Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.Biomed Res Int. 2015;2015:347867. doi: 10.1155/2015/347867. Epub 2015 Jun 16.
• [399] The amyloid precursor protein modulates (2A)-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment.FASEB J. 2017 Oct;31(10):4434-4446. doi: 10.1096/fj.201700346R. Epub 2017 Jun 23.
• [400] A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.PLoS One. 2008 May 21;3(5):e2207. doi: 10.1371/journal.pone.0002207.
• [401] Integration of gene expression and methylation to unravel biological networks in glioblastoma patients.Genet Epidemiol. 2017 Feb;41(2):136-144. doi: 10.1002/gepi.22028. Epub 2016 Dec 26.
• [402] Differential aminoacylase expression in neuroblastoma.Int J Cancer. 2011 Sep 15;129(6):1322-30. doi: 10.1002/ijc.25798. Epub 2011 Apr 1.
• [403] Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.BMC Cell Biol. 2006 Dec 7;7:41. doi: 10.1186/1471-2121-7-41.
• [404] Functional validation of ATF4 and GADD34 in Neuro2a cells by CRISPR/Cas9-mediated genome editing.Mol Cell Biochem. 2018 Mar;440(1-2):65-75. doi: 10.1007/s11010-017-3156-0. Epub 2017 Aug 19.
• [405] Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors.J Immunol Res. 2018 Apr 1;2018:4972410. doi: 10.1155/2018/4972410. eCollection 2018.
• [406] Protective roles of carbonic anhydrase 8 in Machado-Joseph Disease.J Neurosci Res. 2019 Oct;97(10):1278-1297. doi: 10.1002/jnr.24474. Epub 2019 Jun 3.
• [407] Targeting the Chromosomal Passenger Complex Subunit INCENP Induces Polyploidization, Apoptosis, and Senescence in Neuroblastoma.Cancer Res. 2019 Oct 1;79(19):4937-4950. doi: 10.1158/0008-5472.CAN-19-0695. Epub 2019 Aug 15.
• [408] Recurrent intrapulmonary malignant small cell tumor of the thoracopulmonary region with metastasis to the oral cavity: review of literature and case report.Ultrastruct Pathol. 1995 Jul-Aug;19(4):297-303. doi: 10.3109/01913129509064234.
• [409] microRNA-494 Favors HO-1 Expression in Neuroblastoma Cells Exposed to Oxidative Stress in a Bach1-Independent Way.Front Oncol. 2018 Jun 13;8:199. doi: 10.3389/fonc.2018.00199. eCollection 2018.
• [410] Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.Sci Transl Med. 2018 May 16;10(441):eaao4680. doi: 10.1126/scitranslmed.aao4680.
• [411] Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.Expert Opin Drug Discov. 2017 Aug;12(8):801-811. doi: 10.1080/17460441.2017.1340269. Epub 2017 Jun 26.
• [412] Evaluation of potential prognostic value of Bmi-1 gene product and selected markers of proliferation (Ki-67) and apoptosis (p53) in the neuroblastoma group of tumors.Postepy Hig Med Dosw (Online). 2016 Feb 25;70:110-6. doi: 10.5604/17322693.1195843.
• [413] Carnosine modulates the Sp1-Slc31a1/Ctr1 copper-sensing system and influences copper homeostasis in murine CNS-derived cells.Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C235-C245. doi: 10.1152/ajpcell.00106.2018. Epub 2018 Nov 28.
• [414] Pyroptosis induced by enterovirus A71 infection in cultured human neuroblastoma cells.Virology. 2018 Aug;521:69-76. doi: 10.1016/j.virol.2018.05.025. Epub 2018 Jun 7.
• [415] Transcriptome profiling of caspase-2 deficient EMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling.Cell Death Dis. 2019 Jan 22;10(2):56. doi: 10.1038/s41419-018-1296-0.
• [416] Homocysteine induces PUMA-mediated mitochondrial apoptosis in SH-SY5Y cells.Amino Acids. 2016 Nov;48(11):2559-2569. doi: 10.1007/s00726-016-2280-6. Epub 2016 Jun 23.
• [417] Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.Clin Cancer Res. 2007 Apr 15;13(8):2429-40. doi: 10.1158/1078-0432.CCR-06-1762.
• [418] The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation.Front Immunol. 2019 Dec 3;10:2816. doi: 10.3389/fimmu.2019.02816. eCollection 2019.
• [419] Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.PLoS One. 2018 Jul 25;13(7):e0200358. doi: 10.1371/journal.pone.0200358. eCollection 2018.
• [420] Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma.Pediatr Res. 2017 Mar;81(3):480-488. doi: 10.1038/pr.2016.242. Epub 2016 Nov 14.
• [421] CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.Cancer Res. 2000 Jun 1;60(11):3013-8.
• [422] Differential action of polyunsaturated fatty acids and eicosanoids on bleomycin-induced cytotoxicity to neuroblastoma cells and lymphocytes.Arch Med Sci. 2018 Jan;14(1):207-229. doi: 10.5114/aoms.2018.72244. Epub 2017 Dec 19.
• [423] Microarray expression analysis of MYCN-amplified neuroblastoma cells after inhibition of CDK2.Neoplasma. 2017;64(3):351-357. doi: 10.4149/neo_2017_305.
• [424] Metformin Promotes Neuronal Differentiation via Crosstalk between Cdk5 and Sox6 in Neuroblastoma Cells.Evid Based Complement Alternat Med. 2019 Feb 19;2019:1765182. doi: 10.1155/2019/1765182. eCollection 2019.
• [425] MiRNA-124 is a link between measles virus persistent infection and cell division of human neuroblastoma cells.PLoS One. 2017 Oct 26;12(10):e0187077. doi: 10.1371/journal.pone.0187077. eCollection 2017.
• [426] Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep. 2016 Jul 5;6:29090. doi: 10.1038/srep29090.
• [427] Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence.Int J Cancer. 1995 Nov 27;63(5):738-43. doi: 10.1002/ijc.2910630522.
• [428] A silk peptide fraction restores cognitive function in AF64A-induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene.Toxicol Appl Pharmacol. 2017 Jan 1;314:48-54. doi: 10.1016/j.taap.2016.11.008. Epub 2016 Nov 18.
• [429] Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.Int J Mol Sci. 2019 Jul 29;20(15):3700. doi: 10.3390/ijms20153700.
• [430] KDM2B regulates choline kinase expression and neuronal differentiation of neuroblastoma cells.PLoS One. 2019 Jan 10;14(1):e0210207. doi: 10.1371/journal.pone.0210207. eCollection 2019.
• [431] Calcium imaging with genetically encoded sensor Case12: Facile analysis of 7/9 nAChR mutants.PLoS One. 2017 Aug 10;12(8):e0181936. doi: 10.1371/journal.pone.0181936. eCollection 2017.
• [432] Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells. Mol Cell Proteomics. 2015 Feb;14(2):316-28. doi: 10.1074/mcp.M114.041905. Epub 2014 Dec 11.
• [433] miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1.Oncol Res. 2018 Apr 10;26(3):445-455. doi: 10.3727/096504017X14974834436195. Epub 2017 Jun 26.
• [434] Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.Bioorg Med Chem Lett. 2018 Nov 15;28(21):3454-3457. doi: 10.1016/j.bmcl.2018.09.024. Epub 2018 Sep 20.
• [435] Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients.BMC Cancer. 2018 Oct 16;18(1):983. doi: 10.1186/s12885-018-4910-8.
• [436] Hydrogen sulfide generation from l-cysteine in the human glioblastoma-astrocytoma U-87 MG and neuroblastoma SHSY5Y cell lines.Acta Biochim Pol. 2017;64(1):171-176. doi: 10.18388/abp.2016_1394. Epub 2017 Mar 14.
• [437] CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.Cancer Res. 2018 Mar 15;78(6):1471-1483. doi: 10.1158/0008-5472.CAN-17-0454. Epub 2017 Dec 19.
• [438] Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.Mol Cancer Res. 2011 Jul;9(7):815-23. doi: 10.1158/1541-7786.MCR-10-0367. Epub 2011 Jun 3.
• [439] A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene. 2015 Jun;34(26):3357-68. doi: 10.1038/onc.2014.269. Epub 2014 Sep 1.
• [440] Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.Mol Cancer Res. 2017 Jun;15(6):744-752. doi: 10.1158/1541-7786.MCR-16-0285. Epub 2017 Feb 8.
• [441] Preclinical Pharmacokinetics and Dosimetry Studies of (124)I/(131)I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models.J Nucl Med. 2019 Oct;60(10):1414-1420. doi: 10.2967/jnumed.118.225409. Epub 2019 Mar 29.
• [442] Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.Oncotarget. 2016 Apr 5;7(14):18774-86. doi: 10.18632/oncotarget.7933.
• [443] Aromatase/Seladin-1 Interactions in Human Neuronal Cell Culture, the Hippocampus of Healthy Rats and Transgenic Alzheimer's Disease Mice.Pharmacology. 2018;102(1-2):42-52. doi: 10.1159/000488765. Epub 2018 May 29.
• [444] Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.Biochem J. 2018 Jan 31;475(2):531-545. doi: 10.1042/BCJ20170597.
• [445] Identification of BIRC6 as a novel intervention target for neuroblastoma therapy.BMC Cancer. 2012 Jul 12;12:285. doi: 10.1186/1471-2407-12-285.
• [446] CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against A(25-35)-induced neurotoxicity by inhibiting the pCRMP2/NMDAR2B signaling pathway.Chem Biol Interact. 2019 May 25;305:28-39. doi: 10.1016/j.cbi.2019.03.005. Epub 2019 Mar 12.
• [447] NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.J Mol Neurosci. 1994-1995;5(4):241-58. doi: 10.1007/BF02736725.
• [448] Endothelins may modulate invasion and proliferation of Ewing's sarcoma and neuroblastoma.Clin Sci (Lond). 2002 Aug;103 Suppl 48:322S-326S. doi: 10.1042/CS103S322S.
• [449] Involvement of the EGF Receptor in MAPK Signaling Activation by a 50 Hz Magnetic Field in Human Neuroblastoma Cells.Cell Physiol Biochem. 2019;52(4):893-907. doi: 10.33594/000000062.
• [450] Biased signaling agonist of dopamine D3 receptor induces receptor internalization independent of -arrestin recruitment.Pharmacol Res. 2019 May;143:48-57. doi: 10.1016/j.phrs.2019.03.003. Epub 2019 Mar 4.
• [451] A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.Cell Signal. 2007 Mar;19(3):634-45. doi: 10.1016/j.cellsig.2006.08.014. Epub 2006 Aug 30.
• [452] IRE1 is critical for Kaempferol-induced neuroblastoma differentiation.FEBS J. 2019 Apr;286(7):1375-1392. doi: 10.1111/febs.14776. Epub 2019 Feb 19.
• [453] E6-Associated Protein Dependent Estrogen Receptor Regulation of Protein Kinase A Regulatory Subunit R2A Expression in Neuroblastoma.Mol Neurobiol. 2018 Feb;55(2):1714-1724. doi: 10.1007/s12035-017-0449-y. Epub 2017 Feb 18.
• [454] Expression of factor X in both the rat brain and cells of the central nervous system.FEBS Lett. 1999 Dec 17;463(3):387-9. doi: 10.1016/s0014-5793(99)01657-9.
• [455] Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.PLoS One. 2013 Aug 12;8(8):e71656. doi: 10.1371/journal.pone.0071656. eCollection 2013.
• [456] The sulfation of biomimetic glycosaminoglycan substrates controls binding of growth factors and subsequent neural and glial cell growth.Biomater Sci. 2019 Oct 1;7(10):4283-4298. doi: 10.1039/c9bm00964g. Epub 2019 Aug 13.
• [457] Extensive neuronal localization and neurotrophic function of fibroblast growth factor 8 in the nervous system.Brain Res. 2001 Sep 7;912(2):105-15. doi: 10.1016/s0006-8993(01)02726-3.
• [458] Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells. Toxicology. 2019 May 1;419:40-54. doi: 10.1016/j.tox.2019.03.009. Epub 2019 Mar 23.
• [459] Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene.J Mol Neurosci. 2006;29(2):145-52. doi: 10.1385/JMN:29:2:145.
• [460] Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.Clin Cancer Res. 2009 Apr 1;15(7):2222-30. doi: 10.1158/1078-0432.CCR-08-2443. Epub 2009 Mar 10.
• [461] GAPDH-targeted therapy - A new approach for secondary damage after traumatic brain injury on rats.Biochem Biophys Res Commun. 2018 Jul 2;501(4):1003-1008. doi: 10.1016/j.bbrc.2018.05.099. Epub 2018 May 21.
• [462] Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN.Theranostics. 2019 Jan 30;9(4):986-1000. doi: 10.7150/thno.30199. eCollection 2019.
• [463] Glypican-3 expression in malignant small round cell tumors.Oncol Lett. 2019 Mar;17(3):3523-3528. doi: 10.3892/ol.2019.9976. Epub 2019 Jan 25.
• [464] Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas.PLoS One. 2013;8(1):e55316. doi: 10.1371/journal.pone.0055316. Epub 2013 Jan 31.
• [465] Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt.Oncotarget. 2019 Jul 23;10(45):4630-4639. doi: 10.18632/oncotarget.27050. eCollection 2019 Jul 23.
• [466] Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines.J Neurosci Res. 1996 Oct 15;46(2):164-78. doi: 10.1002/(SICI)1097-4547(19961015)46:2<164::AID-JNR4>3.0.CO;2-F.
• [467] Identification and characterization of the promoter region of the GRM3 gene.Biochem Biophys Res Commun. 2001 Aug 17;286(2):381-7. doi: 10.1006/bbrc.2001.5391.
• [468] An endogenous and ectopic expression of metabotropic glutamate receptor 8 (mGluR8) inhibits proliferation and increases chemosensitivity of human neuroblastoma and glioma cells.Cancer Lett. 2018 Sep 28;432:1-16. doi: 10.1016/j.canlet.2018.06.004. Epub 2018 Jun 6.
• [469] Rhabdomyosarcoma of the head and neck in children.Oral Oncol. 2002 Jul;38(5):450-9. doi: 10.1016/s1368-8375(01)00105-1.
• [470] MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.Oncotarget. 2016 Oct 11;7(41):66344-66359. doi: 10.18632/oncotarget.11662.
• [471] The enzyme activity of histone deacetylase 8 is modulated by a redox-switch.Redox Biol. 2019 Jan;20:60-67. doi: 10.1016/j.redox.2018.09.013. Epub 2018 Sep 27.
• [472] Combined Inhibition of ALK and HDAC Induces Synergistic Cytotoxicity in Neuroblastoma Cell Lines.Anticancer Res. 2019 Jul;39(7):3579-3584. doi: 10.21873/anticanres.13504.
• [473] Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism.J Neurosci. 2006 Feb 8;26(6):1864-71. doi: 10.1523/JNEUROSCI.2643-05.2006.
• [474] A natural product from Cannabis sativa subsp. sativa inhibits homeodomain-interacting protein kinase 2 (HIPK2), attenuating MPP(+)-induced apoptosis in human neuroblastoma SH-SY5Y cells.Bioorg Chem. 2017 Jun;72:64-73. doi: 10.1016/j.bioorg.2017.03.011. Epub 2017 Mar 30.
• [475] The complexity of mitochondrial outer membrane permeability and VDAC regulation by associated proteins.J Bioenerg Biomembr. 2018 Oct;50(5):339-354. doi: 10.1007/s10863-018-9765-9. Epub 2018 Jul 12.
• [476] Cockayne syndrome group A and B proteins converge on transcription-linked resolution of non-B DNA.Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12502-12507. doi: 10.1073/pnas.1610198113. Epub 2016 Oct 18.
• [477] Treatment of human neuroblastoma cell line SH-SY5Y with HSP27 siRNA tagged-exosomes decreased differentiation rate into mature neurons.J Cell Physiol. 2019 Nov;234(11):21005-21013. doi: 10.1002/jcp.28704. Epub 2019 Apr 22.
• [478] Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT(1A) Receptor Ligands.Int J Mol Sci. 2018 Oct 20;19(10):3260. doi: 10.3390/ijms19103260.
• [479] Probable involvement of p11 with interferon alpha induced depression.Sci Rep. 2016 Jan 29;6:17029. doi: 10.1038/srep17029.
• [480] Protective effect of 5-HT7 receptor activation against glutamate-induced neurotoxicity in human neuroblastoma SH-SY5Y cells via antioxidative and antiapoptotic pathways.Neurotoxicol Teratol. 2019 Mar-Apr;72:22-28. doi: 10.1016/j.ntt.2019.01.002. Epub 2019 Jan 24.
• [481] A novel PKC- inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma. Int J Biochem Cell Biol. 2011 May;43(5):784-94.
• [482] Interferon- Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor.Mol Neurobiol. 2017 Apr;54(3):1825-1843. doi: 10.1007/s12035-016-9789-2. Epub 2016 Feb 18.
• [483] IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells.Oncogene. 2014 Jan 30;33(5):578-88. doi: 10.1038/onc.2012.630. Epub 2013 Feb 25.
• [484] Low CD4?CD25?CD127?regulatory T cell- and high INF- levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2.Oncoimmunology. 2019 Sep 8;8(12):1661194. doi: 10.1080/2162402X.2019.1661194. eCollection 2019.
• [485] LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.Cancer Cell. 2017 Sep 11;32(3):310-323.e5. doi: 10.1016/j.ccell.2017.08.002. Epub 2017 Aug 31.
• [486] Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.Mol Pharmacol. 1996 Mar;49(3):387-90.
• [487] Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway.Oncogene. 2017 Nov 30;36(48):6701-6711. doi: 10.1038/onc.2017.267. Epub 2017 Aug 7.
• [488] KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.Int J Biol Macromol. 2019 Apr 1;126:318-325. doi: 10.1016/j.ijbiomac.2018.12.105. Epub 2018 Dec 20.
• [489] JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells.PLoS One. 2015 May 7;10(5):e0125343. doi: 10.1371/journal.pone.0125343. eCollection 2015.
• [490] Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation.Oncogenesis. 2019 Jan 4;8(1):3. doi: 10.1038/s41389-018-0112-0.
• [491] NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells.J Immunother. 2017 Sep;40(7):265-276. doi: 10.1097/CJI.0000000000000179.
• [492] Induction of KLF4 contributes to the neurotoxicity of MPP + in M17 Cells: a new implication in parkinson's disease. J Mol Neurosci. 2013 Sep;51(1):109-17.
• [493] The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.J Cell Sci. 2005 Mar 15;118(Pt 6):1245-53. doi: 10.1242/jcs.01704. Epub 2005 Mar 1.
• [494] Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IB/NFB axis through its carbohydrate-recognition domain.Brain Behav Immun. 2020 Jan;83:214-225. doi: 10.1016/j.bbi.2019.10.015. Epub 2019 Oct 25.
• [495] Human chimera-type galectin-3: defining the critical tail length for high-affinity glycoprotein/cell surface binding and functional competition with galectin-1 in neuroblastoma cell growth regulation.Biochimie. 2014 Sep;104:90-9. doi: 10.1016/j.biochi.2014.05.010. Epub 2014 Jun 6.
• [496] Legumain correlates with neuroblastoma differentiation and can be used in prodrug design.Chem Biol Drug Des. 2018 Feb;91(2):534-544. doi: 10.1111/cbdd.13116. Epub 2017 Oct 31.
• [497] Neurotrophic actions of PACAP-38 and LIF on human neuroblastoma SH-SY5Y cells.J Mol Neurosci. 2008 Nov;36(1-3):45-56. doi: 10.1007/s12031-008-9082-6. Epub 2008 May 28.
• [498] Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.Oncotarget. 2014 Aug 30;5(16):6687-700. doi: 10.18632/oncotarget.2235.
• [499] LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study.J Cell Mol Med. 2020 Jan;24(1):1059-1066. doi: 10.1111/jcmm.14827. Epub 2019 Nov 20.
• [500] Differential Effects of Doxazosin on Renin-Angiotensin-System- Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells.CNS Neurol Disord Drug Targets. 2019;18(1):29-36. doi: 10.2174/1871527317666181029111739.
• [501] Expression of the B cell-associated tyrosine kinase gene Lyn in primary neuroblastoma tumours and its modulation during the differentiation of neuroblastoma cell lines.Biochem Biophys Res Commun. 1992 Aug 14;186(3):1403-9. doi: 10.1016/s0006-291x(05)81562-1.
• [502] Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation.Redox Biol. 2019 Jan;20:167-181. doi: 10.1016/j.redox.2018.10.003. Epub 2018 Oct 9.
• [503] Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.J Neural Transm (Vienna). 2018 Nov;125(11):1635-1650. doi: 10.1007/s00702-017-1832-6. Epub 2017 Dec 26.
• [504] ASK1 regulates the survival of neuroblastoma cells by interacting with TLX and stabilizing HIF-1.Cell Signal. 2017 Jan;30:104-117. doi: 10.1016/j.cellsig.2016.11.018. Epub 2016 Nov 24.
• [505] Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome.Biol Direct. 2018 Aug 22;13(1):16. doi: 10.1186/s13062-018-0219-4.
• [506] The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.J Neurochem. 2007 Nov;103(3):962-71. doi: 10.1111/j.1471-4159.2007.04785.x. Epub 2007 Aug 6.
• [507] MARCKS dephosphorylation is involved in bradykinin-induced neurite outgrowth in neuroblastoma SH-SY5Y cells.J Cell Physiol. 2012 Feb;227(2):618-29. doi: 10.1002/jcp.22763.
• [508] Regulation of methionine adenosyltransferase catalytic activity and messenger RNA in SH-SY5Y human neuroblastoma cells.Biochem Pharmacol. 1998 Mar 1;55(5):567-71. doi: 10.1016/s0006-2952(97)00514-5.
• [509] Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor development.Mol Cancer Ther. 2015 Jan;14(1):213-24. doi: 10.1158/1535-7163.MCT-14-0226. Epub 2014 Dec 9.
• [510] Multiple epigenetic biomarkers for evaluation of students' academic performance.Genes Brain Behav. 2019 Jun;18(5):e12559. doi: 10.1111/gbb.12559. Epub 2019 Mar 18.
• [511] Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.Mol Cancer Ther. 2019 Mar;18(3):507-516. doi: 10.1158/1535-7163.MCT-18-0819. Epub 2019 Jan 23.
• [512] Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.ChemMedChem. 2019 Jun 18;14(12):1152-1161. doi: 10.1002/cmdc.201900180. Epub 2019 May 14.
• [513] Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma.Int J Cancer. 1996 Oct 21;69(5):403-7. doi: 10.1002/(SICI)1097-0215(19961021)69:5<403::AID-IJC9>3.0.CO;2-9.
• [514] Assessment of the MT1-MMP expression level of different cell lines by the naked eye.Sci China Life Sci. 2018 Apr;61(4):492-500. doi: 10.1007/s11427-017-9261-9. Epub 2018 Mar 14.
• [515] A 3-Protein Expression Signature of Neuroblastoma for Outcome Prediction.Am J Surg Pathol. 2018 Aug;42(8):1027-1035. doi: 10.1097/PAS.0000000000001082.
• [516] MYCN is amplified during S phase, and cmyb is involved in controlling MYCN expression and amplification in MYCNamplified neuroblastoma cell lines.Mol Med Rep. 2019 Jan;19(1):345-361. doi: 10.3892/mmr.2018.9686. Epub 2018 Nov 22.
• [517] Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.Cancer Lett. 2012 Apr 1;317(1):72-7. doi: 10.1016/j.canlet.2011.11.013. Epub 2011 Nov 13.
• [518] Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells.J Am Chem Soc. 2019 Feb 27;141(8):3613-3622. doi: 10.1021/jacs.8b12872. Epub 2019 Feb 13.
• [519] The mitochondrial disease associated protein Ndufaf2 is dispensable for Complex-1 assembly but critical for the regulation of oxidative stress.Neurobiol Dis. 2013 Oct;58:57-67. doi: 10.1016/j.nbd.2013.05.007. Epub 2013 May 20.
• [520] NEDD9 regulates 3D migratory activity independent of the Rac1 morphology switch in glioma and neuroblastoma.Mol Cancer Res. 2014 Feb;12(2):264-73. doi: 10.1158/1541-7786.MCR-13-0513. Epub 2013 Dec 13.
• [521] Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors.Neurol Med Chir (Tokyo). 2001 Dec;41(12):582-8; discussion 589. doi: 10.2176/nmc.41.582.
• [522] Oxidative stress with tau hyperphosphorylation in memory impaired 1,2-diacetylbenzene-treated mice.Toxicol Lett. 2017 Sep 5;279:53-59. doi: 10.1016/j.toxlet.2017.07.892. Epub 2017 Jul 20.
• [523] NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.Lab Invest. 2018 Feb;98(2):219-227. doi: 10.1038/labinvest.2017.105. Epub 2017 Oct 9.
• [524] Role and targeting of anaplastic lymphoma kinase in cancer.Mol Cancer. 2018 Feb 19;17(1):30. doi: 10.1186/s12943-018-0776-2.
• [525] Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients.Cell Rep. 2016 Jul 26;16(4):979-993. doi: 10.1016/j.celrep.2016.06.052. Epub 2016 Jul 7.
• [526] Expression of NOR-1 and its closely related members of the steroid/thyroid hormone receptor superfamily in human neuroblastoma cell lines.Cancer Lett. 1995 Sep 4;96(1):117-22. doi: 10.1016/0304-3835(95)03921-i.
• [527] NRAS rs2273267 A>T polymorphism reduces neuroblastoma risk in Chinese children.Gene. 2020 Feb 15;727:144262. doi: 10.1016/j.gene.2019.144262. Epub 2019 Nov 21.
• [528] Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles.Small. 2018 Nov;14(45):e1802886. doi: 10.1002/smll.201802886. Epub 2018 Oct 7.
• [529] ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7356-7361. doi: 10.1073/pnas.1801435115. Epub 2018 Jun 25.
• [530] GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkA.J Neurochem. 2019 Apr;149(2):231-241. doi: 10.1111/jnc.14685. Epub 2019 Mar 26.
• [531] GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models.J Drug Target. 2019 Apr;27(4):442-450. doi: 10.1080/1061186X.2018.1533964. Epub 2018 Oct 30.
• [532] Mutations in NTRK3 suggest a novel signaling pathway in human congenital heart disease.Hum Mutat. 2014 Dec;35(12):1459-68. doi: 10.1002/humu.22688. Epub 2014 Nov 7.
• [533] Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.
• [534] Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.Vitam Horm. 2015;97:1-55. doi: 10.1016/bs.vh.2014.10.001. Epub 2015 Jan 14.
• [535] A phylogenetically conserved hnRNP type A/B protein from squid brain.Neurosci Lett. 2019 Mar 23;696:219-224. doi: 10.1016/j.neulet.2019.01.002. Epub 2019 Jan 2.
• [536] DAN plays important compensatory roles in systemic-to-pulmonary shunt associated pulmonary arterial hypertension.Acta Physiol (Oxf). 2019 Jul;226(3):e13263. doi: 10.1111/apha.13263. Epub 2019 Feb 27.
• [537] Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.J Clin Invest. 1993 Sep;92(3):1153-60. doi: 10.1172/JCI116684.
• [538] The influence of PFK-II overexpression on neuroblastoma patients' survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4.Cancer Cell Int. 2019 Nov 14;19:292. doi: 10.1186/s12935-019-1005-9. eCollection 2019.
• [539] The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models.Oncotarget. 2017 Jan 24;8(4):6730-6741. doi: 10.18632/oncotarget.14268.
• [540] LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8971-8983. doi: 10.26355/eurrev_201910_19296.
• [541] A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.Clin Cancer Res. 2016 Jul 1;22(13):3398-409. doi: 10.1158/1078-0432.CCR-15-2081. Epub 2016 Apr 13.
• [542] The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma.Clin Cancer Res. 2017 Aug 1;23(15):4354-4363. doi: 10.1158/1078-0432.CCR-16-2876. Epub 2017 Mar 7.
• [543] CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma.J Int Med Res. 2018 Mar;46(3):1209-1220. doi: 10.1177/0300060517732256. Epub 2018 Jan 11.
• [544] Inhibition of the Neuronal Calcium Sensor DREAM Modulates Presenilin-2 Endoproteolysis.Front Mol Neurosci. 2018 Dec 3;11:449. doi: 10.3389/fnmol.2018.00449. eCollection 2018.
• [545] MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.Cancer Lett. 2016 Feb 28;371(2):214-24. doi: 10.1016/j.canlet.2015.11.045. Epub 2015 Dec 10.
• [546] Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma.Diagn Pathol. 2019 Dec 14;14(1):134. doi: 10.1186/s13000-019-0919-9.
• [547] Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.Br J Cancer. 2020 Feb;122(3):434-444. doi: 10.1038/s41416-019-0669-1. Epub 2019 Dec 6.
• [548] Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.Cancer Immunol Immunother. 2015 Oct;64(10):1215-27. doi: 10.1007/s00262-015-1733-1. Epub 2015 Jun 16.
• [549] Radiolabeling and initial biological evaluation of [(18)F]KBM-1 for imaging RAR- receptors in neuroblastoma.Bioorg Med Chem Lett. 2017 Mar 15;27(6):1425-1427. doi: 10.1016/j.bmcl.2017.01.093. Epub 2017 Feb 1.
• [550] Retinoic acid receptor enhanced the anti-cancer stem cells effect of -carotene by down-regulating expression of delta-like 1 homologue in human neuroblastoma cells.Biochem Biophys Res Commun. 2016 Nov 11;480(2):254-260. doi: 10.1016/j.bbrc.2016.10.041. Epub 2016 Oct 15.
• [551] Retinoic acid receptor gamma is targeted by microRNA-124 and inhibits neurite outgrowth.Neuropharmacology. 2020 Feb;163:107657. doi: 10.1016/j.neuropharm.2019.05.034. Epub 2019 Jun 3.
• [552] SNW1 regulates Notch signaling in neuroblastoma through interacting with RBPJ.Biochem Biophys Res Commun. 2019 Feb 19;509(4):869-876. doi: 10.1016/j.bbrc.2019.01.036. Epub 2019 Jan 12.
• [553] Paratesticular neuroblastoma with N-myc activation.J Pediatr Surg. 1993 Dec;28(12):1612-4. doi: 10.1016/0022-3468(93)90117-4.
• [554] The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo.Oncotarget. 2019 Oct 29;10(59):6323-6333. doi: 10.18632/oncotarget.27259. eCollection 2019 Oct 29.
• [555] Expression of the novel all-trans retinoic acid-related resistance gene HA117 in pediatric solid tumors.J Pediatr Hematol Oncol. 2014 Jan;36(1):45-50. doi: 10.1097/MPH.0b013e31828e5d73.
• [556] Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors.Mol Oncol. 2013 Oct;7(5):944-54. doi: 10.1016/j.molonc.2013.05.004. Epub 2013 Jun 14.
• [557] Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.J Neurosci. 2016 Jan 27;36(4):1316-23. doi: 10.1523/JNEUROSCI.2336-15.2016.
• [558] ROR1 and ROR2-novel targets for neuroblastoma.Pediatr Hematol Oncol. 2019 Sep;36(6):352-364. doi: 10.1080/08880018.2019.1646365. Epub 2019 Aug 23.
• [559] Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis.Front Immunol. 2018 May 31;9:1187. doi: 10.3389/fimmu.2018.01187. eCollection 2018.
• [560] Effect of retinoid X receptor- nuclear export inhibition on apoptosis of neurons invivo and invitro.Mol Med Rep. 2017 Aug;16(2):2037-2044. doi: 10.3892/mmr.2017.6766. Epub 2017 Jun 14.
• [561] Comparison of a calcitonin gene-related peptide receptor in a human neuroblastoma cell line (SK-N-MC) and a calcitonin receptor in a human breast carcinoma cell line (T47D).Ann N Y Acad Sci. 1992 Jun 30;657:106-16. doi: 10.1111/j.1749-6632.1992.tb22760.x.
• [562] Adult neuroblastoma in the retroperitoneum: A case report.Medicine (Baltimore). 2018 Dec;97(51):e13750. doi: 10.1097/MD.0000000000013750.
• [563] Vitamin D(3) protects against A peptide cytotoxicity in differentiated human neuroblastoma SH- SY5Y cells: A role for S1P1/p38MAPK/ATF4 axis.Neuropharmacology. 2017 Apr;116:328-342. doi: 10.1016/j.neuropharm.2017.01.003. Epub 2017 Jan 7.
• [564] Differentiation of Human Embryonic Stem Cells to Sympathetic Neurons: A Potential Model for Understanding Neuroblastoma Pathogenesis.Stem Cells Int. 2018 Nov 1;2018:4391641. doi: 10.1155/2018/4391641. eCollection 2018.
• [565] Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma.Endocr Relat Cancer. 2008 Sep;15(3):777-86. doi: 10.1677/ERC-08-0072. Epub 2008 May 22.
• [566] Inhibition of Sirtuin 6 Induces Neuroblastoma Differentiation.Anticancer Res. 2018 Feb;38(2):647-654. doi: 10.21873/anticanres.12268.
• [567] Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.J Neurosci. 2016 Oct 5;36(40):10425-10439. doi: 10.1523/JNEUROSCI.0183-16.2016.
• [568] Deficiency of Calcium-Independent Phospholipase A2 Beta Induces Brain Iron Accumulation through Upregulation of Divalent Metal Transporter 1.PLoS One. 2015 Oct 27;10(10):e0141629. doi: 10.1371/journal.pone.0141629. eCollection 2015.
• [569] Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[(18)F]FGln PET Imaging.Mol Imaging Biol. 2019 Dec;21(6):1117-1126. doi: 10.1007/s11307-019-01330-9.
• [570] Norepinephrine-Transporter-Targeted and DNA-Co-Targeted Theranostic Guanidines.J Med Chem. 2020 Mar 12;63(5):2051-2073. doi: 10.1021/acs.jmedchem.9b00437. Epub 2019 Jul 3.
• [571] Phytochemical, antioxidant, anti-proliferative and antimicrobial properties of Catharanthus roseus root extract, saponin-enriched and aqueous fractions.Mol Biol Rep. 2019 Jun;46(3):3265-3273. doi: 10.1007/s11033-019-04786-8. Epub 2019 Apr 3.
• [572] Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30-year-old mystery.Am J Med Genet A. 2010 Jun;152A(6):1531-5. doi: 10.1002/ajmg.a.33384.
• [573] Lentivirus-mediated siRNA knockdown of SPHK1 inhibits proliferation and tumorigenesis of neuroblastoma.Onco Targets Ther. 2018 Oct 18;11:7187-7196. doi: 10.2147/OTT.S180962. eCollection 2018.
• [574] ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor.Cancer Res Treat. 2018 Apr;50(2):495-505. doi: 10.4143/crt.2016.577. Epub 2017 May 22.
• [575] Targeting the Difficult-to-Drug CD71 and MYCN with Gambogic Acid and Vorinostat in a Class of Neuroblastomas.Cell Physiol Biochem. 2019;53(1):258-280. doi: 10.33594/000000134.
• [576] TGFR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.Clin Cancer Res. 2017 Feb 1;23(3):804-813. doi: 10.1158/1078-0432.CCR-16-1743. Epub 2016 Oct 10.
• [577] TIAM1 variants improve clinical outcome in neuroblastoma.Oncotarget. 2017 Jul 11;8(28):45286-45297. doi: 10.18632/oncotarget.16787.
• [578] Innate immune sensor laboratory of genetics and physiology 2 suppresses tumor cell growth and functions as a prognostic marker in neuroblastoma.Cancer Sci. 2018 Nov;109(11):3494-3502. doi: 10.1111/cas.13790. Epub 2018 Oct 4.
• [579] Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.BMC Cancer. 2019 May 20;19(1):473. doi: 10.1186/s12885-019-5700-7.
• [580] Inhibition of N-myc expression sensitizes human neuroblastoma IMR-32 cells expressing caspase-8 to TRAIL.Cell Prolif. 2019 May;52(3):e12577. doi: 10.1111/cpr.12577. Epub 2019 Feb 6.
• [581] Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.Jpn J Cancer Res. 1989 Dec;80(12):1149-52. doi: 10.1111/j.1349-7006.1989.tb01645.x.
• [582] Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy.Int J Mol Sci. 2019 Sep 25;20(19):4764. doi: 10.3390/ijms20194764.
• [583] Dopaminergic neurotoxins induce cell death by attenuating NF-B-mediated regulation of TRPC1 expression and autophagy.FASEB J. 2018 Mar;32(3):1640-1652. doi: 10.1096/fj.201700662RR. Epub 2018 Jan 3.
• [584] HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells.J Neurovirol. 2019 Feb;25(1):101-113. doi: 10.1007/s13365-018-0692-7. Epub 2018 Nov 5.
• [585] A critical role of the transient receptor potential melastatin 2 channel in a positive feedback mechanism for reactive oxygen species-induced delayed cell death. J Cell Physiol. 2019 Apr;234(4):3647-3660. doi: 10.1002/jcp.27134. Epub 2018 Sep 19.
• [586] Activation of transient receptor potential melastatin 7 (TRPM7) channel increases basal autophagy and reduces amyloid -peptide.Biochem Biophys Res Commun. 2017 Nov 4;493(1):494-499. doi: 10.1016/j.bbrc.2017.08.163. Epub 2017 Sep 1.
• [587] The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.J Neurosci. 2014 May 21;34(21):7253-65. doi: 10.1523/JNEUROSCI.4936-13.2014.
• [588] Characterization of two neuroblastoma cell lines expressing recombinant nerve growth factor receptors.J Neurochem. 1991 Jan;56(1):67-74. doi: 10.1111/j.1471-4159.1991.tb02563.x.
• [589] The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.J Exp Clin Cancer Res. 2018 Oct 25;37(1):258. doi: 10.1186/s13046-018-0931-z.
• [590] Targeted Inhibition of ULK1 Promotes Apoptosis and Suppresses Tumor Growth and Metastasis in Neuroblastoma.Mol Cancer Ther. 2018 Nov;17(11):2365-2376. doi: 10.1158/1535-7163.MCT-18-0176. Epub 2018 Aug 30.
• [591] HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma.Nat Med. 2016 Oct;22(10):1180-1186. doi: 10.1038/nm.4180. Epub 2016 Sep 12.
• [592] Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II.Peptides. 2003 Feb;24(2):301-6. doi: 10.1016/s0196-9781(03)00039-1.
• [593] ?(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells. J Mol Neurosci. 2012 Feb;46(2):285-92. doi: 10.1007/s12031-011-9552-0. Epub 2011 May 21.
• [594] Tumour suppressive effects of WEE1 gene silencing in neuroblastomas.J Cancer Res Ther. 2016 Jan-Mar;12(1):221-7. doi: 10.4103/0973-1482.165861.
• [595] YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling.Cancer Res. 2019 Dec 15;79(24):6204-6214. doi: 10.1158/0008-5472.CAN-19-1415. Epub 2019 Oct 31.
• [596] Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma.Biochem Biophys Res Commun. 2010 Sep 10;400(1):53-9. doi: 10.1016/j.bbrc.2010.08.001. Epub 2010 Aug 5.
• [597] Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis.Cell Death Dis. 2011 Mar 3;2(3):e125. doi: 10.1038/cddis.2011.8.
• [598] Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma.Clin Cancer Res. 2005 May 1;11(9):3485-93. doi: 10.1158/1078-0432.CCR-04-1781.
• [599] Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.Eur J Cancer. 1997 Oct;33(12):1997-2001. doi: 10.1016/s0959-8049(97)00278-5.
• [600] ATXN8 -62 G/A promoter polymorphism and risk of Taiwanese Parkinson's disease.Eur J Neurol. 2012 Nov;19(11):1462-9. doi: 10.1111/j.1468-1331.2012.03749.x. Epub 2012 May 12.
• [601] New signalling pathway involved in the anti-proliferative action of vitamin D?and its analogues in human neuroblastoma cells. A role for ceramide kinase.Neuropharmacology. 2012 Sep;63(4):524-37. doi: 10.1016/j.neuropharm.2012.04.026. Epub 2012 May 8.
• [602] Collaborative and reciprocal effects of ciliary neurotrophic factor and nerve growth factor on the neuronal phenotype of human neuroblastoma cells.J Neurochem. 1998 Apr;70(4):1411-20. doi: 10.1046/j.1471-4159.1998.70041411.x.
• [603] CUL7 is a novel antiapoptotic oncogene.Cancer Res. 2007 Oct 15;67(20):9616-22. doi: 10.1158/0008-5472.CAN-07-0644.
• [604] Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.Cancer Res. 2007 Mar 1;67(5):2331-8. doi: 10.1158/0008-5472.CAN-06-3041.
• [605] Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate.Pediatr Blood Cancer. 2010 Sep;55(3):464-70. doi: 10.1002/pbc.22603.
• [606] Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma.Int J Cancer. 2012 Jun 1;130(11):2591-8. doi: 10.1002/ijc.26295. Epub 2011 Aug 30.
• [607] Identification of an octamer-1 transcription factor binding site in the promoter of the mouse mu-opioid receptor gene.J Neurochem. 1996 Oct;67(4):1352-9. doi: 10.1046/j.1471-4159.1996.67041352.x.
• [608] OncomiRs: the discovery and progress of microRNAs in cancers.Mol Cancer. 2007 Sep 25;6:60. doi: 10.1186/1476-4598-6-60.
• [609] Inhibition of PKR protects against tunicamycin-induced apoptosis in neuroblastoma cells.Gene. 2014 Feb 15;536(1):90-6. doi: 10.1016/j.gene.2013.11.074. Epub 2013 Dec 14.
• [610] Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.Mol Carcinog. 2014 Mar;53(3):230-42. doi: 10.1002/mc.21969. Epub 2012 Oct 12.
• [611] Dysbindin-1, a schizophrenia-related protein, interacts with HDAC3.Neurosci Lett. 2014 Oct 17;582:120-4. doi: 10.1016/j.neulet.2014.08.046. Epub 2014 Sep 6.
• [612] 5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity.Brain Res. 2007 May 29;1149:14-7. doi: 10.1016/j.brainres.2007.02.038. Epub 2007 Feb 24.
• [613] Inhibition of rabies virus replication by interferon-stimulated gene 15 and its activating enzyme UBA7.Infect Genet Evol. 2017 Dec;56:44-53. doi: 10.1016/j.meegid.2017.10.016. Epub 2017 Oct 19.
• [614] IP(3)-mediated Ca(2+) signals in human neuroblastoma SH-SY5Y cells with exogenous overexpression of type 3 IP(3) receptor.Cell Calcium. 2002 Aug;32(2):71-81. doi: 10.1016/s0143-4160(02)00092-1.
• [615] Expression of Ras-GRF in the SK-N-BE neuroblastoma accelerates retinoic-acid-induced neuronal differentiation and increases the functional expression of the IRK1 potassium channel.Eur J Neurosci. 1999 Mar;11(3):959-66. doi: 10.1046/j.1460-9568.1999.00504.x.
• [616] Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma.Int J Oncol. 2013 Jan;42(1):134-40. doi: 10.3892/ijo.2012.1684. Epub 2012 Nov 6.
• [617] Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.Mol Cancer Ther. 2007 Oct;6(10):2634-41. doi: 10.1158/1535-7163.MCT-06-0492.
• [618] Concurrent protective and destructive signaling of JNK2 in neuroblastoma cells.Cell Signal. 2009 Jun;21(6):873-80. doi: 10.1016/j.cellsig.2009.01.032.
• [619] Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections.Hum Pathol. 2004 Nov;35(11):1397-403. doi: 10.1016/j.humpath.2004.07.014.
• [620] Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models.Clin Cancer Res. 2005 Apr 1;11(7):2680-5. doi: 10.1158/1078-0432.CCR-04-1917.
• [621] A NOTCH3 transcriptional module induces cell motility in neuroblastoma.Clin Cancer Res. 2013 Jul 1;19(13):3485-94. doi: 10.1158/1078-0432.CCR-12-3021. Epub 2013 May 6.
• [622] Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21830-5. doi: 10.1073/pnas.0906831106. Epub 2009 Dec 14.
• [623] Flow cytometry analysis of single-strand DNA damage in neuroblastoma cell lines using the F7-26 monoclonal antibody.Cytometry A. 2007 Nov;71(11):951-60. doi: 10.1002/cyto.a.20458.
• [624] Novel interventions targeting on apoptosis and necrosis induced by aluminum chloride in neuroblastoma cells.J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):137-48.
• [625] Pin1 levels are downregulated during ER stress in human neuroblastoma cells.Neurogenetics. 2007 Jan;8(1):21-7. doi: 10.1007/s10048-006-0060-2. Epub 2006 Sep 14.
• [626] Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.J Biol Chem. 2009 Jul 3;284(27):18357-67. doi: 10.1074/jbc.M109.015453. Epub 2009 May 5.
• [627] Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.Carcinogenesis. 2020 May 14;41(3):284-295. doi: 10.1093/carcin/bgz153.
• [628] Ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) prevents cell death in a cellular model of Parkinson's disease.Biochem Biophys Res Commun. 2018 Nov 30;506(3):516-521. doi: 10.1016/j.bbrc.2018.10.094. Epub 2018 Oct 22.
• [629] Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.Eur J Cancer. 2010 Oct;46(15):2771-80. doi: 10.1016/j.ejca.2010.05.010.
• [630] RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.Biochim Biophys Acta. 2013 Dec;1832(12):2368-78. doi: 10.1016/j.bbadis.2013.09.008. Epub 2013 Sep 21.
• [631] VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours.Histopathology. 2012 Dec;61(6):1006-16. doi: 10.1111/j.1365-2559.2012.04307.x. Epub 2012 Jul 17.
• [632] Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters.Oncogene. 2016 Jun 9;35(23):3037-48. doi: 10.1038/onc.2015.360. Epub 2015 Oct 5.
• [633] Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.N Engl J Med. 2008 Jun 12;358(24):2585-93. doi: 10.1056/NEJMoa0708698. Epub 2008 May 7.
• [634] Uncoupling protein-4 (UCP4) increases ATP supply by interacting with mitochondrial Complex II in neuroblastoma cells.PLoS One. 2012;7(2):e32810. doi: 10.1371/journal.pone.0032810. Epub 2012 Feb 29.
• [635] Arsenic impairs insulin signaling in differentiated neuroblastoma SH-SY5Y cells.Neurotoxicology. 2018 May;66:22-31. doi: 10.1016/j.neuro.2018.03.004. Epub 2018 Mar 8.
• [636] Protective function of SLC30A10 induced via PERK-ATF4 pathway against 1-methyl-4-phenylpyridinium.Biochem Biophys Res Commun. 2017 Sep 2;490(4):1307-1313. doi: 10.1016/j.bbrc.2017.07.018. Epub 2017 Jul 5.
• [637] Protective roles of SLC30A3 against endoplasmic reticulum stress via ERK1/2 activation.Biochem Biophys Res Commun. 2016 Oct 28;479(4):853-859. doi: 10.1016/j.bbrc.2016.09.119. Epub 2016 Sep 24.
• [638] Knockdown of zinc transporter ZIP8 expression inhibits neuroblastoma progression and metastasis invitro.Mol Med Rep. 2018 Jul;18(1):477-485. doi: 10.3892/mmr.2018.8944. Epub 2018 May 2.
• [639] Functional expression of choline transporter-like protein 1 (CTL1) in human neuroblastoma cells and its link to acetylcholine synthesis.Neurochem Int. 2011 Feb;58(3):354-65. doi: 10.1016/j.neuint.2010.12.011. Epub 2010 Dec 23.
• [640] A Christianson syndrome-linked deletion mutation (?287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death.Mol Neurodegener. 2016 Sep 2;11(1):63. doi: 10.1186/s13024-016-0129-9.
• [641] Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA- dependent protein kinase complex in an isoform-dependent manner.PLoS One. 2009;4(1):e4199. doi: 10.1371/journal.pone.0004199. Epub 2009 Jan 14.
• [642] Tumor necrosis factor-related apoptosis-inducing ligand reduces the expression of the neuroprotective Na(+) /Ca(2+) exchanger isoform NCX3 in human neuroblastoma SH-SY5Y cells.FEBS J. 2019 Feb;286(4):737-749. doi: 10.1111/febs.14732. Epub 2019 Jan 8.
• [643] ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells.Br J Cancer. 2009 Jan 13;100(1):96-105. doi: 10.1038/sj.bjc.6604833.
• [644] The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.Int J Oncol. 2009 Mar;34(3):697-705. doi: 10.3892/ijo_00000196.
• [645] Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.Genes Chromosomes Cancer. 2007 Jan;46(1):45-52. doi: 10.1002/gcc.20387.
• [646] Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor.Genes Chromosomes Cancer. 2007 Apr;46(4):327-35. doi: 10.1002/gcc.20413.
• [647] Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions. Pediatr Blood Cancer. 2013 Mar;60(3):383-9.
• [648] Polyamine synthesis as a target of MYC oncogenes.J Biol Chem. 2018 Nov 30;293(48):18757-18769. doi: 10.1074/jbc.TM118.003336. Epub 2018 Nov 7.
• [649] HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin.Cell Death Differ. 2019 Oct;26(10):1942-1954. doi: 10.1038/s41418-018-0264-7. Epub 2019 Jan 25.
• [650] Clinical implications of CES2 RNA expression in neuroblastoma.J Pediatr Surg. 2013 Mar;48(3):502-9. doi: 10.1016/j.jpedsurg.2012.10.004.
• [651] Effect of Taurine on Alterations in Deiodinase 3 Expression Induced by BDE 209 in Human Neuroblasoma-Derived SK-N-AS Cells.Adv Exp Med Biol. 2019;1155:847-856. doi: 10.1007/978-981-13-8023-5_71.
• [652] Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity.Oncogene. 2019 Dec;38(50):7504-7520. doi: 10.1038/s41388-019-0967-3. Epub 2019 Aug 23.
• [653] MiR-513c suppresses neuroblastoma cell migration, invasion, and proliferation through direct targeting glutaminase (GLS).Cancer Biomark. 2017 Dec 6;20(4):589-596. doi: 10.3233/CBM-170577.
• [654] p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.Cancer Res. 2016 May 15;76(10):3025-35. doi: 10.1158/0008-5472.CAN-15-1939. Epub 2016 Mar 29.
• [655] Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.Nat Genet. 2012 Oct;44(10):1126-30. doi: 10.1038/ng.2387. Epub 2012 Sep 2.
• [656] Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue.Free Radic Biol Med. 2014 Apr;69:167-71. doi: 10.1016/j.freeradbiomed.2014.01.021. Epub 2014 Jan 29.
• [657] Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites.Cell Chem Biol. 2018 Apr 19;25(4):471-482.e7. doi: 10.1016/j.chembiol.2018.01.012. Epub 2018 Feb 22.
• [658] The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors.Biochem J. 2011 May 15;436(1):145-55. doi: 10.1042/BJ20101685.
• [659] Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility.Clin Cancer Res. 2017 Jan 15;23(2):466-477. doi: 10.1158/1078-0432.CCR-16-0354. Epub 2016 Jul 7.
• [660] Free radicals impair the anti-oxidative stress activity of DJ-1 through the formation of SDS-resistant dimer.Free Radic Res. 2017 Apr;51(4):397-412. doi: 10.1080/10715762.2017.1324201.
• [661] Ubiquitin ligase TRAF2 attenuates the transcriptional activity of the core clock protein BMAL1 and affects the maximal Per1 mRNA level of the circadian clock in cells.FEBS J. 2018 Aug;285(16):2987-3001. doi: 10.1111/febs.14595. Epub 2018 Jul 5.
• [662] Link between spermine oxidase and apoptosis antagonizing transcription factor: A new pathway in neuroblastoma.Int J Oncol. 2019 Nov;55(5):1149-1156. doi: 10.3892/ijo.2019.4878. Epub 2019 Sep 13.
• [663] Drd2 expression in the high alcohol-preferring and low alcohol-preferring mice.Mamm Genome. 2008 Feb;19(2):69-76. doi: 10.1007/s00335-007-9089-2. Epub 2008 Jan 23.
• [664] Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.Pharmacogenet Genomics. 2007 Sep;17(9):709-17. doi: 10.1097/FPC.0b013e3280e1cc92.
• [665] Expression profiling of sulfotransferases in human cell lines derived from extra-hepatic tissues.Biol Pharm Bull. 2001 Nov;24(11):1258-62. doi: 10.1248/bpb.24.1258.
• [666] A dinucleotide deletion in amyloid precursor protein (APP) mRNA associated with sporadic Alzheimer's disease results in efficient secretion of truncated APP isoforms from neuroblastoma cell cultures.J Neurochem. 2001 Mar;76(5):1308-14. doi: 10.1046/j.1471-4159.2001.00122.x.
• [667] Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.BMC Cancer. 2016 Oct 10;16(1):781. doi: 10.1186/s12885-016-2820-1.
• [668] Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cells.Exp Neurol. 2009 Feb;215(2):236-42. doi: 10.1016/j.expneurol.2008.10.007. Epub 2008 Oct 28.
• [669] -Carotene 15,15'-oxygenase inhibits cancer cell stemness and metastasis by regulating differentiation-related miRNAs in human neuroblastoma.J Nutr Biochem. 2019 Jul;69:31-43. doi: 10.1016/j.jnutbio.2019.03.010. Epub 2019 Mar 28.
• [670] Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.J Biol Chem. 1996 Oct 11;271(41):25107-16. doi: 10.1074/jbc.271.41.25107.
• [671] Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients.J Mol Diagn. 2020 Feb;22(2):236-246. doi: 10.1016/j.jmoldx.2019.10.012. Epub 2019 Dec 16.
• [672] Human dTMP kinase: gene expression and enzymatic activity coinciding with cell cycle progression and cell growth.DNA Cell Biol. 1994 May;13(5):461-71. doi: 10.1089/dna.1994.13.461.
• [673] MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease?.Hum Mol Genet. 2012 Feb 1;21(3):609-22. doi: 10.1093/hmg/ddr495. Epub 2011 Oct 31.
• [674] Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.Neurochem Int. 2010 Mar;56(4):597-602. doi: 10.1016/j.neuint.2010.01.002. Epub 2010 Jan 11.
• [675] Anti-tumor effect of sulfasalazine in neuroblastoma.Biochem Pharmacol. 2019 Apr;162:237-249. doi: 10.1016/j.bcp.2019.01.007. Epub 2019 Jan 9.
• [676] Purification, activity, and expression levels of two uridine-cytidine kinase isoforms in neuroblastoma cell lines.Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):613-618. doi: 10.1080/15257770.2015.1124998.
• [677] Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease.Mol Immunol. 2007 Jan;44(4):541-57. doi: 10.1016/j.molimm.2006.02.006. Epub 2006 Apr 17.
• [678] Seaweed extracts and unsaturated fatty acid constituents from the green alga Ulva lactuca as activators of the cytoprotective Nrf2-ARE pathway.Free Radic Biol Med. 2013 Apr;57:141-53. doi: 10.1016/j.freeradbiomed.2012.12.019. Epub 2013 Jan 4.
• [679] S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance.Cancer Res. 1999 Apr 15;59(8):1852-6.
• [680] Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis.Endocrinology. 2013 Sep;154(9):3209-18. doi: 10.1210/en.2013-1241. Epub 2013 Jul 3.
• [681] Transcriptional regulation of acetoacetyl-CoA synthetase by Sp1 in neuroblastoma cells.Biochem Biophys Res Commun. 2018 Jan 1;495(1):652-658. doi: 10.1016/j.bbrc.2017.11.068. Epub 2017 Nov 11.
• [682] Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM To Suppress Neuroblastoma Progression.J Proteome Res. 2019 Nov 1;18(11):3850-3866. doi: 10.1021/acs.jproteome.9b00245. Epub 2019 Oct 11.
• [683] Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells.FEBS Lett. 2011 Oct 3;585(19):2965-71. doi: 10.1016/j.febslet.2011.08.003. Epub 2011 Aug 11.
• [684] The Leber congenital amaurosis protein AIPL1 and EB proteins co-localize at the photoreceptor cilium.PLoS One. 2015 Mar 23;10(3):e0121440. doi: 10.1371/journal.pone.0121440. eCollection 2015.
• [685] Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUG) in neuroblastoma patient samples with chromosome arm 2p rearrangements.Genes Chromosomes Cancer. 2020 Jan;59(1):50-57. doi: 10.1002/gcc.22790. Epub 2019 Sep 2.
• [686] Exogenous expression of miRNA-3613-3p causes APAF1 downregulation and affects several proteins involved in apoptosis in BE(2)-C human neuroblastoma cells.Int J Oncol. 2018 Oct;53(4):1787-1799. doi: 10.3892/ijo.2018.4509. Epub 2018 Jul 31.
• [687] Nuclear localization of amyloid- precursor protein-binding protein Fe65 is dependent on regulated intramembrane proteolysis.PLoS One. 2017 Mar 21;12(3):e0173888. doi: 10.1371/journal.pone.0173888. eCollection 2017.
• [688] The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells.Oncotarget. 2017 Jan 31;8(5):8189-8205. doi: 10.18632/oncotarget.14138.
• [689] Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress.Oncogene. 2007 Nov 15;26(52):7302-12. doi: 10.1038/sj.onc.1210542. Epub 2007 May 28.
• [690] Truncated apolipoprotein C-I induces apoptosis in neuroblastoma by activating caspases in the extrinsic and intrinsic pathways.Oncol Rep. 2017 Sep;38(3):1797-1805. doi: 10.3892/or.2017.5819. Epub 2017 Jul 14.
• [691] Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4.Nat Commun. 2018 Jul 19;9(1):2829. doi: 10.1038/s41467-018-05286-2.
• [692] MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).J Biol Chem. 2011 Feb 11;286(6):4150-64. doi: 10.1074/jbc.M110.167817. Epub 2010 Nov 30.
• [693] Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells.J Biochem. 2012 Jun;151(6):611-20. doi: 10.1093/jb/mvs033. Epub 2012 Mar 26.
• [694] Beta-amyloid induces apoptosis of neuronal cells by inhibition of the Arg/N-end rule pathway proteolytic activity.Aging (Albany NY). 2019 Aug 24;11(16):6134-6152. doi: 10.18632/aging.102177. Epub 2019 Aug 24.
• [695] Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.Cancer Res. 2017 Sep 15;77(18):5142-5157. doi: 10.1158/0008-5472.CAN-16-2586. Epub 2017 Jul 7.
• [696] ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.Hum Mol Genet. 2017 May 1;26(9):1656-1669. doi: 10.1093/hmg/ddx070.
• [697] PMCA4 (ATP2B4) mutation in familial spastic paraplegia causes delay in intracellular calcium extrusion.Brain Behav. 2015 Apr;5(4):e00321. doi: 10.1002/brb3.321. Epub 2015 Feb 16.
• [698] Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.Oncotarget. 2016 Apr 19;7(16):21840-52. doi: 10.18632/oncotarget.8187.
• [699] B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.Cancer Sci. 2013 Dec;104(12):1600-8. doi: 10.1111/cas.12294. Epub 2013 Oct 28.
• [700] Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.Pediatr Blood Cancer. 2018 Nov;65(11):e27354. doi: 10.1002/pbc.27354. Epub 2018 Jul 14.
• [701] -1,4-Galactosyltransferase III enhances invasive phenotypes via 1-integrin and predicts poor prognosis in neuroblastoma.Clin Cancer Res. 2013 Apr 1;19(7):1705-16. doi: 10.1158/1078-0432.CCR-12-2367. Epub 2013 Feb 26.
• [702] BAG2 Is Repressed by NF-B Signaling, and Its Overexpression Is Sufficient to Shift A1-42 from Neurotrophic to Neurotoxic in Undifferentiated SH-SY5Y Neuroblastoma.J Mol Neurosci. 2015 Sep;57(1):83-9. doi: 10.1007/s12031-015-0579-5. Epub 2015 May 19.
• [703] Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells.Sci Rep. 2017 Feb 1;7:41420. doi: 10.1038/srep41420.
• [704] Neuroprotective role of BNIP3 under oxidative stress through autophagy in neuroblastoma cells.Mol Biol Rep. 2014 Sep;41(9):5729-34. doi: 10.1007/s11033-014-3444-7. Epub 2014 Jun 14.
• [705] Novel genes FAM134C, C3orf10 and ENOX1 are regulated by NRF-1 and differentially regulate neurite outgrowth in neuroblastoma cells and hippocampal neurons.Gene. 2013 Oct 15;529(1):7-15. doi: 10.1016/j.gene.2013.08.006. Epub 2013 Aug 9.
• [706] BAG-1L Protects SH-SY5Y Neuroblastoma Cells Against Hypoxia/Re-oxygenation Through Up-Regulating HSP70 and Activating PI3K/AKT Signaling Pathway.Neurochem Res. 2017 Oct;42(10):2861-2868. doi: 10.1007/s11064-017-2304-y. Epub 2017 May 18.
• [707] Altered expression of carbonic anhydrase-related protein XI in neuronal cells expressing mutant ataxin-3.Cerebellum. 2013 Jun;12(3):338-49. doi: 10.1007/s12311-012-0430-2.
• [708] CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells.Biochem Cell Biol. 2012 Aug;90(4):558-64. doi: 10.1139/o2012-011. Epub 2012 Apr 5.
• [709] Calcipotriol inhibits -synuclein aggregation in SH-SY5Y neuroblastoma cells by a Calbindin-D28k-dependent mechanism.J Neurochem. 2017 Apr;141(2):263-274. doi: 10.1111/jnc.13971.
• [710] SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR?10 in human neuroblastoma cells.Int J Oncol. 2016 Oct;49(4):1394-406. doi: 10.3892/ijo.2016.3646. Epub 2016 Aug 3.
• [711] Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.Int J Oncol. 2019 Dec;55(6):1372-1384. doi: 10.3892/ijo.2019.4896. Epub 2019 Oct 7.
• [712] Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma.BMC Cancer. 2011 Feb 11;11:66. doi: 10.1186/1471-2407-11-66.
• [713] 17-estradiol-induced regulation of the novel 5-HT1A-related transcription factors NUDR and Freud-1 in SH SY5Y cells.Cell Mol Neurobiol. 2012 May;32(4):517-21. doi: 10.1007/s10571-012-9809-3. Epub 2012 Feb 11.
• [714] CCM2 mediates death signaling by the TrkA receptor tyrosine kinase.Neuron. 2009 Sep 10;63(5):585-91. doi: 10.1016/j.neuron.2009.08.020.
• [715] Diminished cytolytic activity of T cells with reduced DNAM-1 expression in neuroblastoma patients.Clin Immunol. 2019 Jun;203:63-71. doi: 10.1016/j.clim.2019.04.006. Epub 2019 Apr 15.
• [716] Effects of CD2-associated protein deficiency on amyloid- in neuroblastoma cells and in an APP transgenic mouse model.Mol Neurodegener. 2015 Mar 19;10:12. doi: 10.1186/s13024-015-0006-y.
• [717] CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells.Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1173-85. doi: 10.1016/j.bbagrm.2012.08.001. Epub 2012 Aug 19.
• [718] p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.Hum Mol Genet. 2014 Dec 20;23(25):6826-37. doi: 10.1093/hmg/ddu406. Epub 2014 Aug 7.
• [719] CFC1 is a cancer stemness-regulating factor in neuroblastoma.Oncotarget. 2017 Jul 11;8(28):45046-45059. doi: 10.18632/oncotarget.18464.
• [720] Upregulation of LYAR induces neuroblastoma cell proliferation and survival.Cell Death Differ. 2017 Sep;24(9):1645-1654. doi: 10.1038/cdd.2017.98. Epub 2017 Jul 7.
• [721] Down-regulation of CHERP inhibits neuroblastoma cell proliferation and induces apoptosis through ER stress induction.Oncotarget. 2017 Sep 15;8(46):80956-80970. doi: 10.18632/oncotarget.20898. eCollection 2017 Oct 6.
• [722] Chromogranin A regulates neuroblastoma proliferation and phenotype.Biol Open. 2019 Mar 4;8(3):bio036566. doi: 10.1242/bio.036566.
• [723] Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.Pediatr Hematol Oncol. 2018 Mar;35(2):156-165. doi: 10.1080/08880018.2018.1464087. Epub 2018 May 8.
• [724] The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia.Mol Cell Biol. 1996 Sep;16(9):5069-80. doi: 10.1128/MCB.16.9.5069.
• [725] Autophagy Promotes Survival of CHP-212 Neuroblastoma Cells Treated With Casiopenas.Anticancer Res. 2019 Jul;39(7):3687-3695. doi: 10.21873/anticanres.13517.
• [726] Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells.Oncol Rep. 2013 Apr;29(4):1629-36. doi: 10.3892/or.2013.2286. Epub 2013 Feb 12.
• [727] Quantitative Proteomics of Presynaptic Mitochondria Reveal an Overexpression and Biological Relevance of Neuronal MitoNEET in Postnatal Brain Development.Dev Neurobiol. 2019 Apr;79(4):370-386. doi: 10.1002/dneu.22684. Epub 2019 May 9.
• [728] CDGSH Iron Sulfur Domain 2 Deficiency Inhibits Cell Proliferation and Induces Cell Differentiation of Neuroblastoma.Pathol Oncol Res. 2020 Jul;26(3):1725-1733. doi: 10.1007/s12253-019-00753-7. Epub 2019 Oct 22.
• [729] MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN.Oncotarget. 2018 Apr 6;9(26):18160-18179. doi: 10.18632/oncotarget.24793. eCollection 2018 Apr 6.
• [730] The all-trans retinoic acid (atRA)-regulated gene Calmin (Clmn) regulates cell cycle exit and neurite outgrowth in murine neuroblastoma (Neuro2a) cells.Exp Cell Res. 2012 Jan 1;318(1):85-93. doi: 10.1016/j.yexcr.2011.10.002. Epub 2011 Oct 6.
• [731] Recombinant heat shock protein 78 enhances enterovirus 71 propagation in Vero cells and is induced in SK-N-SH cells during the infection.Arch Virol. 2017 Jun;162(6):1649-1660. doi: 10.1007/s00705-017-3287-3. Epub 2017 Feb 24.
• [732] Dual Roles of Ascidian Chondromodulin-1: Promoting Cell Proliferation Whilst Suppressing the Growth of Tumor Cells.Mar Drugs. 2018 Feb 11;16(2):59. doi: 10.3390/md16020059.
• [733] Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.Oncotarget. 2015 May 30;6(15):13295-308. doi: 10.18632/oncotarget.3745.
• [734] A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-B degradation and cell growth suppression in neuroblastoma.Oncogene. 2017 Oct 12;36(41):5745-5756. doi: 10.1038/onc.2017.181. Epub 2017 Jun 12.
• [735] CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process.EMBO J. 2011 Jan 5;30(1):181-93. doi: 10.1038/emboj.2010.285. Epub 2010 Nov 19.
• [736] Differential DNA damage response to UV and hydrogen peroxide depending of differentiation stage in a neuroblastoma model.Neurotoxicology. 2012 Oct;33(5):1086-95. doi: 10.1016/j.neuro.2012.05.017. Epub 2012 Jun 9.
• [737] RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children.Gene. 2018 Jul 1;662:83-87. doi: 10.1016/j.gene.2018.04.015. Epub 2018 Apr 10.
• [738] Down-regulation of C-terminal binding protein 2 (CtBP2) inhibits proliferation, migration, and invasion of human SHSY5Y cells in vitro.Neurosci Lett. 2017 Apr 24;647:104-109. doi: 10.1016/j.neulet.2017.02.006. Epub 2017 Feb 6.
• [739] Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder.Nat Commun. 2017 Oct 17;8(1):774. doi: 10.1038/s41467-017-00831-x.
• [740] Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.Oncogene. 2015 Apr 23;34(17):2251-60. doi: 10.1038/onc.2014.159. Epub 2014 Jun 9.
• [741] Clinical features of ATRX or DAXX mutated neuroblastoma.J Pediatr Surg. 2014 Dec;49(12):1835-8. doi: 10.1016/j.jpedsurg.2014.09.029. Epub 2014 Nov 14.
• [742] Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis.PLoS Pathog. 2018 Jan 11;14(1):e1006778. doi: 10.1371/journal.ppat.1006778. eCollection 2018 Jan.
• [743] Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma.Brain Sci. 2019 Oct 19;9(10):284. doi: 10.3390/brainsci9100284.
• [744] DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.Neurobiol Dis. 2018 Jun;114:184-193. doi: 10.1016/j.nbd.2018.02.013. Epub 2018 Feb 24.
• [745] RNA helicase A is a downstream mediator of KIF1B tumor-suppressor function in neuroblastoma.Cancer Discov. 2014 Apr;4(4):434-51. doi: 10.1158/2159-8290.CD-13-0362. Epub 2014 Jan 27.
• [746] The rs3743205 SNP is important for the regulation of the dyslexia candidate gene DYX1C1 by estrogen receptor and DNA methylation.Mol Endocrinol. 2012 Apr;26(4):619-29. doi: 10.1210/me.2011-1376. Epub 2012 Mar 1.
• [747] Upregulation of the Sarco-Endoplasmic Reticulum Calcium ATPase 1 Truncated Isoform Plays a Pathogenic Role in Alzheimer's Disease.Cells. 2019 Nov 28;8(12):1539. doi: 10.3390/cells8121539.
• [748] The Structure in Solution of Fibronectin Type III Domain 14 Reveals Its Synergistic Heparin Binding Site.Biochemistry. 2018 Oct 23;57(42):6045-6049. doi: 10.1021/acs.biochem.8b00771. Epub 2018 Oct 11.
• [749] A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells.Sci Rep. 2017 Nov 9;7(1):15130. doi: 10.1038/s41598-017-15417-2.
• [750] X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism.Hum Mol Genet. 2013 Mar 1;22(5):941-51. doi: 10.1093/hmg/dds499. Epub 2012 Nov 25.
• [751] NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.Cell Death Dis. 2015 Aug 6;6(8):e1841. doi: 10.1038/cddis.2015.207.
• [752] MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3.Cancer Lett. 2010 Mar 28;289(2):195-207. doi: 10.1016/j.canlet.2009.08.019. Epub 2009 Oct 7.
• [753] Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study.J Hematol Oncol. 2017 May 16;10(1):108. doi: 10.1186/s13045-017-0477-0.
• [754] MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.Cell Death Differ. 2017 Sep;24(9):1564-1576. doi: 10.1038/cdd.2017.79. Epub 2017 Jun 2.
• [755] De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.Clin Cancer Res. 2007 Oct 15;13(20):6001-9. doi: 10.1158/1078-0432.CCR-07-0071.
• [756] Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.Hum Mol Genet. 2009 Feb 1;18(3):525-34. doi: 10.1093/hmg/ddn380. Epub 2008 Nov 10.
• [757] Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.Arch Pathol Lab Med. 2016 Oct;140(10):1026-37. doi: 10.5858/arpa.2016-0218-RA.
• [758] Loss of Elp3 Impairs the Acetylation and Distribution of Connexin-43 in the Developing Cerebral Cortex.Front Cell Neurosci. 2017 May 1;11:122. doi: 10.3389/fncel.2017.00122. eCollection 2017.
• [759] Endonuclease G mediates -synuclein cytotoxicity during Parkinson's disease.EMBO J. 2013 Nov 27;32(23):3041-54. doi: 10.1038/emboj.2013.228. Epub 2013 Oct 15.
• [760] Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.EBioMedicine. 2018 Apr;30:113-119. doi: 10.1016/j.ebiom.2018.03.003. Epub 2018 Mar 7.
• [761] ERP44 inhibits human lung cancer cell migration mainly via IP3R2.Aging (Albany NY). 2016 Jun;8(6):1276-86. doi: 10.18632/aging.100984.
• [762] Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis.Oncogene. 2018 Mar;37(11):1417-1429. doi: 10.1038/s41388-017-0039-5. Epub 2018 Jan 11.
• [763] Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance.Nucleic Acids Res. 2003 Jun 1;31(11):2769-77. doi: 10.1093/nar/gkg396.
• [764] MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressiveness.Cell Death Dis. 2014 Sep 4;5(9):e1401. doi: 10.1038/cddis.2014.356.
• [765] A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma.Target Oncol. 2015 Dec;10(4):523-33. doi: 10.1007/s11523-014-0354-5. Epub 2015 Jan 6.
• [766] Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death.J Cell Physiol. 2011 Jul;226(7):1763-70. doi: 10.1002/jcp.22505.
• [767] DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.PLoS One. 2012;7(11):e48401. doi: 10.1371/journal.pone.0048401. Epub 2012 Nov 7.
• [768] Enhanced Neurogenic Biomarker Expression and Reinnervation in HumanAcute Skin Wounds Treated by Electrical Stimulation.J Invest Dermatol. 2017 Mar;137(3):737-747. doi: 10.1016/j.jid.2016.09.038. Epub 2016 Nov 14.
• [769] Flotillin-1 regulates oncogenic signaling in neuroblastoma cells by regulating ALK membrane association.Cancer Res. 2014 Jul 15;74(14):3790-801. doi: 10.1158/0008-5472.CAN-14-0241. Epub 2014 May 15.
• [770] PGC-1 or FNDC5 Is Involved in Modulating the Effects of A(1-42) Oligomers on Suppressing the Expression of BDNF, a Beneficial Factor for Inhibiting Neuronal Apoptosis, A Deposition and Cognitive Decline of APP/PS1 Tg Mice.Front Aging Neurosci. 2017 Mar 21;9:65. doi: 10.3389/fnagi.2017.00065. eCollection 2017.
• [771] Functional characterization of two enhancers located downstream FOXP2.BMC Med Genet. 2019 May 2;20(1):65. doi: 10.1186/s12881-019-0810-2.
• [772] Mitochondrial Ferritin Protects Hydrogen Peroxide-Induced Neuronal Cell Damage.Aging Dis. 2017 Jul 21;8(4):458-470. doi: 10.14336/AD.2016.1108. eCollection 2017 Jul.
• [773] Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.Oncotarget. 2011 Dec;2(12):976-83. doi: 10.18632/oncotarget.410.
• [774] Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation.Cell Rep. 2017 Mar 21;18(12):2932-2942. doi: 10.1016/j.celrep.2017.02.065.
• [775] Identification of GALNT14 as a novel neuroblastoma predisposition gene.Oncotarget. 2015 Sep 22;6(28):26335-46. doi: 10.18632/oncotarget.4501.
• [776] A brain-specific Grb2-associated regulator of extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) (GAREM) subtype, GAREM2, contributes to neurite outgrowth of neuroblastoma cells by regulating Erk signaling.J Biol Chem. 2013 Oct 11;288(41):29934-42. doi: 10.1074/jbc.M113.492520. Epub 2013 Sep 3.
• [777] Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase.J Neurochem. 2010 May;113(4):819-25. doi: 10.1111/j.1471-4159.2010.06648.x. Epub 2010 Feb 17.
• [778] Aberrant O-glycosylation modulates aggressiveness in neuroblastoma.Oncotarget. 2018 Sep 25;9(75):34176-34188. doi: 10.18632/oncotarget.26169. eCollection 2018 Sep 25.
• [779] Involvement of membrane protein GDE2 in retinoic acid-induced neurite formation in Neuro2A cells.FEBS Lett. 2007 Feb 20;581(4):712-8. doi: 10.1016/j.febslet.2007.01.035. Epub 2007 Jan 24.
• [780] Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.Oncotarget. 2015 Dec 1;6(38):40655-66. doi: 10.18632/oncotarget.5821.
• [781] Glutamate receptor 2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.Neurology. 2018 Aug 21;91(8):e714-e723. doi: 10.1212/WNL.0000000000006035. Epub 2018 Jul 25.
• [782] Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.Math Biosci Eng. 2019 Aug 8;16(6):7217-7229. doi: 10.3934/mbe.2019362.
• [783] Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma.Cancer Cell. 2017 Sep 11;32(3):271-273. doi: 10.1016/j.ccell.2017.08.011.
• [784] Alanine Scanning Mutagenesis of the C-Terminal Cytosolic End of Gpm6a Identifies Key Residues Essential for the Formation of Filopodia.Front Mol Neurosci. 2018 Sep 4;11:314. doi: 10.3389/fnmol.2018.00314. eCollection 2018.
• [785] Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.PLoS Genet. 2017 May 18;13(5):e1006787. doi: 10.1371/journal.pgen.1006787. eCollection 2017 May.
• [786] Modulation of IGF1R Signaling Pathway by GIGYF1 in High Glucose-Induced SHSY-5Y Cells.DNA Cell Biol. 2018 Dec;37(12):1044-1054. doi: 10.1089/dna.2018.4336. Epub 2018 Oct 30.
• [787] GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.Cancer Res. 2014 May 1;74(9):2604-16. doi: 10.1158/0008-5472.CAN-13-1904. Epub 2014 Jan 13.
• [788] Akt2 regulates metastatic potential in neuroblastoma.PLoS One. 2013;8(2):e56382. doi: 10.1371/journal.pone.0056382. Epub 2013 Feb 26.
• [789] (R)--Lipoyl-Gly-l-Pro-l-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease.Neuropeptides. 2017 Dec;66:52-58. doi: 10.1016/j.npep.2017.09.001. Epub 2017 Oct 2.
• [790] Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.Oncotarget. 2016 Nov 22;7(47):76816-76826. doi: 10.18632/oncotarget.12713.
• [791] Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy.Cancer Med. 2019 Aug;8(10):4821-4835. doi: 10.1002/cam4.2389. Epub 2019 Jul 5.
• [792] The Cellular Coactivator HCF-1 Is Required for Glucocorticoid Receptor-Mediated Transcription of Bovine Herpesvirus 1 Immediate Early Genes.J Virol. 2018 Aug 16;92(17):e00987-18. doi: 10.1128/JVI.00987-18. Print 2018 Sep 1.
• [793] MEG3, HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1 and p53 pathways.Sci Rep. 2016 Nov 8;6:36268. doi: 10.1038/srep36268.
• [794] Promoter-associated proteins of EPAS1 identified by enChIP-MS - A putative role of HDX as a negative regulator.Biochem Biophys Res Commun. 2018 May 5;499(2):291-298. doi: 10.1016/j.bbrc.2018.03.150. Epub 2018 Mar 26.
• [795] HEN1 and HEN2: a subgroup of basic helix-loop-helix genes that are coexpressed in a human neuroblastoma.Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8492-6. doi: 10.1073/pnas.89.18.8492.
• [796] Notch pathway activation induces neuroblastoma tumor cell growth arrest.Pediatr Blood Cancer. 2012 May;58(5):682-9. doi: 10.1002/pbc.23202. Epub 2011 Jul 8.
• [797] UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.Cancer. 2013 Feb 15;119(4):915-23. doi: 10.1002/cncr.27785. Epub 2012 Sep 18.
• [798] Expression and epigenetic modulation of sonic hedgehog-GLI1 pathway genes in neuroblastoma cell lines and tumors.Tumour Biol. 2011 Feb;32(1):113-27. doi: 10.1007/s13277-010-0105-x. Epub 2010 Sep 10.
• [799] Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study.Oncoimmunology. 2018 May 10;7(8):e1461305. doi: 10.1080/2162402X.2018.1461305. eCollection 2018.
• [800] Systematic Analysis of Gene Expression Profiles Controlled by hnRNP Q and hnRNP R, Two Closely Related Human RNA Binding Proteins Implicated in mRNA Processing Mechanisms.Front Mol Biosci. 2018 Aug 30;5:79. doi: 10.3389/fmolb.2018.00079. eCollection 2018.
• [801] Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation.Tumour Biol. 1996;17(1):34-47. doi: 10.1159/000217965.
• [802] Recombinant human Tat-Hsp70-2: A tool for neuroprotection.Protein Expr Purif. 2017 Oct;138:18-24. doi: 10.1016/j.pep.2016.07.005. Epub 2016 Jul 9.
• [803] Heat shock protein 70 as a supplementary receptor facilitates enterovirus 71 infections in vitro.Microb Pathog. 2019 Mar;128:106-111. doi: 10.1016/j.micpath.2018.12.032. Epub 2018 Dec 21.
• [804] Stress Conditions Increase Vimentin Cleavage by Omi/HtrA2 Protease in Human Primary Neurons and Differentiated Neuroblastoma Cells.Mol Neurobiol. 2015 Dec;52(3):1077-1092. doi: 10.1007/s12035-014-8906-3. Epub 2014 Oct 8.
• [805] A-Induced Insulin Resistance and the Effects of Insulin on the Cholesterol Synthesis Pathway and A Secretion in Neural Cells.Neurosci Bull. 2016 Jun;32(3):227-38. doi: 10.1007/s12264-016-0034-9. Epub 2016 May 20.
• [806] ICAM-2 confers a non-metastatic phenotype in neuroblastoma cells by interaction with -actinin.Oncogene. 2015 Mar 19;34(12):1553-62. doi: 10.1038/onc.2014.87. Epub 2014 Apr 7.
• [807] IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.J Clin Oncol. 2015 Apr 10;33(11):1285-93. doi: 10.1200/JCO.2014.55.9880. Epub 2015 Mar 9.
• [808] MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF- signalling pathway.Carcinogenesis. 2012 May;33(5):976-85. doi: 10.1093/carcin/bgs114. Epub 2012 Mar 1.
• [809] Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.Oncol Rep. 2004 Oct;12(4):811-6.
• [810] ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.Cancer Med. 2018 Sep;7(9):4554-4569. doi: 10.1002/cam4.1634. Epub 2018 Aug 9.
• [811] Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.Mol Cancer. 2015 Feb 21;14:47. doi: 10.1186/s12943-015-0320-6.
• [812] BRI2 ectodomain affects A42 fibrillation and tau truncation in human neuroblastoma cells.Cell Mol Life Sci. 2015 Apr;72(8):1599-611. doi: 10.1007/s00018-014-1769-y. Epub 2014 Oct 22.
• [813] Silencing Intersectin 1 Slows Orthotopic Neuroblastoma Growth in Mice.J Pediatr Hematol Oncol. 2017 Nov;39(8):e413-e418. doi: 10.1097/MPH.0000000000000931.
• [814] Calsenilin regulates presenilin 1/-secretase-mediated N-cadherin -cleavage and -catenin signaling.FASEB J. 2011 Dec;25(12):4174-83. doi: 10.1096/fj.11-185926. Epub 2011 Aug 18.
• [815] The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.J Natl Cancer Inst. 2015 Apr 29;107(6):djv080. doi: 10.1093/jnci/djv080. Print 2015 Jun.
• [816] KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.J Clin Oncol. 2016 Jul 20;34(21):2443-51. doi: 10.1200/JCO.2015.64.9558. Epub 2016 Apr 11.
• [817] Alleles of keratin 1 in families and populations.Hum Immunol. 2013 Nov;74(11):1453-8. doi: 10.1016/j.humimm.2013.05.003. Epub 2013 May 23.
• [818] Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the association of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells.J Biol Chem. 2013 Sep 20;288(38):27396-27405. doi: 10.1074/jbc.M113.490102. Epub 2013 Aug 13.
• [819] Novel Notch signaling inhibitor NSI? suppresses nuclear translocation of the Notch intracellular domain.Int J Mol Med. 2019 Oct;44(4):1574-1584. doi: 10.3892/ijmm.2019.4280. Epub 2019 Jul 19.
• [820] Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma.Mol Cancer Res. 2015 Mar;13(3):470-82. doi: 10.1158/1541-7786.MCR-14-0337. Epub 2015 Jan 6.
• [821] Different profiles of the mRNA levels of DNA repair genes in MCF-7 and SH-SY5Y cells after treatment with combination of cisplatin, 50-Hz electromagnetic field and bleomycin.Biomed Pharmacother. 2017 Oct;94:564-568. doi: 10.1016/j.biopha.2017.07.115. Epub 2017 Aug 4.
• [822] Overexpression of quality control proteins reduces prion conversion in prion-infected cells.J Biol Chem. 2018 Oct 12;293(41):16069-16082. doi: 10.1074/jbc.RA118.002754. Epub 2018 Aug 28.
• [823] Oncogenic LMO3 collaborates with HEN2 to enhance neuroblastoma cell growth through transactivation of Mash1.PLoS One. 2011 May 5;6(5):e19297. doi: 10.1371/journal.pone.0019297.
• [824] Reelin signalling in neuroblastoma: migratory switch in metastatic stages.Int J Oncol. 2012 Aug;41(2):681-9. doi: 10.3892/ijo.2012.1488. Epub 2012 May 18.
• [825] LRSAM1 Depletion Affects Neuroblastoma SH-SY5Y Cell Growth and Morphology: The LRSAM1 c.2047-1G>A Loss-of-Function Variant Fails to Rescue The Phenotype.Cell J. 2018 Oct;20(3):340-347. doi: 10.22074/cellj.2018.5352. Epub 2018 May 15.
• [826] HsMAD2 mRNA expression may be a predictor of sensitivity to paclitaxel and survival in neuroblastoma.Pediatr Surg Int. 2011 Feb;27(2):217-23. doi: 10.1007/s00383-010-2780-5.
• [827] Autophagy is associated with chemoresistance in neuroblastoma.BMC Cancer. 2016 Nov 15;16(1):891. doi: 10.1186/s12885-016-2906-9.
• [828] Overexpression of tissue-nonspecific alkaline phosphatase increases the expression of neurogenic differentiation markers in the human SH-SY5Y neuroblastoma cell line.Bone. 2015 Oct;79:150-61. doi: 10.1016/j.bone.2015.05.033. Epub 2015 May 29.
• [829] Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.Cancer Lett. 2016 Feb 1;371(1):79-89. doi: 10.1016/j.canlet.2015.11.025. Epub 2015 Nov 23.
• [830] Interactions between amyloid- and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.PLoS One. 2012;7(3):e33120. doi: 10.1371/journal.pone.0033120. Epub 2012 Mar 6.
• [831] Downregulation of MSP58 suppresses cell proliferation in neuroblastoma cell lines.Neuroreport. 2012 Nov 14;23(16):932-6. doi: 10.1097/WNR.0b013e328359566e.
• [832] Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma.Cancer Res. 2018 Apr 15;78(8):1935-1947. doi: 10.1158/0008-5472.CAN-17-1860. Epub 2018 Jan 30.
• [833] Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.Neoplasia. 2004 Sep-Oct;6(5):558-68. doi: 10.1593/neo.04316.
• [834] Label-Free Quantitative Proteomics in a Methylmalonyl-CoA Mutase-Silenced Neuroblastoma Cell Line.Int J Mol Sci. 2018 Nov 13;19(11):3580. doi: 10.3390/ijms19113580.
• [835] HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-BE neuroblastoma cell line.PLoS One. 2014 Aug 19;9(8):e105481. doi: 10.1371/journal.pone.0105481. eCollection 2014.
• [836] Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.BMC Cancer. 2010 May 5;10:181. doi: 10.1186/1471-2407-10-181.
• [837] The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma.Cell Cycle. 2012 Feb 1;11(3):569-81. doi: 10.4161/cc.11.3.19063. Epub 2012 Feb 1.
• [838] MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors.Cell Death Dis. 2018 Aug 30;9(9):895. doi: 10.1038/s41419-018-0924-z.
• [839] Exploring Shared Susceptibility between Two Neural Crest Cells Originating Conditions: Neuroblastoma and Congenital Heart Disease.Genes (Basel). 2019 Aug 30;10(9):663. doi: 10.3390/genes10090663.
• [840] Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin.Oncotarget. 2017 Dec 16;9(4):4427-4439. doi: 10.18632/oncotarget.23333. eCollection 2018 Jan 12.
• [841] Mouse Neuroblastoma CB(1) Cannabinoid Receptor-Stimulated [(35)S]GTPS Binding: Total and Antibody-Targeted G Protein-Specific Scintillation Proximity Assays.Methods Enzymol. 2017;593:1-21. doi: 10.1016/bs.mie.2017.06.028. Epub 2017 Jul 19.
• [842] Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.Nat Genet. 2011 Jun 19;43(7):663-7. doi: 10.1038/ng.861.
• [843] A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.Oncotarget. 2012 May;3(5):535-45. doi: 10.18632/oncotarget.498.
• [844] Molecular evaluation of abnormalities of the short arm of chromosome 1 in neuroblastoma.Genes Chromosomes Cancer. 1990 Jul;2(2):137-46. doi: 10.1002/gcc.2870020210.
• [845] Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma.Cancer Sci. 2011 Sep;102(9):1645-50. doi: 10.1111/j.1349-7006.2011.01995.x. Epub 2011 Jul 3.
• [846] miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10.Biomed Pharmacother. 2018 Jul;103:1312-1318. doi: 10.1016/j.biopha.2018.04.153. Epub 2018 May 7.
• [847] Myosin Va interacts with the exosomal protein spermine synthase.Biosci Rep. 2019 Mar 1;39(3):BSR20182189. doi: 10.1042/BSR20182189. Print 2019 Mar 29.
• [848] Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.Cancer Res. 2018 Dec 1;78(23):6621-6631. doi: 10.1158/0008-5472.CAN-18-0545. Epub 2018 Sep 13.
• [849] Prokineticin signaling is required for the maintenance of a de novo population of c-KIT?cells to sustain neuroblastoma progression.Oncogene. 2015 Feb 19;34(8):1019-34. doi: 10.1038/onc.2014.24. Epub 2014 Mar 17.
• [850] Inhibition of paclitaxel-induced decreases in calcium signaling.J Biol Chem. 2012 Nov 2;287(45):37907-16. doi: 10.1074/jbc.M112.385070. Epub 2012 Sep 17.
• [851] The mechanism of alternative splicing of the X-linked NDUFB11 gene of the respiratory chain complex I, impact of rotenone treatment in neuroblastoma cells.Biochim Biophys Acta. 2013 Feb;1829(2):211-8. doi: 10.1016/j.bbagrm.2012.12.001. Epub 2012 Dec 12.
• [852] Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.PLoS One. 2013 Oct 10;8(10):e77753. doi: 10.1371/journal.pone.0077753. eCollection 2013.
• [853] Calreticulin Regulates VEGF-A in Neuroblastoma Cells.Mol Neurobiol. 2015 Aug;52(1):758-70. doi: 10.1007/s12035-014-8901-8. Epub 2014 Oct 7.
• [854] Neurogenic differentiation factor 1 promotes colorectal cancer cell proliferation and tumorigenesis by suppressing the p53/p21 axis.Cancer Sci. 2020 Jan;111(1):175-185. doi: 10.1111/cas.14233. Epub 2019 Dec 10.
• [855] Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.J Exp Clin Cancer Res. 2019 Dec 5;38(1):482. doi: 10.1186/s13046-019-1481-8.
• [856] Neuroglobin overexpression plays a pivotal role in neuroprotection through mitochondrial raft-like microdomains in neuroblastoma SK-N-BE2 cells.Mol Cell Neurosci. 2018 Apr;88:167-176. doi: 10.1016/j.mcn.2018.01.007. Epub 2018 Jan 31.
• [857] NHLH2: at the intersection of obesity and fertility.Trends Endocrinol Metab. 2013 Aug;24(8):385-90. doi: 10.1016/j.tem.2013.04.003. Epub 2013 May 17.
• [858] High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.PLoS One. 2013 Oct 25;8(10):e78481. doi: 10.1371/journal.pone.0078481. eCollection 2013.
• [859] NLGN3 promotes neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway.Eur J Pharmacol. 2019 Aug 15;857:172423. doi: 10.1016/j.ejphar.2019.172423. Epub 2019 May 28.
• [860] microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma.Clin Cancer Res. 2017 Jun 1;23(11):2905-2918. doi: 10.1158/1078-0432.CCR-16-1591. Epub 2016 Dec 21.
• [861] Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV.Genomics. 2006 Apr;87(4):483-9. doi: 10.1016/j.ygeno.2005.11.004. Epub 2006 Jan 25.
• [862] DR-nm23 gene expression in neuroblastoma cells: relationship to integrin expression, adhesion characteristics, and differentiation.J Natl Cancer Inst. 1997 Sep 3;89(17):1300-10. doi: 10.1093/jnci/89.17.1300.
• [863] Acetylation of NDPK-D Regulates Its Subcellular Localization and Cell Survival.PLoS One. 2015 Oct 1;10(10):e0139616. doi: 10.1371/journal.pone.0139616. eCollection 2015.
• [864] A new potent analgesic agent with reduced liability to produce morphine tolerance.Brain Res Bull. 2015 Aug;117:32-8. doi: 10.1016/j.brainresbull.2015.07.005. Epub 2015 Jul 30.
• [865] Stimulation of adenosine A2A receptors reduces intracellular cholesterol accumulation and rescues mitochondrial abnormalities in human neural cell models of Niemann-Pick C1.Neuropharmacology. 2016 Apr;103:155-62. doi: 10.1016/j.neuropharm.2015.11.022. Epub 2015 Nov 26.
• [866] Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.J Neurosci Res. 2002 Sep 1;69(5):642-52. doi: 10.1002/jnr.10330.
• [867] CRHR1 Mediates the Up-Regulation of Synapsin I Induced by Nesfatin-1 Through ERK 1/2 Signaling in SH-SY5Y Cells.Cell Mol Neurobiol. 2018 Apr;38(3):627-633. doi: 10.1007/s10571-017-0509-x. Epub 2017 Jun 12.
• [868] Chromosome t(7;11)(p15;p15) translocation in acute myeloid leukemia coexisting with multilineage dyspoiesis and mutations in NRAS and WT1: A case report and literature review.Oncol Lett. 2017 May;13(5):3066-3070. doi: 10.3892/ol.2017.5823. Epub 2017 Mar 7.
• [869] The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.Int J Cancer. 2010 May 1;126(9):2012-24. doi: 10.1002/ijc.25074.
• [870] Interaction between optineurin and Rab1a regulates autophagosome formation in neuroblastoma cells.J Neurosci Res. 2018 Mar;96(3):407-415. doi: 10.1002/jnr.24143. Epub 2017 Aug 26.
• [871] Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma.Oncotarget. 2016 Apr 26;7(17):24018-26. doi: 10.18632/oncotarget.8116.
• [872] Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.PLoS One. 2018 Mar 9;13(3):e0192028. doi: 10.1371/journal.pone.0192028. eCollection 2018.
• [873] The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.BMC Neurosci. 2011 Aug 8;12:81. doi: 10.1186/1471-2202-12-81.
• [874] Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma.Nat Commun. 2018 Dec 14;9(1):5331. doi: 10.1038/s41467-018-07580-5.
• [875] The protein l-isoaspartyl (d-aspartyl) methyltransferase protects against dopamine-induced apoptosis in neuroblastoma SH-SY5Y cells.Neuroscience. 2015 Jun 4;295:139-50. doi: 10.1016/j.neuroscience.2015.03.026. Epub 2015 Mar 20.
• [876] Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology.Brain Res. 2004 Oct 1;1022(1-2):164-72. doi: 10.1016/j.brainres.2004.07.026.
• [877] Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity.Biochimie. 2018 Apr;147:122-129. doi: 10.1016/j.biochi.2018.01.008. Epub 2018 Feb 6.
• [878] ALS-associated peripherin spliced transcripts form distinct protein inclusions that are neuroprotective against oxidative stress.Exp Neurol. 2014 Nov;261:217-29. doi: 10.1016/j.expneurol.2014.05.024. Epub 2014 Jun 4.
• [879] Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.Cancer Sci. 2015 Mar;106(3):237-43. doi: 10.1111/cas.12598. Epub 2015 Feb 4.
• [880] Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors.Clin Cancer Res. 2000 Feb;6(2):551-8.
• [881] PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4.J Mol Cell Biol. 2018 Apr 1;10(2):147-160. doi: 10.1093/jmcb/mjy007.
• [882] RNA Interference Silencing of Glycogen Synthase Kinase 3 Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.Neurochem Res. 2016 Sep;41(9):2470-80. doi: 10.1007/s11064-016-1960-7. Epub 2016 Jun 2.
• [883] Downregulation of the PHLDA1 gene in IMR-32 neuroblastoma cells increases levels of AuroraA, TRKB and affects proteins involved in apoptosis and autophagy pathways.Int J Oncol. 2016 Aug;49(2):823-37. doi: 10.3892/ijo.2016.3572. Epub 2016 Jun 8.
• [884] PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line.Exp Cell Res. 2016 Mar 1;342(1):62-71. doi: 10.1016/j.yexcr.2016.02.014. Epub 2016 Feb 19.
• [885] Intersectin 1 is required for neuroblastoma tumorigenesis.Oncogene. 2012 Nov 15;31(46):4828-34. doi: 10.1038/onc.2011.643. Epub 2012 Jan 23.
• [886] Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex.PLoS One. 2017 May 9;12(5):e0177046. doi: 10.1371/journal.pone.0177046. eCollection 2017.
• [887] PPP2R2B CAG repeat length in the Han Chinese in Taiwan: Association analyses in neurological and psychiatric disorders and potential functional implications.Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):124-9. doi: 10.1002/ajmg.b.30785.
• [888] Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model of Parkinson's disease.J Mol Neurosci. 2013 Nov;51(3):863-70. doi: 10.1007/s12031-013-0075-8. Epub 2013 Jul 31.
• [889] Assessing LINE-1 retrotransposition activity in neuroblastoma cells exposed to extremely low-frequency pulsed magnetic fields.Mutat Res. 2012 Dec 12;749(1-2):76-81. doi: 10.1016/j.mrgentox.2012.07.004. Epub 2012 Sep 7.
• [890] Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.J Cell Biochem. 1997 Dec 1;67(3):297-303.
• [891] Suppression of RIZ in biologically unfavourable neuroblastomas.Int J Oncol. 2010 Nov;37(5):1323-30. doi: 10.3892/ijo_00000784.
• [892] The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats.J Mol Neurosci. 2009 Feb;37(2):135-45. doi: 10.1007/s12031-008-9139-6. Epub 2008 Aug 27.
• [893] A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.Cancer Res. 2011 Jan 15;71(2):404-12. doi: 10.1158/0008-5472.CAN-10-2627. Epub 2010 Dec 1.
• [894] Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+.Neurosci Lett. 2008 Mar 15;433(3):219-24. doi: 10.1016/j.neulet.2007.12.068. Epub 2008 Jan 17.
• [895] Role of Prickle1 and Prickle2 in neurite outgrowth in murine neuroblastoma cells.Methods Mol Biol. 2012;839:173-85. doi: 10.1007/978-1-61779-510-7_14.
• [896] Regulatory effects of the long noncoding RNA RP11?43N12.1 and microRNA?24?p axis on the neuronal apoptosis induced by the inflammatory reactions of microglia.Int J Mol Med. 2018 Sep;42(3):1741-1755. doi: 10.3892/ijmm.2018.3736. Epub 2018 Jun 20.
• [897] Down-Regulation of Phosphoribosyl Pyrophosphate Synthetase 1 Inhibits Neuroblastoma Cell Proliferation.Cells. 2019 Aug 22;8(9):955. doi: 10.3390/cells8090955.
• [898] Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.BMC Cancer. 2019 Jun 6;19(1):542. doi: 10.1186/s12885-019-5772-4.
• [899] Loss of the Chr16p11.2 ASD candidate gene QPRT leads to aberrant neuronal differentiation in the SH-SY5Y neuronal cell model.Mol Autism. 2018 Nov 6;9:56. doi: 10.1186/s13229-018-0239-z. eCollection 2018.
• [900] Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience.Genome Med. 2017 Nov 29;9(1):100. doi: 10.1186/s13073-017-0486-1.
• [901] Rab15 alternative splicing is altered in spheres of neuroblastoma cells.Oncol Rep. 2012 Jun;27(6):2045-9. doi: 10.3892/or.2012.1731. Epub 2012 Mar 15.
• [902] C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.Brain. 2017 Apr 1;140(4):887-897. doi: 10.1093/brain/awx024.
• [903] Expression of co-factors (SMRT and Trip-1) for retinoic acid receptors in human neuroectodermal cell lines.Biochem Biophys Res Commun. 1997 May 8;234(1):278-82. doi: 10.1006/bbrc.1997.6626.
• [904] New 2-Oxoindolin Phosphonates as Novel Agents to Treat Cancer: A Green Synthesis and Molecular Modeling.Molecules. 2018 Aug 8;23(8):1981. doi: 10.3390/molecules23081981.
• [905] A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.Int J Cancer. 2014 Mar 15;134(6):1335-45. doi: 10.1002/ijc.28463. Epub 2013 Sep 14.
• [906] Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.BMC Cancer. 2015 Jul 10;15:514. doi: 10.1186/s12885-015-1463-y.
• [907] Cytoskeletal remodeling by C3G to induce neurite-like extensions and inhibit motility in highly invasive breast carcinoma cells.Biochim Biophys Acta. 2011 Mar;1813(3):456-65. doi: 10.1016/j.bbamcr.2011.01.004. Epub 2011 Jan 9.
• [908] The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.Mol Cancer. 2012 Jun 13;11:40. doi: 10.1186/1476-4598-11-40.
• [909] RBX1-mediated ubiquitination of SESN2 promotes cell death upon prolonged mitochondrial damage in SH-SY5Y neuroblastoma cells.Mol Cell Biochem. 2018 Sep;446(1-2):1-9. doi: 10.1007/s11010-017-3267-7. Epub 2018 Jan 2.
• [910] Garlic-derived diallyl disulfide modulates peroxisome proliferator activated receptor gamma co-activator 1 alpha in neuroblastoma cells.Biochem Pharmacol. 2013 Feb 1;85(3):335-44. doi: 10.1016/j.bcp.2012.11.007. Epub 2012 Nov 23.
• [911] Regulatory factor X1-induced down-regulation of transforming growth factor 2 transcription in human neuroblastoma cells.J Biol Chem. 2012 Jun 29;287(27):22730-9. doi: 10.1074/jbc.M111.338590. Epub 2012 May 11.
• [912] Endogenous RGS14 is a cytoplasmic-nuclear shuttling protein that localizes to juxtanuclear membranes and chromatin-rich regions of the nucleus.PLoS One. 2017 Sep 21;12(9):e0184497. doi: 10.1371/journal.pone.0184497. eCollection 2017.
• [913] Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.Clin Cancer Res. 2013 Sep 15;19(18):5092-103. doi: 10.1158/1078-0432.CCR-12-2211. Epub 2013 Jul 17.
• [914] Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.PLoS One. 2013;8(1):e52321. doi: 10.1371/journal.pone.0052321. Epub 2013 Jan 4.
• [915] Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation.Cancer Lett. 2013 Jan 1;328(1):168-75. doi: 10.1016/j.canlet.2012.08.015. Epub 2012 Aug 17.
• [916] RSAD2 and AIM2 Modulate Coxsackievirus A16 and Enterovirus A71 Replication in Neuronal Cells in Different Ways That May Be Associated with Their 5' Nontranslated Regions.J Virol. 2018 Feb 26;92(6):e01914-17. doi: 10.1128/JVI.01914-17. Print 2018 Mar 15.
• [917] Amyloid production is regulated by 2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.J Biol Chem. 2017 Jun 16;292(24):10153-10168. doi: 10.1074/jbc.M116.743070. Epub 2017 May 5.
• [918] A-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.Biochim Biophys Acta. 2016 May;1864(5):609-21. doi: 10.1016/j.bbapap.2016.02.003. Epub 2016 Feb 5.
• [919] Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells.Cell Death Differ. 2008 May;15(5):879-88. doi: 10.1038/cdd.2008.8. Epub 2008 Feb 1.
• [920] Valproate robustly enhances AP-1 mediated gene expression.Brain Res Mol Brain Res. 1999 Jan 22;64(1):52-8. doi: 10.1016/s0169-328x(98)00303-9.
• [921] Selenoprotein S is required for clearance of C99 through endoplasmic reticulum-associated degradation.Biochem Biophys Res Commun. 2017 Apr 29;486(2):444-450. doi: 10.1016/j.bbrc.2017.03.060. Epub 2017 Mar 16.
• [922] Structural insights into pro-aggregation effects of C. elegans CRAM-1 and its human ortholog SERF2.Sci Rep. 2018 Oct 5;8(1):14891. doi: 10.1038/s41598-018-33143-1.
• [923] miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3 and SFRP1.Biomed Pharmacother. 2016 Oct;83:508-513. doi: 10.1016/j.biopha.2016.07.010. Epub 2016 Jul 18.
• [924] Circulating SH2B1 is associated with an increased risk of gastric cancer.Oncol Lett. 2018 May;15(5):7305-7311. doi: 10.3892/ol.2018.8196. Epub 2018 Mar 7.
• [925] Src homology 2 domain containing protein 5 (SH2D5) binds the breakpoint cluster region protein, BCR, and regulates levels of Rac1-GTP.J Biol Chem. 2014 Dec 19;289(51):35397-408. doi: 10.1074/jbc.M114.615112. Epub 2014 Oct 20.
• [926] Serine catabolism regulates mitochondrial redox control during hypoxia.Cancer Discov. 2014 Dec;4(12):1406-17. doi: 10.1158/2159-8290.CD-14-0250. Epub 2014 Sep 3.
• [927] ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.Mol Carcinog. 2019 Nov;58(11):1998-2007. doi: 10.1002/mc.23091. Epub 2019 Jul 31.
• [928] Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage.Cancer Manag Res. 2018 Nov 9;10:5591-5603. doi: 10.2147/CMAR.S172509. eCollection 2018.
• [929] A cullin-RING ubiquitin ligase targets exogenous -synuclein and inhibits Lewy body-like pathology.Sci Transl Med. 2019 Jun 5;11(495):eaau6722. doi: 10.1126/scitranslmed.aau6722.
• [930] Botulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells.Oncotarget. 2016 May 31;7(22):33220-8. doi: 10.18632/oncotarget.8903.
• [931] Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins.RNA Biol. 2014;11(11):1430-46. doi: 10.1080/15476286.2014.996494.
• [932] SOD3 Ameliorates A(25-35)-Induced Oxidative Damage in SH-SY5Y Cells by Inhibiting the Mitochondrial Pathway.Cell Mol Neurobiol. 2017 Apr;37(3):513-525. doi: 10.1007/s10571-016-0390-z. Epub 2016 Jun 7.
• [933] Nrf2-regulated miR-380-3p Blocks the Translation of Sp3 Protein and Its Mediation of Paraquat-Induced Toxicity in Mouse Neuroblastoma N2a Cells.Toxicol Sci. 2019 Oct 1;171(2):515-529. doi: 10.1093/toxsci/kfz162.
• [934] The inverse F-BAR domain protein srGAP2 acts through srGAP3 to modulate neuronal differentiation and neurite outgrowth of mouse neuroblastoma cells.PLoS One. 2013;8(3):e57865. doi: 10.1371/journal.pone.0057865. Epub 2013 Mar 7.
• [935] Re-localization of cellular protein SRp20 during poliovirus infection: bridging a viral IRES to the host cell translation apparatus.PLoS Pathog. 2011 Jul;7(7):e1002127. doi: 10.1371/journal.ppat.1002127. Epub 2011 Jul 14.
• [936] Time-lapse imaging of neuroblastoma cells to determine cell fate upon gene knockdown.PLoS One. 2012;7(12):e50988. doi: 10.1371/journal.pone.0050988. Epub 2012 Dec 12.
• [937] Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene.BMC Med Genet. 2013 Oct 2;14:102. doi: 10.1186/1471-2350-14-102.
• [938] Lin28B and miR-142-3p regulate neuronal differentiation by modulating Staufen1 expression.Cell Death Differ. 2018 Feb;25(2):432-443. doi: 10.1038/cdd.2017.182. Epub 2017 Nov 3.
• [939] Huntingtin-Associated Protein 1A Regulates Store-Operated Calcium Entry in Medium Spiny Neurons From Transgenic YAC128 Mice, a Model of Huntington's Disease.Front Cell Neurosci. 2018 Oct 26;12:381. doi: 10.3389/fncel.2018.00381. eCollection 2018.
• [940] STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin.J Biol Chem. 2012 Aug 24;287(35):29285-9. doi: 10.1074/jbc.C112.345397. Epub 2012 Jul 10.
• [941] CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.J Clin Invest. 2018 Jan 2;128(1):446-462. doi: 10.1172/JCI90793. Epub 2017 Dec 4.
• [942] Schwann cells protect against CaMKII- and PKA-dependent Acrylamide-induced Synapsin I phosphorylation.Brain Res. 2018 Dec 15;1701:18-27. doi: 10.1016/j.brainres.2018.07.019. Epub 2018 Jul 17.
• [943] Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes.Hum Mol Genet. 2012 Jul 15;21(14):3156-72. doi: 10.1093/hmg/dds142. Epub 2012 Apr 17.
• [944] Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.BMC Cancer. 2019 Oct 21;19(1):970. doi: 10.1186/s12885-019-6149-4.
• [945] Pregabalin and gabapentin inhibit substance P-induced NF-kappaB activation in neuroblastoma and glioma cells.J Cell Biochem. 2008 Oct 1;105(2):414-23. doi: 10.1002/jcb.21837.
• [946] Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells.PLoS One. 2017 May 3;12(5):e0176851. doi: 10.1371/journal.pone.0176851. eCollection 2017.
• [947] Matrine Inhibits Neuroblastoma Cell Proliferation and Migration by Enhancing Tribbles 3 Expression.Oncol Res. 2018 Aug 23;26(7):1133-1142. doi: 10.3727/096504018X15168461629558. Epub 2018 Jan 31.
• [948] Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma.Cancer Discov. 2018 May;8(5):582-599. doi: 10.1158/2159-8290.CD-16-0861. Epub 2018 Mar 6.
• [949] Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.Mol Oncol. 2016 Feb;10(2):344-59. doi: 10.1016/j.molonc.2015.10.020. Epub 2015 Nov 7.
• [950] miR-200a inhibits tumor proliferation by targeting AP-2 in neuroblastoma cells.Asian Pac J Cancer Prev. 2014;15(11):4671-6. doi: 10.7314/apjcp.2014.15.11.4671.
• [951] Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma.Oncogene. 2018 Oct;37(40):5451-5465. doi: 10.1038/s41388-018-0326-9. Epub 2018 Jun 7.
• [952] The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells.Neurosci Lett. 2010 Jan 4;468(2):136-40. doi: 10.1016/j.neulet.2009.10.084. Epub 2009 Nov 4.
• [953] Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by A-stimulated THP-1 supernatant and the involvement of p38 pathway activation.Life Sci. 2012 Oct 22;91(15-16):809-15. doi: 10.1016/j.lfs.2012.08.028. Epub 2012 Sep 6.
• [954] Favorable prognostic role of tropomodulins in neuroblastoma.Oncotarget. 2018 Jun 5;9(43):27092-27103. doi: 10.18632/oncotarget.25491. eCollection 2018 Jun 5.
• [955] TIPE? suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3kinase/AKT signaling pathway.Mol Med Rep. 2018 May;17(5):7017-7026. doi: 10.3892/mmr.2018.8789. Epub 2018 Mar 20.
• [956] All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.J Cell Biochem. 2017 Dec;118(12):4358-4369. doi: 10.1002/jcb.26090. Epub 2017 May 8.
• [957] Methylglyoxal produced by amyloid- peptide-induced nitrotyrosination of triosephosphate isomerase triggers neuronal death in Alzheimer's disease.J Alzheimers Dis. 2014;41(1):273-88. doi: 10.3233/JAD-131685.
• [958] Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma.Drug Des Devel Ther. 2018 Oct 23;12:3549-3561. doi: 10.2147/DDDT.S147384. eCollection 2018.
• [959] A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.Cancer Res. 2019 Dec 15;79(24):6166-6177. doi: 10.1158/0008-5472.CAN-19-0008. Epub 2019 Oct 15.
• [960] Inhibition of neuroblastoma cell growth by TREX1-mutated human lymphocytes.Oncol Rep. 2012 May;27(5):1689-94. doi: 10.3892/or.2012.1696. Epub 2012 Feb 22.
• [961] TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons.Mol Neurobiol. 2019 Apr;56(4):2640-2652. doi: 10.1007/s12035-018-1238-y. Epub 2018 Jul 26.
• [962] Carvacrol Depends on Heme Oxygenase-1 (HO-1) to Exert Antioxidant, Anti-inflammatory, and Mitochondria-Related Protection in the Human Neuroblastoma SH-SY5Y Cells Line Exposed to Hydrogen Peroxide.Neurochem Res. 2019 Apr;44(4):884-896. doi: 10.1007/s11064-019-02724-5. Epub 2019 Jan 16.
• [963] Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes.Cell Death Differ. 2019 Jul;26(7):1346-1364. doi: 10.1038/s41418-018-0220-6. Epub 2018 Oct 19.
• [964] PPP3CB contributes to poor prognosis through activating nuclear factor of activated T-cells signaling in neuroblastoma.Mol Carcinog. 2019 Mar;58(3):426-435. doi: 10.1002/mc.22939. Epub 2018 Dec 13.
• [965] Identification of -N-catenin as a novel tumor suppressor in neuroblastoma.Oncotarget. 2019 Aug 20;10(49):5028-5040. doi: 10.18632/oncotarget.27096. eCollection 2019 Aug 20.
• [966] The testosterone metabolite 3-androstanediol inhibits oxidative stress-induced ERK phosphorylation and neurotoxicity in SH-SY5Y cells through an MKP3/DUSP6-dependent mechanism.Neurosci Lett. 2019 Mar 23;696:60-66. doi: 10.1016/j.neulet.2018.12.012. Epub 2018 Dec 12.
• [967] ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State.Mol Cancer Res. 2020 Jan;18(1):68-78. doi: 10.1158/1541-7786.MCR-19-0187. Epub 2019 Oct 17.
• [968] Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.Genes Chromosomes Cancer. 2020 May;59(5):277-285. doi: 10.1002/gcc.22827. Epub 2019 Dec 3.
• [969] Effects of GADL1 overexpression on cell migration and the associated morphological changes.Sci Rep. 2019 Mar 28;9(1):5298. doi: 10.1038/s41598-019-41689-x.
• [970] The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells.J Cell Physiol. 2018 May;233(5):4282-4293. doi: 10.1002/jcp.26247. Epub 2017 Nov 24.
• [971] GDNF family receptor alpha 2 promotes neuroblastoma cell proliferation by interacting with PTEN.Biochem Biophys Res Commun. 2019 Mar 12;510(3):339-344. doi: 10.1016/j.bbrc.2018.12.169. Epub 2019 Feb 2.
• [972] Krppel-like factor 9 promotes neuroblastoma differentiation via targeting the sonic hedgehog signaling pathway.Pediatr Blood Cancer. 2020 Mar;67(3):e28108. doi: 10.1002/pbc.28108. Epub 2019 Nov 29.
• [973] New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma.Cancer Lett. 2019 Apr 1;446:90-102. doi: 10.1016/j.canlet.2019.01.014. Epub 2019 Jan 19.
• [974] LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors.Cell Death Differ. 2020 Apr;27(4):1225-1242. doi: 10.1038/s41418-019-0425-3. Epub 2019 Oct 10.
• [975] FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-1 induced LMO1 via control of let-7 expression.Brain Res. 2019 Feb 1;1704:219-228. doi: 10.1016/j.brainres.2018.10.015. Epub 2018 Oct 12.
• [976] RNA-Binding Proteomics Reveals MATR3 Interacting with lncRNA SNHG1 To Enhance Neuroblastoma Progression.J Proteome Res. 2019 Jan 4;18(1):406-416. doi: 10.1021/acs.jproteome.8b00693. Epub 2018 Dec 14.
• [977] High Glucose Enhances Bupivacaine-Induced Neurotoxicity via MCU-Mediated Oxidative Stress in SH-SY5Y Cells.Oxid Med Cell Longev. 2019 Feb 18;2019:7192798. doi: 10.1155/2019/7192798. eCollection 2019.
• [978] PRIMA-1(MET)-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level.J Exp Clin Cancer Res. 2019 Feb 12;38(1):69. doi: 10.1186/s13046-019-1066-6.
• [979] The activity of the Striatal-enriched protein tyrosine phosphatase in neuronal cells is modulated by adenosine A(2A) receptor.J Neurochem. 2020 Feb;152(3):284-298. doi: 10.1111/jnc.14866. Epub 2019 Oct 10.
• [980] RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway.FEBS Open Bio. 2019 Jan 28;9(3):490-497. doi: 10.1002/2211-5463.12586. eCollection 2019 Mar.
• [981] Role of SNHG7-miR-653-5p-STAT2 feedback loop in regulating neuroblastoma progression.J Cell Physiol. 2019 Aug;234(8):13403-13412. doi: 10.1002/jcp.28017. Epub 2019 Jan 8.
• [982] Unveiling Ga(III) phthalocyanine-a different photosensitizer in neuroblastoma cellular model.J Cell Mol Med. 2019 Feb;23(2):1086-1094. doi: 10.1111/jcmm.14009. Epub 2018 Nov 19.
• [983] Integrated olfaction, gustation and toxicity detection by a versatile bioengineered cell-based biomimetic sensor.Bioelectrochemistry. 2019 Aug;128:1-8. doi: 10.1016/j.bioelechem.2019.02.009. Epub 2019 Feb 21.
• [984] Transcriptional Elongation Regulator 1 Affects Transcription and Splicing of Genes Associated with Cellular Morphology and Cytoskeleton Dynamics and Is Required for Neurite Outgrowth in Neuroblastoma Cells and Primary Neuronal Cultures.Mol Neurobiol. 2017 Dec;54(10):7808-7823. doi: 10.1007/s12035-016-0284-6. Epub 2016 Nov 14.
• [985] Dendritic cell factor 1 inhibits proliferation and migration and induces apoptosis of neuroblastoma cells by inhibiting the ERK signaling pathway.Oncol Rep. 2019 Jan;41(1):103-112. doi: 10.3892/or.2018.6796. Epub 2018 Oct 16.
• [986] Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers.Biochem Biophys Res Commun. 2005 Sep 2;334(3):875-83. doi: 10.1016/j.bbrc.2005.06.176.
• [987] Characterization of a specific interaction between ADAM23 and cellular prion protein.Neurosci Lett. 2009 Sep 11;461(1):16-20. doi: 10.1016/j.neulet.2009.05.049. Epub 2009 May 27.
• [988] Regulation of cell proliferation and apoptosis in neuroblastoma cells by ccp1, a FGF2 downstream gene.BMC Cancer. 2010 Nov 30;10:657. doi: 10.1186/1471-2407-10-657.
• [989] The transcription of the human fructose-bisphosphate aldolase C gene is activated by nerve-growth-factor-induced B factor in human neuroblastoma cells.Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):245-50. doi: 10.1042/bj3230245.
• [990] Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma.Genes Chromosomes Cancer. 2002 Mar;33(3):285-94. doi: 10.1002/gcc.10030.
• [991] In-situ cytidine-deaminase activity and chromosome 1P deletion in human neuroblastoma cells.Anticancer Res. 1997 Jan-Feb;17(1A):457-9.
• [992] HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway.J Neurochem. 2004 Nov;91(3):613-22. doi: 10.1111/j.1471-4159.2004.02754.x.
• [993] Overlapping expression of ARFGEF2 and Filamin A in the neuroependymal lining of the lateral ventricles: insights into the cause of periventricular heterotopia.J Comp Neurol. 2006 Jan 20;494(3):476-84. doi: 10.1002/cne.20806.
• [994] Involvement of p114-RhoGEF and Lfc in Wnt-3a- and dishevelled-induced RhoA activation and neurite retraction in N1E-115 mouse neuroblastoma cells.Mol Biol Cell. 2010 Oct 15;21(20):3590-600. doi: 10.1091/mbc.E10-02-0095. Epub 2010 Sep 1.
• [995] ARID1B alterations identify aggressive tumors in neuroblastoma.Oncotarget. 2017 Jul 11;8(28):45943-45950. doi: 10.18632/oncotarget.17500.
• [996] Differential expression of ARID3B in normal adult tissue and carcinomas.Gene. 2014 Jun 10;543(1):174-80. doi: 10.1016/j.gene.2014.04.007. Epub 2014 Apr 3.
• [997] Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expression.Gastroenterology. 2011 Feb;140(2):572-582.e2. doi: 10.1053/j.gastro.2010.10.044. Epub 2010 Oct 25.
• [998] Identification and characterization of ASXL3 gene in silico.Int J Oncol. 2004 Jun;24(6):1617-22.
• [999] The promoter of human acetylcholinesterase is activated by a cyclic adenosine 3',5'-monophosphate-dependent pathway in cultured NG108-15 neuroblastoma cells.Neurosci Lett. 2000 Jul 7;288(1):81-5. doi: 10.1016/s0304-3940(00)01200-3.
• [1000] The transcription factor ATF5: role in neurodevelopment and neural tumors.J Neurochem. 2009 Jan;108(1):11-22. doi: 10.1111/j.1471-4159.2008.05749.x. Epub 2008 Nov 15.
• [1001] Bach2 is involved in neuronal differentiation of N1E-115 neuroblastoma cells.Exp Cell Res. 2006 Jul 15;312(12):2264-78. doi: 10.1016/j.yexcr.2006.03.018. Epub 2006 Apr 24.
• [1002] Sensitive Ewing sarcoma and neuroblastoma cell lines have increased levels of BAD expression and decreased levels of BAR expression compared to resistant cell lines.Cancer Lett. 2007 Mar 8;247(1):110-4. doi: 10.1016/j.canlet.2006.03.033. Epub 2006 May 11.
• [1003] Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.Oncogene. 2008 Feb 28;27(10):1439-48. doi: 10.1038/sj.onc.1210770. Epub 2007 Sep 10.
• [1004] CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene.J Biol Chem. 2006 Oct 27;281(43):32272-83. doi: 10.1074/jbc.M602776200. Epub 2006 Sep 1.
• [1005] Identification of genes associated with paraquat-induced toxicity in SH-SY5Y cells by PCR array focused on apoptotic pathways. J Toxicol Environ Health A. 2008;71(22):1457-67. doi: 10.1080/15287390802329364.
• [1006] Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):60-70. doi: 10.1097/PAI.0000000000000028.
• [1007] Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.Oncogene. 2006 Mar 23;25(13):1931-42. doi: 10.1038/sj.onc.1209225.
• [1008] DNA binding activity of the fetal Alz-50 clone 1 (FAC1) protein is enhanced by phosphorylation.Biochem Biophys Res Commun. 1999 Jul 14;260(3):785-9. doi: 10.1006/bbrc.1999.0986.
• [1009] A requirement for the POU transcription factor, Brn-2, in corticotropin-releasing hormone expression in a neuronal cell line.Mol Endocrinol. 1999 Aug;13(8):1237-48. doi: 10.1210/mend.13.8.0327.
• [1010] The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines.Cancer Res. 2004 Oct 15;64(20):7288-95. doi: 10.1158/0008-5472.CAN-04-1610.
• [1011] Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.J Neuroimmunol. 2008 Dec 15;205(1-2):86-93. doi: 10.1016/j.jneuroim.2008.09.012. Epub 2008 Oct 22.
• [1012] Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.Oncogene. 2010 Nov 4;29(44):5957-68. doi: 10.1038/onc.2010.332. Epub 2010 Aug 9.
• [1013] Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors. Cancer Biol Ther. 2005 Mar;4(3):277-81. doi: 10.4161/cbt.4.3.1497. Epub 2005 Mar 20.
• [1014] Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.J Clin Invest. 2009 Jun;119(6):1524-36. doi: 10.1172/JCI37869.
• [1015] Cdc6 knockdown inhibits human neuroblastoma cell proliferation.Mol Cell Biochem. 2008 Apr;311(1-2):189-97. doi: 10.1007/s11010-008-9709-5. Epub 2008 Feb 8.
• [1016] Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line.Eur Arch Otorhinolaryngol. 2006 Feb;263(2):127-34. doi: 10.1007/s00405-005-0936-z. Epub 2005 Dec 28.
• [1017] Neuroblastoma cell lines showing smooth muscle cell phenotypes.Diagn Mol Pathol. 2000 Dec;9(4):221-8. doi: 10.1097/00019606-200012000-00007.
• [1018] Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.Cytogenet Cell Genet. 2000;89(1-2):62-6. doi: 10.1159/000015566.
• [1019] DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription.Mol Cell Biol. 2000 Dec;20(24):9120-6. doi: 10.1128/MCB.20.24.9120-9126.2000.
• [1020] Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.Clin Cancer Res. 2003 Oct 1;9(12):4595-605.
• [1021] Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.Oncogene. 2003 Apr 17;22(15):2343-51. doi: 10.1038/sj.onc.1206324.
• [1022] Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions.Gene. 2007 Aug 15;398(1-2):114-22. doi: 10.1016/j.gene.2007.03.022. Epub 2007 Apr 25.
• [1023] CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation.Oncoimmunology. 2019 Feb 18;8(5):e1577126. doi: 10.1080/2162402X.2019.1577126. eCollection 2019.
• [1024] DAP-5 is involved in MycN/IFNgamma-induced apoptosis in human neuroblastoma cells.Cancer Lett. 2001 Jan 26;162(2):237-43. doi: 10.1016/s0304-3835(00)00644-3.
• [1025] ERdj5 sensitizes neuroblastoma cells to endoplasmic reticulum stress-induced apoptosis.J Biol Chem. 2009 Mar 6;284(10):6282-90. doi: 10.1074/jbc.M806189200. Epub 2009 Jan 4.
• [1026] Involvement of GTA protein NC2beta in neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation.Mol Cancer. 2008 Jun 6;7:52. doi: 10.1186/1476-4598-7-52.
• [1027] Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology.Eur J Cancer. 2005 Mar;41(4):635-46. doi: 10.1016/j.ejca.2004.12.021.
• [1028] Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression.BMC Cancer. 2004 Nov 15;4:80. doi: 10.1186/1471-2407-4-80.
• [1029] High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.Int J Oncol. 2003 Apr;22(4):815-22.
• [1030] Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas.Eur J Clin Invest. 2001 Oct;31(10):907-14. doi: 10.1046/j.1365-2362.2001.00892.x.
• [1031] Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer. 2007 Nov 19;97(10):1416-24. doi: 10.1038/sj.bjc.6604032. Epub 2007 Oct 16.
• [1032] Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing.J Biol Chem. 1999 May 14;274(20):13818-23. doi: 10.1074/jbc.274.20.13818.
• [1033] Ets transcription factors ER81 and Elk1 regulate the transcription of the human presenilin 1 gene promoter.Brain Res Mol Brain Res. 2003 May 12;113(1-2):57-66. doi: 10.1016/s0169-328x(03)00090-1.
• [1034] Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines.Jpn J Cancer Res. 1997 Apr;88(4):394-400. doi: 10.1111/j.1349-7006.1997.tb00395.x.
• [1035] The NBPF1 promoter has been recruited from the unrelated EVI5 gene before simian radiation.Mol Biol Evol. 2009 Jun;26(6):1321-32. doi: 10.1093/molbev/msp047. Epub 2009 Mar 12.
• [1036] Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.J Pediatr Hematol Oncol. 2000 May-Jun;22(3):197-205. doi: 10.1097/00043426-200005000-00003.
• [1037] Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells.Eur Neuropsychopharmacol. 2009 May;19(5):356-62. doi: 10.1016/j.euroneuro.2008.12.012. Epub 2009 Feb 3.
• [1038] Anaplastic large cell neuroblastoma.Pediatr Dev Pathol. 2009 Jan-Feb;12(1):1-5. doi: 10.2350/07-04-0255.1.
• [1039] Flt-3 and its ligand are expressed in neural crest-derived tumors and promote survival and proliferation of their cell lines.Lab Invest. 2001 Jul;81(7):1025-37. doi: 10.1038/labinvest.3780314.
• [1040] FMRP RNA targets: identification and validation.Genes Brain Behav. 2005 Aug;4(6):341-9. doi: 10.1111/j.1601-183X.2005.00144.x.
• [1041] The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.Oncogene. 2009 Jun 11;28(23):2245-56. doi: 10.1038/onc.2009.80. Epub 2009 May 4.
• [1042] Peroxynitrite induces GADD34, 45, and 153 VIA p38 MAPK in human neuroblastoma SH-SY5Y cells.Free Radic Biol Med. 2001 Jan 15;30(2):213-21. doi: 10.1016/s0891-5849(00)00461-5.
• [1043] Gas1 is induced during and participates in excitotoxic neuronal death.Mol Cell Neurosci. 2002 Mar;19(3):417-29. doi: 10.1006/mcne.2001.1092.
• [1044] Isolation, tissue expression, and chromosomal assignment of a novel human gene which encodes a protein with RING finger motif.J Hum Genet. 1998;43(4):272-4. doi: 10.1007/s100380050088.
• [1045] GMEB1, a novel endogenous caspase inhibitor, prevents hypoxia- and oxidative stress-induced neuronal apoptosis.Neurosci Lett. 2008 Jun 13;438(1):34-7. doi: 10.1016/j.neulet.2008.04.023. Epub 2008 Apr 11.
• [1046] Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.PLoS One. 2010 Sep 17;5(9):e12825. doi: 10.1371/journal.pone.0012825.
• [1047] Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells.Mol Genet Metab. 1998 Oct;65(2):155-64. doi: 10.1006/mgme.1998.2747.
• [1048] HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells.J Cell Mol Med. 2007 Mar-Apr;11(2):299-306. doi: 10.1111/j.1582-4934.2007.00020.x.
• [1049] Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma.Oncogene. 2014 Jun 19;33(25):3316-24. doi: 10.1038/onc.2013.290. Epub 2013 Jul 22.
• [1050] Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells.J Endocrinol. 1998 Nov;159(2):227-32. doi: 10.1677/joe.0.1590227.
• [1051] Interferon alpha but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells.J Biol Chem. 2004 Jun 18;279(25):26789-96. doi: 10.1074/jbc.M401517200. Epub 2004 Apr 15.
• [1052] A comparative immunohistochemical analysis of small round cell tumors of childhood: utility of peripherin and alpha-internexin as markers for neuroblastomas.Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):344-8. doi: 10.1097/PAI.0b013e318165fe78.
• [1053] ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.Nat Commun. 2019 Dec 9;10(1):5622. doi: 10.1038/s41467-019-13515-5.
• [1054] Expression of KIF3C kinesin during neural development and in vitro neuronal differentiation.J Neurochem. 2001 May;77(3):741-53. doi: 10.1046/j.1471-4159.2001.00277.x.
• [1055] KBP-cytoskeleton interactions underlie developmental anomalies in Goldberg-Shprintzen syndrome.Hum Mol Genet. 2013 Jun 15;22(12):2387-99. doi: 10.1093/hmg/ddt083. Epub 2013 Feb 19.
• [1056] Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells.Oncogene. 2003 Sep 18;22(40):6277-88. doi: 10.1038/sj.onc.1206631.
• [1057] LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.J Cell Mol Med. 2020 Jan;24(2):1160-1168. doi: 10.1111/jcmm.14836. Epub 2019 Dec 12.
• [1058] Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells.FEBS Lett. 2008 Aug 20;582(19):2826-32. doi: 10.1016/j.febslet.2008.07.021. Epub 2008 Jul 24.
• [1059] High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis.FEBS Lett. 2006 Jan 23;580(2):627-32. doi: 10.1016/j.febslet.2005.12.089. Epub 2006 Jan 5.
• [1060] Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk.Nat Commun. 2017 Sep 18;8(1):569. doi: 10.1038/s41467-017-00408-8.
• [1061] Induction of two DNA mismatch repair proteins, MSH2 and MSH6, in differentiated human neuroblastoma SH-SY5Y cells exposed to doxorubicin.J Neurochem. 1999 Mar;72(3):974-9. doi: 10.1046/j.1471-4159.1999.0720974.x.
• [1062] Structure and promoter analysis of the human unc-33-like phosphoprotein gene. E-box required for maximal expression in neuroblastoma and myoblasts.J Biol Chem. 2000 Jun 2;275(22):16560-8. doi: 10.1074/jbc.M001312200.
• [1063] Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion.Endocrinology. 2005 Oct;146(10):4445-55. doi: 10.1210/en.2005-0467. Epub 2005 Jun 30.
• [1064] A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos.Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3422-7. doi: 10.1073/pnas.052017399.
• [1065] Human Nck-associated protein 1 and its binding protein affect the metabolism of beta-amyloid precursor protein with Swedish mutation.Neurosci Lett. 2001 Dec 4;316(1):50-4. doi: 10.1016/s0304-3940(01)02370-9.
• [1066] ERAP140/Nbla10993 is a novel favorable prognostic indicator for neuroblastoma induced in response to retinoic acid.Oncol Rep. 2008 Jun;19(6):1381-8.
• [1067] Overexpression of neurogenin1 induces neurite outgrowth in F11 neuroblastoma cells.Exp Mol Med. 2002 Dec 31;34(6):469-75. doi: 10.1038/emm.2002.65.
• [1068] Neurogenin-2-transduced human neural progenitor cells attenuate neonatal hypoxic-ischemic brain injury.Transl Res. 2017 May;183:121-136.e9. doi: 10.1016/j.trsl.2016.12.010. Epub 2016 Dec 29.
• [1069] Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells. J Neural Transm (Vienna). 2012 Jan;119(1):17-24.
• [1070] Two novel genes, human neugrin and mouse m-neugrin, are upregulated with neuronal differentiation in neuroblastoma cells.Biochem Biophys Res Commun. 2000 Dec 20;279(2):526-33. doi: 10.1006/bbrc.2000.3971.
• [1071] mAtNOS1 regulates mitochondrial functions and apoptosis of human neuroblastoma cells.Biochim Biophys Acta. 2008 Jun;1780(6):921-6. doi: 10.1016/j.bbagen.2008.02.006. Epub 2008 Mar 4.
• [1072] Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.Mol Biol Cell. 2006 Nov;17(11):4888-95. doi: 10.1091/mbc.e06-04-0301. Epub 2006 Sep 13.
• [1073] Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors.Cancer Genet Cytogenet. 2002 May;135(1):42-7. doi: 10.1016/s0165-4608(01)00640-9.
• [1074] Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.Tissue Antigens. 2001 Feb;57(2):110-7. doi: 10.1034/j.1399-0039.2001.057002110.x.
• [1075] Family of human oxysterol binding protein (OSBP) homologues. A novel member implicated in brain sterol metabolism.J Lipid Res. 1999 Dec;40(12):2204-11.
• [1076] Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.Clin Cancer Res. 2007 Jun 1;13(11):3191-7. doi: 10.1158/1078-0432.CCR-06-2846.
• [1077] Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties.Mol Cell Biol. 2006 Apr;26(8):3215-30. doi: 10.1128/MCB.26.8.3215-3230.2006.
• [1078] PDYN, a gene implicated in brain/mental disorders, is targeted by REST in the adult human brain.Biochim Biophys Acta. 2014 Nov;1839(11):1226-32. doi: 10.1016/j.bbagrm.2014.09.001. Epub 2014 Sep 8.
• [1079] Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastoma.J Cell Physiol. 2009 Jun;219(3):707-15. doi: 10.1002/jcp.21719.
• [1080] Pitx3 promoter directs Cre-recombinase specifically in a human neuroblastoma cell line.Mol Cell Biochem. 2008 Feb;309(1-2):223-7. doi: 10.1007/s11010-007-9655-7. Epub 2007 Nov 30.
• [1081] The gene for a new brain specific RhoA exchange factor maps to the highly unstable chromosomal region 1p36.2-1p36.3.Oncogene. 2001 Nov 1;20(50):7307-17. doi: 10.1038/sj.onc.1204921.
• [1082] Noninvasive monitoring of apoptosis versus necrosis in a neuroblastoma cell line expressing a nuclear pore protein tagged with the green fluorescent protein.Exp Cell Res. 1998 Feb 1;238(2):371-6. doi: 10.1006/excr.1997.3846.
• [1083] Integrin-dependent neuroblastoma cell adhesion and migration on laminin is regulated by expression levels of two enzymes in the O-mannosyl-linked glycosylation pathway, PomGnT1 and GnT-Vb.Exp Cell Res. 2006 Sep 10;312(15):2837-50. doi: 10.1016/j.yexcr.2006.05.022. Epub 2006 Jun 21.
• [1084] Silencing DJ-1 reveals its contribution in paraquat-induced autophagy.J Neurochem. 2009 May;109(3):889-98. doi: 10.1111/j.1471-4159.2009.06020.x.
• [1085] Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists.Cell Signal. 2008 Jun;20(6):1209-20. doi: 10.1016/j.cellsig.2008.02.010. Epub 2008 Feb 19.
• [1086] Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines.Oncogene. 2002 Aug 29;21(38):5823-34. doi: 10.1038/sj.onc.1205735.
• [1087] Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma.Cancer Lett. 2001 Jul 26;168(2):191-5. doi: 10.1016/s0304-3835(01)00540-7.
• [1088] Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.Int J Oncol. 2012 Sep;41(3):893-902. doi: 10.3892/ijo.2012.1514. Epub 2012 Jun 12.
• [1089] Neuroblastoma-derived sulfhydryl oxidase, a new member of the sulfhydryl oxidase/Quiescin6 family, regulates sensitization to interferon gamma-induced cell death in human neuroblastoma cells.Cancer Res. 2003 Nov 15;63(22):7742-52.
• [1090] Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation.Oncogene. 2008 May 22;27(23):3339-44. doi: 10.1038/sj.onc.1210987. Epub 2008 Jan 21.
• [1091] Interaction of receptor-activity-modifying protein1 with tubulin.Biochim Biophys Acta. 2007 Aug;1770(8):1145-50. doi: 10.1016/j.bbagen.2007.04.002. Epub 2007 Apr 11.
• [1092] The guanine nucleotide exchange factor, C3G regulates differentiation and survival of human neuroblastoma cells.J Neurochem. 2008 Dec;107(5):1424-35. doi: 10.1111/j.1471-4159.2008.05710.x. Epub 2008 Oct 24.
• [1093] RB2/p130 ectopic gene expression in neuroblastoma stem cells: evidence of cell-fate restriction and induction of differentiation.Biochem J. 2001 Dec 15;360(Pt 3):569-77. doi: 10.1042/0264-6021:3600569.
• [1094] A culture device demonstrates that hydrostatic pressure increases mRNA of RGS5 in neuroblastoma and CHC1-L in lymphocytic cells.Cells Tissues Organs. 2003;174(4):155-61. doi: 10.1159/000072718.
• [1095] Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma.J Pediatr Surg. 2007 Nov;42(11):1831-40. doi: 10.1016/j.jpedsurg.2007.07.008.
• [1096] Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA.J Mol Diagn. 2005 Feb;7(1):89-96. doi: 10.1016/S1525-1578(10)60013-X.
• [1097] Neuronal cell lines transfected with the dopamine D2 receptor gene promoter as a model for studying the effects of antidepressant drugs.Brain Res Mol Brain Res. 2004 Sep 10;128(1):75-82. doi: 10.1016/j.molbrainres.2004.06.006.
• [1098] Identification of human SEP1 as a glial cell line-derived neurotrophic factor-inducible protein and its expression in the nervous system.Neuroscience. 2003;121(4):899-906. doi: 10.1016/s0306-4522(03)00487-1.
• [1099] Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.J Pediatr Surg. 2005 Feb;40(2):349-58. doi: 10.1016/j.jpedsurg.2004.10.032.
• [1100] The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
• [1101] Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?.J Neurol. 2009 Aug;256 Suppl 3:286-92. doi: 10.1007/s00415-009-5246-8.
• [1102] Markedly induced expression of LR11 in atherosclerosis.J Atheroscler Thromb. 2000;7(1):21-5. doi: 10.5551/jat1994.7.21.
• [1103] Sprouty2 regulates growth and differentiation of human neuroblastoma cells through RET tyrosine kinase.Cancer Sci. 2007 Jun;98(6):815-21. doi: 10.1111/j.1349-7006.2007.00457.x. Epub 2007 Mar 27.
• [1104] The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.Cell Death Differ. 2020 Feb;27(2):790-807. doi: 10.1038/s41418-019-0386-6. Epub 2019 Jul 8.
• [1105] SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells.Neurochem Res. 2003 Apr;28(3-4):449-60. doi: 10.1023/a:1022848718109.
• [1106] Expression of SSX-2 and SSX-4 genes in neuroblastoma.Int J Biol Markers. 2002 Oct-Dec;17(4):219-23. doi: 10.1177/172460080201700401.
• [1107] Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.J Natl Cancer Inst. 2007 Jul 18;99(14):1107-19. doi: 10.1093/jnci/djm044. Epub 2007 Jul 10.
• [1108] Teneurin 2 is expressed by the neurons of the thalamofugal visual system in situ and promotes homophilic cell-cell adhesion in vitro.Development. 2002 Oct;129(20):4697-705. doi: 10.1242/dev.129.20.4697.
• [1109] Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.Genes Chromosomes Cancer. 2002 Oct;35(2):113-20. doi: 10.1002/gcc.10034.
• [1110] Specific alternative HOX11 transcripts are expressed in paediatric neural tumours and T-cell acute lymphoblastic leukaemia.Gene. 2003 Dec 24;323:89-99. doi: 10.1016/j.gene.2003.09.001.
• [1111] Induction of a VLA-2 (CD49b)-expressing effector T cell population by a cell-based neuroblastoma vaccine expressing CD137L.J Immunol. 2008 Oct 1;181(7):4621-31. doi: 10.4049/jimmunol.181.7.4621.
• [1112] Genes modulated by histone acetylation as new effectors of butyrate activity.FEBS Lett. 2001 Jun 22;499(3):199-204. doi: 10.1016/s0014-5793(01)02539-x.
• [1113] Expression of prosalusin in human neuroblastoma cells.Peptides. 2009 Jul;30(7):1362-7. doi: 10.1016/j.peptides.2009.03.021. Epub 2009 Apr 9.
• [1114] Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis.Int J Cancer. 2004 Nov 10;112(3):365-75. doi: 10.1002/ijc.20431.
• [1115] Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.Br J Cancer. 2006 Jun 19;94(12):1845-52. doi: 10.1038/sj.bjc.6603186. Epub 2006 May 23.
• [1116] Cell death induced by mitochondrial complex I inhibition is mediated by Iron Regulatory Protein 1.Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2202-2209. doi: 10.1016/j.bbadis.2017.05.015. Epub 2017 May 11.
• [1117] Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42(IP4) (centaurin 1; ADAP1) in neuroblastoma cells.Neurochem Int. 2011 Nov;59(6):936-44. doi: 10.1016/j.neuint.2011.07.004. Epub 2011 Jul 23.
• [1118] Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.Am J Surg Pathol. 2009 Sep;33(9):1416-20. doi: 10.1097/PAS.0b013e3181a9cd6c.
• [1119] Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases. FEBS J. 2005 Nov;272(22):5808-20. doi: 10.1111/j.1742-4658.2005.04976.x.
• [1120] p53 family members regulate the expression of the apolipoprotein D gene.J Biol Chem. 2009 Jan 9;284(2):872-83. doi: 10.1074/jbc.M807185200. Epub 2008 Nov 11.
• [1121] The Neuroprotective Effects of Brazilian Green Propolis on Neurodegenerative Damage in Human Neuronal SH-SY5Y Cells.Oxid Med Cell Longev. 2017;2017:7984327. doi: 10.1155/2017/7984327. Epub 2017 Feb 6.
• [1122] ARID1A gene knockdown promotes neuroblastoma migration and invasion.Neoplasma. 2017;64(3):367-376. doi: 10.4149/neo_2017_307.
• [1123] N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.EMBO J. 1993 Jan;12(1):195-200. doi: 10.1002/j.1460-2075.1993.tb05645.x.
• [1124] Second Reported Case of Pediatric Bladder Alveolar Soft Part Sarcoma as Secondary Malignancy After Prior Cytotoxic Chemotherapy.Urology. 2019 Aug;130:148-150. doi: 10.1016/j.urology.2019.04.002. Epub 2019 Apr 12.
• [1125] Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.Int J Cancer. 2019 Nov 15;145(10):2781-2791. doi: 10.1002/ijc.32361. Epub 2019 May 31.
• [1126] HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer's Disease Brain.Mol Neurobiol. 2017 Jan;54(1):188-199. doi: 10.1007/s12035-015-9644-x. Epub 2016 Jan 6.
• [1127] Bombesin induces angiogenesis and neuroblastoma growth.Cancer Lett. 2007 Aug 18;253(2):273-81. doi: 10.1016/j.canlet.2007.02.007. Epub 2007 Mar 26.
• [1128] Interactions between BIM Protein and Beta-Amyloid May Reveal a Crucial Missing Link between Alzheimer's Disease and Neuronal Cell Death.ACS Chem Neurosci. 2019 Aug 21;10(8):3555-3564. doi: 10.1021/acschemneuro.9b00177. Epub 2019 Jun 12.
• [1129] Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.Ann Diagn Pathol. 2018 Jun;34:1-12. doi: 10.1016/j.anndiagpath.2017.11.011. Epub 2017 Nov 29.
• [1130] CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells.Int J Mol Sci. 2019 Jan 1;20(1):131. doi: 10.3390/ijms20010131.
• [1131] Coexistence of neuroblastoma and ganglioneuroma in a girl with a hemizygous deletion of chromosome 11q14.1-23.3.Am J Med Genet A. 2016 Feb;170A(2):492-497. doi: 10.1002/ajmg.a.37430. Epub 2015 Oct 13.
• [1132] Identification of novel human tumor cell-specific CaMK-II variants.Biochim Biophys Acta. 1997 Mar 1;1355(3):281-92. doi: 10.1016/s0167-4889(96)00141-3.
• [1133] Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells.J Cell Biochem. 2019 Sep;120(9):15119-15130. doi: 10.1002/jcb.28774. Epub 2019 Apr 25.
• [1134] The potential role of CAMSAP1L1 in symptomatic epilepsy.Neurosci Lett. 2013 Nov 27;556:146-51. doi: 10.1016/j.neulet.2013.10.020. Epub 2013 Oct 20.
• [1135] CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.Cancer Res. 2011 Apr 15;71(8):3142-51. doi: 10.1158/0008-5472.CAN-10-3014. Epub 2011 Mar 8.
• [1136] Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.J Neuroimmunol. 1996 May;66(1-2):29-40. doi: 10.1016/0165-5728(96)00015-x.
• [1137] CDC174, a novel component of the exon junction complex whose mutation underlies a syndrome of hypotonia and psychomotor developmental delay. Hum Mol Genet. 2015 Nov 15;24(22):6485-91. doi: 10.1093/hmg/ddv357. Epub 2015 Sep 10.
• [1138] Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.Oncogene. 1995 Mar 16;10(6):1087-93.
• [1139] HNRNP Q suppresses polyglutamine huntingtin aggregation by post-transcriptional regulation of vaccinia-related kinase 2.J Neurochem. 2019 May;149(3):413-426. doi: 10.1111/jnc.14638. Epub 2019 Jan 4.
• [1140] MeHg affects the activation of FAK, Src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells.Toxicology. 2018 Feb 1;394:35-44. doi: 10.1016/j.tox.2017.11.019. Epub 2017 Nov 29.
• [1141] CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.Oncotarget. 2017 Mar 21;8(12):19768-19779. doi: 10.18632/oncotarget.15519.
• [1142] Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma.Nat Genet. 1994 Jul;7(3):370-5. doi: 10.1038/ng0794-370.
• [1143] CCAAT/enhancer binding protein is a transcriptional repressor of -synuclein.Cell Death Differ. 2020 Feb;27(2):509-524. doi: 10.1038/s41418-019-0368-8. Epub 2019 Jun 17.
• [1144] Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.Biochem J. 2001 May 1;355(Pt 3):715-24. doi: 10.1042/bj3550715.
• [1145] Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis.Epileptic Disord. 2016 Sep 1;18(S2):120-127. doi: 10.1684/epd.2016.0857.
• [1146] Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.Oncotarget. 2016 Mar 29;7(13):15977-85. doi: 10.18632/oncotarget.7434.
• [1147] CHL1 gene acts as a tumor suppressor in human neuroblastoma.Oncotarget. 2018 May 25;9(40):25903-25921. doi: 10.18632/oncotarget.25403. eCollection 2018 May 25.
• [1148] Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model.Clin Cancer Res. 2018 Jun 1;24(11):2585-2593. doi: 10.1158/1078-0432.CCR-17-3811. Epub 2018 Mar 7.
• [1149] Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma.Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7351-E7360. doi: 10.1073/pnas.1800039115. Epub 2018 Jul 18.
• [1150] Clozapine induces chloride channel-4 expression through PKA activation and modulates CDK5 expression in SH-SY5Y and U87 cells.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:168-73. doi: 10.1016/j.pnpbp.2014.09.002. Epub 2014 Sep 20.
• [1151] SV-Bay: structural variant detection in cancer genomes using a Bayesian approach with correction for GC-content and read mappability.Bioinformatics. 2016 Apr 1;32(7):984-92. doi: 10.1093/bioinformatics/btv751. Epub 2016 Jan 6.
• [1152] 9-cis-retinoic acid selectively activates the cellular retinoic acid binding protein-II gene in human neuroblastoma cells.Arch Biochem Biophys. 1995 Jun 1;319(2):457-63. doi: 10.1006/abbi.1995.1317.
• [1153] Regulation of CRABP-II expression by MycN in Wilms tumor.Exp Cell Res. 2008 Dec 10;314(20):3663-8. doi: 10.1016/j.yexcr.2008.09.029. Epub 2008 Oct 14.
• [1154] The role of CT10 regulation of kinase-like in cancer.Future Oncol. 2014 Dec;10(16):2687-97. doi: 10.2217/fon.14.199.
• [1155] Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.Mol Ther. 2018 Mar 7;26(3):755-773. doi: 10.1016/j.ymthe.2017.12.017. Epub 2017 Dec 22.
• [1156] Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer's disease.J Food Drug Anal. 2019 Apr;27(2):551-564. doi: 10.1016/j.jfda.2018.11.009. Epub 2019 Jan 12.
• [1157] Codon 201(Gly) polymorphic type of the DCC gene is related to disseminated neuroblastoma.Neoplasia. 2001 Jul-Aug;3(4):267-72. doi: 10.1038/sj.neo.7900169.
• [1158] Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration.Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26287. Epub 2016 Oct 12.
• [1159] Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib.Mol Neurobiol. 2019 Feb;56(2):1451-1460. doi: 10.1007/s12035-018-1133-6. Epub 2018 Jun 10.
• [1160] DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer.Cancer. 2012 Feb 15;118(4):888-98. doi: 10.1002/cncr.26352. Epub 2011 Jul 14.
• [1161] The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.Front Oncol. 2017 May 31;7:111. doi: 10.3389/fonc.2017.00111. eCollection 2017.
• [1162] C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.Mol Cancer. 2017 May 25;16(1):95. doi: 10.1186/s12943-017-0661-4.
• [1163] Rare MYC-amplified Neuroblastoma With Large Cell Histology.Pediatr Dev Pathol. 2018 Sep-Oct;21(5):461-466. doi: 10.1177/1093526617749670. Epub 2018 Feb 9.
• [1164] Targeting c-kit receptor in neuroblastomas and colorectal cancers using stem cell factor (SCF)-based recombinant bacterial toxins.Appl Microbiol Biotechnol. 2016 Jan;100(1):263-77. doi: 10.1007/s00253-015-6978-2. Epub 2015 Oct 1.
• [1165] Silencing of DMBT1 in neuroblastoma cell lines is not due to methylation of CCWGG motifs on its promoter.Neoplasma. 2006;53(1):15-8.
• [1166] TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.Nat Commun. 2018 Nov 19;9(1):4866. doi: 10.1038/s41467-018-06699-9.
• [1167] The atypical guanine nucleotide exchange factor Dock4 regulates neurite differentiation through modulation of Rac1 GTPase and actin dynamics.J Biol Chem. 2013 Jul 5;288(27):20034-45. doi: 10.1074/jbc.M113.458612. Epub 2013 May 17.
• [1168] Mutational dynamics between primary and relapse neuroblastomas.Nat Genet. 2015 Aug;47(8):872-7. doi: 10.1038/ng.3349. Epub 2015 Jun 29.
• [1169] Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma.Cancer Sci. 2013 Dec;104(12):1586-92. doi: 10.1111/cas.12278. Epub 2013 Oct 21.
• [1170] MYCN-induced E2F5 promotes neuroblastoma cell proliferation through regulating cell cycle progression.Biochem Biophys Res Commun. 2019 Mar 26;511(1):35-40. doi: 10.1016/j.bbrc.2019.01.087. Epub 2019 Feb 11.
• [1171] Cytogenetic analysis of primary neuroblastoma with del(1), del(14), hsr, and dmin chromosomes. Cancer Genet Cytogenet. 1991 Sep;55(2):231-4. doi: 10.1016/0165-4608(91)90082-6.
• [1172] Application of Serum ELAVL4 (HuD) Antigen Assay for Small Cell Lung Cancer Diagnosis.Anticancer Res. 2017 Aug;37(8):4515-4522. doi: 10.21873/anticanres.11848.
• [1173] Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.Exp Mol Pathol. 2013 Dec;95(3):313-8. doi: 10.1016/j.yexmp.2013.07.001. Epub 2013 Aug 3.
• [1174] Cloning of human ENC-1 and evaluation of its expression and regulation in nervous system tumors.Exp Cell Res. 1998 Aug 1;242(2):470-7. doi: 10.1006/excr.1998.4109.
• [1175] 5-HT1B and other related serotonergic proteins are altered in APPswe mutation. Neurosci Lett. 2015 May 6;594:137-43.
• [1176] Dynamic and selective HERV RNA expression in neuroblastoma cells subjected to variation in oxygen tension and demethylation.APMIS. 2016 Jan-Feb;124(1-2):140-9. doi: 10.1111/apm.12494.
• [1177] FAM163A, a positive regulator of ERK signaling pathway, interacts with 14-3-3 and promotes cell proliferation in squamous cell lung carcinoma.Onco Targets Ther. 2019 Aug 13;12:6393-6406. doi: 10.2147/OTT.S214731. eCollection 2019.
• [1178] Over-expression of CLN3P, the Batten disease protein, inhibits PANDER-induced apoptosis in neuroblastoma cells: further evidence that CLN3P has anti-apoptotic properties.Mol Genet Metab. 2006 Jun;88(2):178-83. doi: 10.1016/j.ymgme.2006.01.011. Epub 2006 Mar 3.
• [1179] Oxidative Stress Regulated Iron Regulatory Protein IRP2 Through FBXL5-Mediated Ubiquitination-Proteasome Way in SH-SY5Y Cells.Front Neurosci. 2019 Jan 29;13:20. doi: 10.3389/fnins.2019.00020. eCollection 2019.
• [1180] A rational approach to genetic testing for sarcoma.Diagn Mol Pathol. 2009 Mar;18(1):1-10. doi: 10.1097/PDM.0b013e318181fa05.
• [1181] A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.Oncogene. 2020 Jan;39(5):1080-1097. doi: 10.1038/s41388-019-1044-7. Epub 2019 Oct 7.
• [1182] Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.Oncogene. 2012 Mar 22;31(12):1571-81. doi: 10.1038/onc.2011.344. Epub 2011 Aug 22.
• [1183] Stable cell lines of human SH-SY5Y uniformly expressing wild-type or mutant-type FERM domain containing 7 gene.Exp Ther Med. 2017 Sep;14(3):2277-2283. doi: 10.3892/etm.2017.4730. Epub 2017 Jul 9.
• [1184] Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.Blood. 2008 Apr 1;111(7):3802-12. doi: 10.1182/blood-2007-07-096065. Epub 2008 Jan 14.
• [1185] FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.J Exp Clin Cancer Res. 2019 Sep 11;38(1):400. doi: 10.1186/s13046-019-1414-6.
• [1186] Chlorpyrifos activates cell pyroptosis and increases susceptibility on oxidative stress-induced toxicity by miR-181/SIRT1/PGC-1/Nrf2 signaling pathway in human neuroblastoma SH-SY5Y cells: Implication for association between chlorpyrifos and Parkinson's disease. Environ Toxicol. 2019 Jun;34(6):699-707. doi: 10.1002/tox.22736. Epub 2019 Mar 5.
• [1187] GALNT9 gene expression is a prognostic marker in neuroblastoma patients.Clin Chem. 2013 Jan;59(1):225-33. doi: 10.1373/clinchem.2012.192328. Epub 2012 Nov 7.
• [1188] CMT-linked loss-of-function mutations in GDAP1 impair store-operated Ca(2+) entry-stimulated respiration.Sci Rep. 2017 Feb 21;7:42993. doi: 10.1038/srep42993.
• [1189] miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.Mol Oncol. 2020 Jan;14(1):180-196. doi: 10.1002/1878-0261.12588. Epub 2019 Nov 29.
• [1190] Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry.Nat Genet. 2018 Sep;50(9):1240-1246. doi: 10.1038/s41588-018-0191-z. Epub 2018 Aug 20.
• [1191] Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.Hum Mol Genet. 2015 Mar 1;24(5):1441-56. doi: 10.1093/hmg/ddu561. Epub 2014 Dec 5.
• [1192] Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.PLoS Biol. 2018 May 11;16(5):e2002912. doi: 10.1371/journal.pbio.2002912. eCollection 2018 May.
• [1193] HFE genotype affects exosome phenotype in cancer.Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):1921-1928. doi: 10.1016/j.bbagen.2017.05.014. Epub 2017 May 17.
• [1194] Altering the expression balance of hnRNP C1 and C2 changes the expression of myelination-related genes.Psychiatry Res. 2011 Dec 30;190(2-3):364-6. doi: 10.1016/j.psychres.2011.05.043.
• [1195] Long Noncoding RNA pancEts-1 Promotes Neuroblastoma Progression through hnRNPK-Mediated -Catenin Stabilization.Cancer Res. 2018 Mar 1;78(5):1169-1183. doi: 10.1158/0008-5472.CAN-17-2295. Epub 2018 Jan 8.
• [1196] Modulation of HOX2 gene expression following differentiation of neuronal cell lines.Differentiation. 1992 Sep;51(1):39-47. doi: 10.1111/j.1432-0436.1992.tb00678.x.
• [1197] HOXB5 binds to multi-species conserved sequence (MCS+9.7) of RET gene and regulates RET expression.Int J Biochem Cell Biol. 2014 Jun;51:142-9. doi: 10.1016/j.biocel.2014.04.013. Epub 2014 Apr 29.
• [1198] Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.Anticancer Drugs. 2019 Feb;30(2):117-127. doi: 10.1097/CAD.0000000000000696.
• [1199] The phosphorylation of Hsp20 enhances its association with amyloid- to increase protection against neuronal cell death.Mol Cell Neurosci. 2014 Jul;61:46-55. doi: 10.1016/j.mcn.2014.05.002. Epub 2014 May 20.
• [1200] Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal development.EMBO J. 1992 Jul;11(7):2563-71. doi: 10.1002/j.1460-2075.1992.tb05321.x.
• [1201] Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression.Oncoimmunology. 2017 Apr 28;6(6):e1320626. doi: 10.1080/2162402X.2017.1320626. eCollection 2017.
• [1202] Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.Cell Mol Life Sci. 2019 Jun;76(11):2231-2243. doi: 10.1007/s00018-019-03041-4. Epub 2019 Feb 15.
• [1203] Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines.J Biol Chem. 1998 Aug 14;273(33):21161-8. doi: 10.1074/jbc.273.33.21161.
• [1204] Differential expression of MARCKS and other calmodulin-binding protein kinase C substrates in cultured neuroblastoma and glioma cells.J Neurochem. 1994 Dec;63(6):2314-23. doi: 10.1046/j.1471-4159.1994.63062314.x.
• [1205] Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells.J Neuroimmunol. 1995 Dec 31;63(2):157-62. doi: 10.1016/0165-5728(95)00140-9.
• [1206] ASPP2 Plays a Dual Role in gp120-Induced Autophagy and Apoptosis of Neuroblastoma Cells.Front Neurosci. 2017 Mar 24;11:150. doi: 10.3389/fnins.2017.00150. eCollection 2017.
• [1207] Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.Exp Cell Res. 2013 Mar 10;319(5):660-9. doi: 10.1016/j.yexcr.2012.12.027. Epub 2013 Jan 16.
• [1208] Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid- accumulation modifier.Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2638-43. doi: 10.1073/pnas.1307345111. Epub 2014 Feb 4.
• [1209] Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells.J Cell Physiol. 2006 Jun;207(3):711-21. doi: 10.1002/jcp.20627.
• [1210] LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer's disease.Mol Neurodegener. 2012 Jun 26;7:31. doi: 10.1186/1750-1326-7-31.
• [1211] A cDNA encoding a putative 37 kDa leucine-rich repeat (LRR) protein, p37NB, isolated from S-type neuroblastoma cell has a differential tissue distribution.Biochim Biophys Acta. 1996 Dec 11;1309(3):183-8. doi: 10.1016/s0167-4781(96)00158-3.
• [1212] MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma.Biochim Biophys Acta Gene Regul Mech. 2018 Mar;1861(3):235-245. doi: 10.1016/j.bbagrm.2018.01.007. Epub 2018 Feb 3.
• [1213] NaV1.6 and NaV1.7 channels are major endogenous voltage-gated sodium channels in ND7/23 cells.PLoS One. 2019 Aug 16;14(8):e0221156. doi: 10.1371/journal.pone.0221156. eCollection 2019.
• [1214] A novel, semi-synthetic diterpenoid 16(R and S)-phenylamino-cleroda-3,13(14), Z-dien-15,16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway.Mol Cell Biochem. 2018 Dec;449(1-2):105-115. doi: 10.1007/s11010-018-3347-3. Epub 2018 Apr 11.
• [1215] Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastoma.Mol Carcinog. 2017 Apr;56(4):1290-1301. doi: 10.1002/mc.22591. Epub 2016 Nov 29.
• [1216] Mitofusin-2 regulates inflammation-mediated mouse neuroblastoma N2a cells dysfunction and endoplasmic reticulum stress via the Yap-Hippo pathway.J Physiol Sci. 2019 Sep;69(5):697-709. doi: 10.1007/s12576-019-00685-6. Epub 2019 May 27.
• [1217] Novel protein pp3501 mediates the inhibitory effect of sodium butyrate on SH-SY5Y cell proliferation.J Cell Biochem. 2012 Aug;113(8):2696-703. doi: 10.1002/jcb.24145.
• [1218] Detection of c-mos proto-oncogene expression in human cells.Oncogene. 1993 Jun;8(6):1685-91.
• [1219] The long noncoding RNA HOTAIR promotes Parkinson's disease by upregulating LRRK2 expression.Oncotarget. 2017 Apr 11;8(15):24449-24456. doi: 10.18632/oncotarget.15511.
• [1220] MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.Nanomedicine. 2020 Feb;24:102127. doi: 10.1016/j.nano.2019.102127. Epub 2019 Nov 26.
• [1221] Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.Oncogene. 1990 Dec;5(12):1821-7.
• [1222] Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers.Genes Chromosomes Cancer. 1996 Dec;17(4):205-14. doi: 10.1002/(SICI)1098-2264(199612)17:4<205::AID-GCC2>3.0.CO;2-7.
• [1223] Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.Genes Chromosomes Cancer. 2013 Feb;52(2):191-201. doi: 10.1002/gcc.22019. Epub 2012 Oct 25.
• [1224] Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfecta. Bone. 2017 Jan;94:65-74. doi: 10.1016/j.bone.2016.10.023. Epub 2016 Oct 24.
• [1225] Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults.Nat Commun. 2016 Mar 14;7:10943. doi: 10.1038/ncomms10943.
• [1226] Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2.PLoS One. 2007 Sep 5;2(9):e817. doi: 10.1371/journal.pone.0000817.
• [1227] The Netrin-4/Laminin 1/Neogenin-1 complex mediates migration in SK-N-SH neuroblastoma cells.Cell Adh Migr. 2019 Dec;13(1):33-40. doi: 10.1080/19336918.2018.1506652. Epub 2018 Aug 30.
• [1228] Sialidase NEU4 is involved in glioblastoma stem cell survival.Cell Death Dis. 2014 Aug 21;5(8):e1381. doi: 10.1038/cddis.2014.349.
• [1229] 8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and SW620 metastatic colon cancer cells.J Ethnopharmacol. 2017 Jul 31;207:19-29. doi: 10.1016/j.jep.2017.06.010. Epub 2017 Jun 13.
• [1230] High expressions of neuronatin isoforms in favorable neuroblastoma. J Pediatr Hematol Oncol. 2007 Aug;29(8):551-6. doi: 10.1097/MPH.0b013e3181256b7b.
• [1231] Disabled-1 alternative splicing in human fetal retina and neural tumors.PLoS One. 2011;6(12):e28579. doi: 10.1371/journal.pone.0028579. Epub 2011 Dec 6.
• [1232] Tributyltin induces epigenetic changes and decreases the expression of nuclear respiratory factor-1.Metallomics. 2018 Feb 21;10(2):337-345. doi: 10.1039/c7mt00290d.
• [1233] The nuclear cofactor receptor interacting protein-140 (RIP140) regulates the expression of genes involved in A generation.Neurobiol Aging. 2016 Nov;47:180-191. doi: 10.1016/j.neurobiolaging.2016.08.003. Epub 2016 Aug 12.
• [1234] Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.PLoS One. 2018 Dec 7;13(12):e0208924. doi: 10.1371/journal.pone.0208924. eCollection 2018.
• [1235] High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts.Cancer Gene Ther. 2003 Nov;10(11):859-66. doi: 10.1038/sj.cgt.7700639.
• [1236] Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders.Neuropsychopharmacology. 2017 Sep;42(10):2064-2071. doi: 10.1038/npp.2017.76. Epub 2017 Apr 27.
• [1237] Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.Cancer Res. 2019 Nov 1;79(21):5652-5667. doi: 10.1158/0008-5472.CAN-19-1112. Epub 2019 Sep 9.
• [1238] Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.Int J Cancer. 2006 Apr 15;118(8):1945-53. doi: 10.1002/ijc.21584.
• [1239] Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.Cancer Res. 2017 Jan 15;77(2):509-519. doi: 10.1158/0008-5472.CAN-16-1106. Epub 2017 Jan 9.
• [1240] PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.Cerebellum. 2009 Jun;8(2):98-103. doi: 10.1007/s12311-008-0087-z. Epub 2008 Dec 23.
• [1241] Taking a holistic view of PEST-containing nuclear protein (PCNP) in cancer biology.Cancer Med. 2019 Oct;8(14):6335-6343. doi: 10.1002/cam4.2465. Epub 2019 Sep 5.
• [1242] PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease.Biochim Biophys Acta. 2014 Jun;1840(6):1686-700. doi: 10.1016/j.bbagen.2014.01.004. Epub 2014 Jan 8.
• [1243] Key role for enkephalinergic tone in cortico-striatal-thalamic function.Eur J Neurosci. 2002 Nov;16(9):1819-22. doi: 10.1046/j.1460-9568.2002.02240.x.
• [1244] Influence of hypoxia-dependent factors on the progression of neuroblastoma.Pediatr Surg Int. 2016 Feb;32(2):187-92. doi: 10.1007/s00383-015-3831-8. Epub 2015 Oct 28.
• [1245] Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors.Hum Mol Genet. 2000 Mar 22;9(5):757-63. doi: 10.1093/hmg/9.5.757.
• [1246] cDNA cloning of a novel trypsin inhibitor with similarity to pathogenesis-related proteins, and its frequent expression in human brain cancer cells.Biochim Biophys Acta. 1998 Jan 21;1395(2):202-8. doi: 10.1016/s0167-4781(97)00149-8.
• [1247] PINK1-dependent mitophagy is driven by the UPS and can occur independently of LC3 conversion.Cell Death Differ. 2019 Aug;26(8):1428-1441. doi: 10.1038/s41418-018-0219-z. Epub 2018 Oct 30.
• [1248] Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.Int J Cancer. 1995 Jan 17;60(2):216-20. doi: 10.1002/ijc.2910600215.
• [1249] PIWI-interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells.J Cell Physiol. 2020 Mar;235(3):2286-2299. doi: 10.1002/jcp.29136. Epub 2019 Sep 3.
• [1250] The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. J Biol Chem. 2010 Mar 5;285(10):6904-12. doi: 10.1074/jbc.M109.038331. Epub 2010 Jan 5.
• [1251] Expression of melanin-concentrating hormone receptor messenger ribonucleic acid in tumor tissues of pheochromocytoma, ganglioneuroblastoma, and neuroblastoma.J Clin Endocrinol Metab. 2001 Jan;86(1):369-74. doi: 10.1210/jcem.86.1.7158.
• [1252] The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells.BMC Complement Altern Med. 2018 Jan 10;18(1):9. doi: 10.1186/s12906-017-2065-9.
• [1253] EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A.Oncogene. 2010 May 27;29(21):3134-45. doi: 10.1038/onc.2010.72. Epub 2010 Mar 29.
• [1254] Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells.Oncogene. 2008 Jan 3;27(1):145-54. doi: 10.1038/sj.onc.1210621. Epub 2007 Jul 16.
• [1255] Neurokinin-immunoreactivity in human neuroblastomas. Evidence for selective expression of the preprotachykinin (PPT) II gene.FEBS Lett. 1990 Dec 17;277(1-2):83-7. doi: 10.1016/0014-5793(90)80814-y.
• [1256] Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma.BMC Cancer. 2016 Mar 31;16:259. doi: 10.1186/s12885-016-2293-2.
• [1257] Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.Transl Oncol. 2019 Jan;12(1):84-95. doi: 10.1016/j.tranon.2018.09.011. Epub 2018 Oct 1.
• [1258] FAK-Src-paxillin system expression and disease outcome in human neuroblastoma.Pediatr Hematol Oncol. 2017 May;34(4):221-230. doi: 10.1080/08880018.2017.1360969. Epub 2017 Oct 17.
• [1259] Amyloid beta protein-related death-inducing protein induces G2/M arrest: Implications for neurodegeneration in Alzheimer's disease. J Neurosci Res. 2007 Aug 1;85(10):2262-71. doi: 10.1002/jnr.21351.
• [1260] Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.Nature. 2015 Dec 17;528(7582):418-21. doi: 10.1038/nature15540. Epub 2015 Nov 11.
• [1261] MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.Biochimie. 2017 Aug;139:1-8. doi: 10.1016/j.biochi.2017.04.011. Epub 2017 Apr 27.
• [1262] RAN/RANBP2 polymorphisms and neuroblastoma risk in Chinese children: a three-center case-control study.Aging (Albany NY). 2018 Apr 28;10(4):808-818. doi: 10.18632/aging.101429.
• [1263] Cold Shock Induced Protein RBM3 but Not Mild Hypothermia Protects Human SH-SY5Y Neuroblastoma Cells From MPP(+)-Induced Neurotoxicity.Front Neurosci. 2018 May 3;12:298. doi: 10.3389/fnins.2018.00298. eCollection 2018.
• [1264] The regulator of calcineurin 1 increases adenine nucleotide translocator 1 and leads to mitochondrial dysfunctions.J Neurochem. 2017 Jan;140(2):307-319. doi: 10.1111/jnc.13900. Epub 2016 Dec 20.
• [1265] Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights.Sci Rep. 2017 Oct 13;7(1):13154. doi: 10.1038/s41598-017-13337-9.
• [1266] The REST gene signature predicts drug sensitivity in neuroblastoma cell lines and is significantly associated with neuroblastoma tumor stage.Int J Mol Sci. 2014 Jun 25;15(7):11220-33. doi: 10.3390/ijms150711220.
• [1267] RFC-1 80G>A polymorphism in case-mother/control-mother dyads is associated with risk of nephroblastoma and neuroblastoma.Genet Test Mol Biomarkers. 2015 Feb;19(2):75-81. doi: 10.1089/gtmb.2014.0177. Epub 2014 Dec 23.
• [1268] Alterations in metabolism-related genes induced in SHSY5Y cells by okadaic acid exposure. J Toxicol Environ Health A. 2012;75(13-15):844-56. doi: 10.1080/15287394.2012.690703.
• [1269] Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.J Biol Chem. 2014 May 23;289(21):14569-82. doi: 10.1074/jbc.M114.563031. Epub 2014 Mar 26.
• [1270] Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library.Int J Cancer. 2002 Aug 20;100(6):669-77. doi: 10.1002/ijc.10550.
• [1271] Expression of mdr1/P-glycoprotein and p110 in neuroblastoma.J Pathol. 1995 Jan;175(1):13-22. doi: 10.1002/path.1711750104.
• [1272] SCAPER localizes to primary cilia and its mutation affects cilia length, causing Bardet-Biedl syndrome. Eur J Hum Genet. 2019 Jun;27(6):928-940. doi: 10.1038/s41431-019-0347-z. Epub 2019 Feb 5.
• [1273] High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene. Cancer Genet Cytogenet. 2007 Apr 15;174(2):100-10. doi: 10.1016/j.cancergencyto.2006.11.017.
• [1274] A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.Cell Death Differ. 2018 Dec;25(12):2053-2070. doi: 10.1038/s41418-018-0080-0. Epub 2018 Mar 7.
• [1275] Inhibitors of urokinase and thrombin in cultured neural cells.J Neurochem. 1991 Jan;56(1):234-42. doi: 10.1111/j.1471-4159.1991.tb02586.x.
• [1276] Sestrin2 as Serum Protein Marker and Potential Therapeutic Target for Parkinson's Disease.J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):690-695. doi: 10.1093/gerona/glz234.
• [1277] Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.Cancer Res. 2009 Jan 15;69(2):547-53. doi: 10.1158/0008-5472.CAN-08-2968.
• [1278] Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression.Clin Cancer Res. 2015 Mar 1;21(5):1139-50. doi: 10.1158/1078-0432.CCR-14-1882.
• [1279] Induction of 2.5 OAS gene expression and activity is not sufficient for IFN-gamma-induced neuroblastoma cell differentiation.Int J Cancer. 1995 Jul 17;62(2):223-9. doi: 10.1002/ijc.2910620219.
• [1280] Synphilin-1 has neuroprotective effects on MPP(+)-induced Parkinson's disease model cells by inhibiting ROS production and apoptosis.Neurosci Lett. 2019 Jan 18;690:145-150. doi: 10.1016/j.neulet.2018.10.020. Epub 2018 Oct 11.
• [1281] Different expression levels of spartin cause broad spectrum of cellular consequences in human neuroblastoma cells.Cell Biol Int. 2015 Sep;39(9):1007-15. doi: 10.1002/cbin.10472. Epub 2015 May 8.
• [1282] MAP2 Splicing is Altered in Huntington's Disease.Brain Pathol. 2017 Mar;27(2):181-189. doi: 10.1111/bpa.12387. Epub 2016 Jul 7.
• [1283] Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase.Molecules. 2012 Aug 10;17(8):9559-72. doi: 10.3390/molecules17089559.
• [1284] IKAP/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia.Hum Mol Genet. 2011 Apr 15;20(8):1585-94. doi: 10.1093/hmg/ddr036. Epub 2011 Jan 27.
• [1285] Hypomorphic Pathogenic Variants in TAF13 Are Associated with Autosomal-Recessive Intellectual Disability and Microcephaly. Am J Hum Genet. 2017 Mar 2;100(3):555-561. doi: 10.1016/j.ajhg.2017.01.032.
• [1286] Synthetic high-density lipoprotein nanoconjugate targets neuroblastoma stem cells, blocking migration and self-renewal.Surgery. 2018 May 9:S0039-6060(18)30080-1. doi: 10.1016/j.surg.2018.01.023. Online ahead of print.
• [1287] Depletion of TFAP2E attenuates adriamycin-mediated apoptosis in human neuroblastoma cells.Oncol Rep. 2017 Apr;37(4):2459-2464. doi: 10.3892/or.2017.5477. Epub 2017 Feb 24.
• [1288] Type III TGF- receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.J Clin Invest. 2013 Nov;123(11):4786-98. doi: 10.1172/JCI69657.
• [1289] Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene.Cancer Gene Ther. 2001 Dec;8(12):997-1002. doi: 10.1038/sj.cgt.7700408.
• [1290] Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes.J Mol Neurosci. 1990;2(2):79-84. doi: 10.1007/BF02876914.
• [1291] Knockdown of TNFAIP1 prevents di-(2-ethylhexyl) phthalate-induced neurotoxicity by activating CREB pathway.Chemosphere. 2020 Feb;241:125114. doi: 10.1016/j.chemosphere.2019.125114. Epub 2019 Oct 14.
• [1292] TP53BP2 decreases cell proliferation and induces autophagy in neuroblastoma cell lines.Oncol Lett. 2019 Jun;17(6):4976-4984. doi: 10.3892/ol.2019.10148. Epub 2019 Mar 15.
• [1293] Downregulation of microRNA-3934-5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1.Exp Ther Med. 2019 Nov;18(5):3729-3736. doi: 10.3892/etm.2019.8007. Epub 2019 Sep 13.
• [1294] TRIM proteins in neuroblastoma.Biosci Rep. 2019 Dec 20;39(12):BSR20192050. doi: 10.1042/BSR20192050.
• [1295] Involvement of C/EBP-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis. Toxicol Lett. 2019 Sep 15;312:11-21. doi: 10.1016/j.toxlet.2019.05.003. Epub 2019 May 3.
• [1296] High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.Cancer Lett. 2016 May 1;374(2):315-23. doi: 10.1016/j.canlet.2016.02.021. Epub 2016 Feb 20.
• [1297] TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription.J Cell Sci. 2011 Oct 15;124(Pt 20):3492-502. doi: 10.1242/jcs.088799. Epub 2011 Oct 7.
• [1298] Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.Biochim Biophys Acta Mol Cell Res. 2017 Jan;1864(1):217-230. doi: 10.1016/j.bbamcr.2016.11.003. Epub 2016 Nov 3.
• [1299] The regulation of tetraspanin 8 gene expression-A potential new mechanism in the pathogenesis of bipolar disorder.Am J Med Genet B Neuropsychiatr Genet. 2017 Oct;174(7):740-750. doi: 10.1002/ajmg.b.32571. Epub 2017 Aug 4.
• [1300] Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.Genome Biol. 2012 Oct 3;13(10):R95. doi: 10.1186/gb-2012-13-10-r95.
• [1301] New Targets for Parkinson's Disease: Adhesion G Protein-Coupled Receptor B1 is Downregulated by AMP-Activated Protein Kinase Activation.OMICS. 2018 Jul;22(7):493-501. doi: 10.1089/omi.2018.0047.
• [1302] AMBRA1-Mediated Mitophagy Counteracts Oxidative Stress and Apoptosis Induced by Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells.Front Cell Neurosci. 2018 Apr 18;12:92. doi: 10.3389/fncel.2018.00092. eCollection 2018.
• [1303] AlphaII-spectrin participates in the surface expression of cell adhesion molecule L1 and neurite outgrowth.Exp Cell Res. 2014 Apr 1;322(2):365-80. doi: 10.1016/j.yexcr.2014.01.012. Epub 2014 Jan 24.
• [1304] Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.Hum Mol Genet. 2015 Aug 15;24(16):4516-29. doi: 10.1093/hmg/ddv183. Epub 2015 May 14.
• [1305] LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.Biochim Biophys Acta. 2013 Dec;1832(12):2352-67. doi: 10.1016/j.bbadis.2013.09.009. Epub 2013 Sep 24.
• [1306] Estrogen receptor regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.Cell Death Dis. 2015 Jul 9;6(7):e1812. doi: 10.1038/cddis.2015.181.
• [1307] Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration.Gene. 2013 May 25;521(1):62-8. doi: 10.1016/j.gene.2013.03.029. Epub 2013 Mar 21.
• [1308] The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma.Dis Markers. 2019 Aug 6;2019:1342161. doi: 10.1155/2019/1342161. eCollection 2019.
• [1309] Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.Pediatr Res. 2002 Aug;52(2):279-85. doi: 10.1203/00006450-200208000-00022.
• [1310] Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma.Clin Cancer Res. 2015 Nov 15;21(22):5100-9. doi: 10.1158/1078-0432.CCR-15-0313. Epub 2015 Jul 22.
• [1311] Genome-wide pathway analysis in neuroblastoma.Tumour Biol. 2014 Apr;35(4):3471-85. doi: 10.1007/s13277-013-1459-7. Epub 2013 Nov 30.
• [1312] Human nucleoside diphosphate kinase B (Nm23-H2) from melanoma cells shows altered phosphoryl transfer activity due to the S122P mutation.J Biol Chem. 1999 Jul 16;274(29):20159-64. doi: 10.1074/jbc.274.29.20159.
• [1313] A schizophrenia associated CMYA5 allele displays differential binding with desmin.J Psychiatr Res. 2019 Apr;111:8-15. doi: 10.1016/j.jpsychires.2019.01.007. Epub 2019 Jan 10.
• [1314] U18666A, an activator of sterol regulatory element binding protein pathway, modulates presynaptic dopaminergic phenotype of SH-SY5Y neuroblastoma cells.Synapse. 2017 Sep;71(9). doi: 10.1002/syn.21980. Epub 2017 Jun 20.
• [1315] Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.Clin Cancer Res. 2004 Dec 15;10(24):8493-500. doi: 10.1158/1078-0432.CCR-04-1331.
• [1316] Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma.Eur J Cancer. 2007 Feb;43(3):607-16. doi: 10.1016/j.ejca.2006.09.023. Epub 2007 Jan 11.
• [1317] Integrative bioinformatics analysis characterizing the role of EDC3 in mRNA decay and its association to intellectual disability.BMC Med Genomics. 2018 Apr 23;11(1):41. doi: 10.1186/s12920-018-0358-6.
• [1318] MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.Mol Cancer. 2013 Mar 26;12:23. doi: 10.1186/1476-4598-12-23.
• [1319] Elk-1 interacts with neuronal microtubules and relocalizes to the nucleus upon phosphorylation.Mol Cell Neurosci. 2009 Jan;40(1):111-9. doi: 10.1016/j.mcn.2008.10.004. Epub 2008 Oct 28.
• [1320] Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.BMC Cancer. 2005 Dec 16;5:161. doi: 10.1186/1471-2407-5-161.
• [1321] Generation of a novel live rabies vaccine strain with a high level of safety by introducing attenuating mutations in the nucleoprotein and glycoprotein.Vaccine. 2017 Oct 9;35(42):5622-5628. doi: 10.1016/j.vaccine.2017.08.050. Epub 2017 Sep 4.
• [1322] Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.BMC Cancer. 2010 Jun 14;10:286. doi: 10.1186/1471-2407-10-286.
• [1323] Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation.PLoS One. 2012;7(8):e40728. doi: 10.1371/journal.pone.0040728. Epub 2012 Aug 7.
• [1324] Ifit2 Is a Restriction Factor in Rabies Virus Pathogenicity.J Virol. 2017 Aug 10;91(17):e00889-17. doi: 10.1128/JVI.00889-17. Print 2017 Sep 1.
• [1325] Coexpression of insulin receptor-related receptor and insulin-like growth factor 1 receptor correlates with enhanced apoptosis and dedifferentiation in human neuroblastomas.Clin Cancer Res. 2003 Nov 15;9(15):5683-92.
• [1326] Presenilin-1 holoprotein is an interacting partner of sarco endoplasmic reticulum calcium-ATPase and confers resistance to endoplasmic reticulum stress.J Alzheimers Dis. 2010;20(1):261-73. doi: 10.3233/JAD-2010-1360.
• [1327] A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.Cancer Res. 2012 May 1;72(9):2228-38. doi: 10.1158/0008-5472.CAN-11-2165. Epub 2012 Mar 2.
• [1328] LMO4 is an essential cofactor in the Snail2-mediated epithelial-to-mesenchymal transition of neuroblastoma and neural crest cells.J Neurosci. 2013 Feb 13;33(7):2773-83. doi: 10.1523/JNEUROSCI.4511-12.2013.
• [1329] NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo.Cancer Res. 2012 Sep 1;72(17):4587-96. doi: 10.1158/0008-5472.CAN-12-0943. Epub 2012 Jul 19.
• [1330] Intracellular fragment of NLRR3 (NLRR3-ICD) stimulates ATRA-dependent neuroblastoma differentiation.Biochem Biophys Res Commun. 2014 Oct 10;453(1):86-93. doi: 10.1016/j.bbrc.2014.09.065. Epub 2014 Sep 23.
• [1331] Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene.Cancer Res. 2008 Sep 15;68(18):7352-61. doi: 10.1158/0008-5472.CAN-07-6311.
• [1332] Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma.Int J Oncol. 2008 Mar;32(3):619-23.
• [1333] N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.Neoplasia. 2013 Dec;15(12):1363-70. doi: 10.1593/neo.11606.
• [1334] Nuclear matrix protein (NRP/B) modulates the nuclear factor (Erythroid-derived 2)-related 2 (NRF2)-dependent oxidative stress response.J Biol Chem. 2010 Aug 20;285(34):26190-8. doi: 10.1074/jbc.M109.095786. Epub 2010 May 28.
• [1335] Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes.Oncotarget. 2017 Nov 15;8(63):106296-106310. doi: 10.18632/oncotarget.22435. eCollection 2017 Dec 5.
• [1336] Changes in cholesterol metabolism are associated with PS1 and PS2 gene regulation in SK-N-BE.J Mol Neurosci. 2006;30(3):311-22. doi: 10.1385/JMN:30:3:311.
• [1337] Common genetic variants in NEFL influence gene expression and neuroblastoma risk.Cancer Res. 2014 Dec 1;74(23):6913-24. doi: 10.1158/0008-5472.CAN-14-0431. Epub 2014 Oct 13.
• [1338] Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors.Lab Invest. 1999 Dec;79(12):1461-7.
• [1339] Low-cost dedicated mini-arrays for high-throughput analysis of DNA copy-number alterations in neuroblastoma.Cancer Lett. 2008 Sep 28;269(1):111-6. doi: 10.1016/j.canlet.2008.04.031. Epub 2008 Jun 13.
• [1340] Ethanol induces cell cycle arrest and triggers apoptosis via Sp1-dependent p75NTR expression in human neuroblastoma cells.Cell Biol Toxicol. 2013 Oct;29(5):365-80. doi: 10.1007/s10565-013-9260-3. Epub 2013 Sep 12.
• [1341] VIP gene transcription is regulated by far upstream enhancer and repressor elements.Biochem Biophys Res Commun. 2001 Jun 1;284(1):211-8. doi: 10.1006/bbrc.2001.4948.
• [1342] PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.Int J Oncol. 2013 Apr;42(4):1408-16. doi: 10.3892/ijo.2013.1836. Epub 2013 Feb 21.
• [1343] Prox1 suppresses the proliferation of neuroblastoma cells via a dual action in p27-Kip1 and Cdc25A.Oncogene. 2013 Feb 21;32(8):947-60. doi: 10.1038/onc.2012.129. Epub 2012 Apr 16.
• [1344] Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction.Sci Rep. 2013;3:1351. doi: 10.1038/srep01351.
• [1345] Aberrant splicing of the PTPRD gene mimics microdeletions identified at this locus in neuroblastomas.Genes Chromosomes Cancer. 2008 Mar;47(3):197-202. doi: 10.1002/gcc.20521.
• [1346] Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins.J Biol Chem. 2001 Mar 23;276(12):9460-7. doi: 10.1074/jbc.M008744200. Epub 2000 Dec 19.
• [1347] Alpha-parvalbumin reduces depolarization-induced elevations of cytosolic free calcium in human neuroblastoma cells.Cell Calcium. 1996 Jun;19(6):527-33. doi: 10.1016/s0143-4160(96)90062-7.
• [1348] LncRNA SNHG1 promotes -synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.Neurotoxicology. 2018 Sep;68:212-221. doi: 10.1016/j.neuro.2017.12.001. Epub 2017 Dec 5.
• [1349] Effects of intronic single nucleotide polymorphisms (iSNPs) of a polysialyltransferase, ST8SIA2 gene found in psychiatric disorders on its gene products.Biochem Biophys Res Commun. 2016 Sep 23;478(3):1123-9. doi: 10.1016/j.bbrc.2016.08.079. Epub 2016 Aug 24.
• [1350] Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.Free Radic Biol Med. 2014 Apr;69:136-44. doi: 10.1016/j.freeradbiomed.2013.12.025. Epub 2014 Jan 27.
• [1351] Retinoids and a retinoic acid receptor differentially modulate thymosin beta 10 gene expression in transfected neuroblastoma cells.Cell Mol Neurobiol. 1992 Feb;12(1):45-58. doi: 10.1007/BF00711638.
• [1352] Functional and profiling studies prove that prostate cancer upregulated neuroblastoma thymosin beta is the true human homologue of rat thymosin beta15.FEBS Lett. 2007 Oct 16;581(25):4809-15. doi: 10.1016/j.febslet.2007.09.003. Epub 2007 Sep 12.